document type sequence filename description text html head head body bgcolor ffffff link blue vlink purple style font family time roman style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align right style margin text align right font size face time roman style font size font weight bold exhibit nbsp font align right style margin text align right font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold collaboration license agreement font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size this collaboration license agreement style font weight bold agreement made entered into november nbsp style font weight bold execution date between geron corporation delaware corporation with office commonwealth drive menlo park california style font weight bold geron janssen biotech nbsp pennsylvania corporation with office ridgeview drive horsham pennsylvania style font weight bold janssen geron janssen time referred herein collectively style font weight bold party individually style font weight bold party font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold background recital font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size whereas geron company having considerable knowledge experience discovering researching developing telomerase inhibitor been developing proprietary drug candidate imetelstat also known treating certain hematologic myeloid malignancy owns otherwise control certain patent right know other right related imetelstat font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size whereas janssen considerable knowledge experience directly through delegation certain affiliate developing promoting marketing various pharmaceutical product throughout world font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size whereas janssen under confidentiality term prior cdas defined below reviewed proprietary information provided geron third party collaborator relating geron imetelstat program janssen desire obtain certain license right relating imetelstat from geron collaborate with geron further development imetelstat term condition hereof font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size whereas geron willing grant janssen certain license right relating imetelstat term condition hereof font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size therefore consideration covenant obligation contained herein party hereby agree follows font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold definition font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size unless context otherwise requires term this agreement with initial letter capitalized shall have meaning described below meaning designated indicated place throughout this agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold acceptance font font size style font size mean reference drug application receipt written communication from applicable regulatory authority acknowledging that received drug application that drug application sufficiently complete permit substantive review approval purpose illustrative purpose acceptance provided filing communication letter where submitted rolling basis acceptance will occur until part module forming have been completed font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size submitted acknowledged that sufficiently complete permit such substantive review acceptance provided form written confirmation from that submission validated with respect eligibility review centralized procedure considered sufficiently complete permit such substantive review font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold accounting standard font font size style font size mean gaap international financial reporting standard ifrs appropriate generally consistently applied compliance with applicable throughout relevant company organization relevant time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold action font font size style font size mean claim action cause action suit whether contract tort otherwise litigation whether equity whether civil criminal controversy assessment arbitration investigation hearing charge complaint demand notice proceeding from before governmental authority font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold active substance font font size style font size mean nbsp active pharmaceutical ingredient drug substance comprising unconjugated conjugated form nbsp bioequivalent such pharmaceutical ingredient drug substance described clause nbsp homologous oligonucleotide having substantial identity oligonucleotide sequence having pharmaceutically pharmacologically equivalent telomerase inhibitory activity other biological activity that relevant time recognized another regulatory authority predominant primary mechanism action human such reflected associated product labelling package insert information relevant time unconjugated conjugated form nbsp salt hydrate solvate polymorph stereoisomer prodrug metabolite foregoing pharmaceutical ingredient drug substance described clause nbsp avoidance doubt active substance include lipid conjugated form with peptide like chemistry linkage backbone such example thiophosphoramidate covalently linked lipid group other than palmitoyl purpose illustration clarity notwithstanding foregoing composition matter covered claim pending time issued patent right within imetelstat patent family shall deemed active substance hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold acquiror font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold additional development proposal font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold additional study font font size style font size mean those clinical study forth work plan other than initial study font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold affiliate font font size style font size mean with respect designated party entity entity controlling controlled under common control with such party entity purpose this definition only control mean nbsp where entity corporate entity direct indirect ownership more stock share having right vote election director such entity nbsp where entity other than corporate entity possession directly indirectly power direct cause direction management policy such entity whether through ownership voting security contract otherwise font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold aggregate detail effort font font size style font size mean aggregate number detail determined janssen good faith provided janssen geron where geron exercised promotion option order promote licensed product accordance with promotional plan during given janssen calendar year portion thereof following regulatory approval licensed product united state during which there innovator protection united state such licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold agreement font font size style font size meaning forth preamble font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold alliance manager font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean acute myeloid leukemia also known acute myelogenous leukemia acute nonlymphocytic leukemia font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold ancillary agreement font font size style font size mean collectively manufacturing agreement pharmacovigilance agreement transfer agreement nbsp promotion agreement each upon execution thereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold anti corruption font font size style font size mean fcpa related regulation united state equivalent anti bribery regulation under applicable other jurisdiction font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold applicable font font size style font size mean applicable provision national supranational regional state local treaty statute rule regulation administrative code guidance ordinance judgment decree directive injunction order permit from court arbitrator regulatory authority governmental authority having jurisdiction over related subject item font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold approved material font font size style font size mean promotional material licensed product having regulatory approval promote territory including product label insert sale force training material such licensed product each case approved janssen supplied geron which used geron detailing licensed product promote territory pursuant promotion agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold audited party font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold audited site font font size style font size mean site facility party affiliate third party sublicensees third party contractor such under existing third party agreement subcontractor hereunder case which clinical study manufacturing licensed product human conducted which undergoing inspection audit regulatory authority party provided hereunder such pursuant section nbsp section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold auditing party font font size style font size meaning forth section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold balance ceiling font font size style font size meaning forth section nbsp font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold bankruptcy code font font size style font size mean title united state code amended superseded from time time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold bankruptcy font font size style font size mean with respect party that nbsp party been declared insolvent bankrupt court competent jurisdiction nbsp voluntary involuntary petition bankruptcy filed court competent jurisdiction against party such petition dismissed within ninety after filing nbsp party made executed assignment substantially asset benefit creditor font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold bioequivalent font font size style font size mean with respect drug substance active pharmaceutical ingredient contained pharmaceutical product reference drug substance active pharmaceutical ingredient another pharmaceutical product that nbsp substance pharmaceutically pharmacologically equivalent each other through same predominant primary mechanism action their bioavailabilities rate extent availability after administration same molar dose similar such degree that their effect with respect both efficacy safety expected essentially same nbsp substance would recognized regulatory authority being biologically equivalent biosimilar vivo such that regulatory approval such substance could supported reference regulatory approval other font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold breaching party font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold budget variance limit font font size style font size mean amount that annual basis percent aggregate budgeted amount janssen calendar year pursuant development budget forth such year taking into consideration nbsp unexpended amount under development budget rolled over from immediately prior janssen calendar year applicable janssen calendar year delay development activity under associated with such amount underspending with regard development activity under associated with such amount nbsp increase development budget acceleration into applicable janssen calendar year timing development activity previously planned under subsequent janssen calendar year provided that such increase acceleration limited month provided that baseline development budget such subsequent janssen calendar year reduced such amount accordingly font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold business font font size style font size mean weekday which banking institution united state generally open business font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold capa font font size style font size mean written recovery plan proposal corrective preventative action font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size clinical development plan mean written plan activity associated budget agreed party including operation section nbsp overall program collaborative development licensed product toward regulatory approval major market country certain oncology indication field including clinical study funded together party applicable funding ratio respective funding percentage provided hereunder font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold change control font font size style font size mean with respect specified party nbsp acquisition directly indirectly person group whether single transaction multiple transaction more than voting power such party beneficial ownership right acquire such beneficial ownership more than outstanding equity convertible security such party including tender offer exchange offer nbsp merger consolidation share exchange business combination recapitalization sale majority asset having fair market value determined board director such party good faith excess fair market value asset such party subsidiary immediately prior such sale similar corporate transaction involving such party whether including more wholly owned subsidiary such party other than nbsp transaction involving solely such party more affiliate hand more such party affiliate other hand nbsp transaction which stockholder such party immediately prior such transaction hold least voting power surviving company ultimate parent company surviving company nbsp result single multiple transaction nbsp person group occupation majority seat other than vacant seat board director similar governing body such party director person were nbsp member such body execution date this agreement nbsp appointed member such body execution date this agreement member such body appointed nbsp nominated election such body person described preceding clause nbsp nbsp adoption plan relating liquidation dissolution such party purpose this definition term group beneficial ownership shall have meaning accorded security exchange rule nbsp thereunder effect execution date hereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold claim font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold clinical investigation font font size style font size mean applicable relating human clinical investigation such part then current good clinical practice each effect amended from time time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold know font font size style font size mean know relating chemistry manufacture control active substance licensed product such data information typically contained section including data procedure technique information resulting from test method development stability testing process development process validation process scale formulation development delivery system development quality assurance quality control development other related activity excluding know pertaining assay measuring telomerase activity telomere length such included geron assay know font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold collaboration activity font font size style font size mean party collaborative activity performed directly permitted hereunder their behalf through their affiliate third party sublicensees third party subcontractor performed extent expressly provided hereunder nbsp development program under nbsp promoting licensed product under promotional plan event geron exercised right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold combination product font font size style font size mean nbsp licensed product that includes addition least active substance more other drug substance active ingredient font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp bundling licensed product with another product field combination sold together single invoiced price font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold commercialization commercialize font font size style font size mean activity directed marketing promoting offering sale selling product field including commercial manufacturing conducting post marketing study developing coordinating speaker program managed care contract sale detailing medical affair activity distribution importation activity support thereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold competing oncology product font font size style font size mean reference particular licensed product other product that clinical development approved field treating oncology indication acting through same predominant primary mechanism action human licensed product that substitutable pharmaceutical formulary licensed product promote territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold compliance working group font font size style font size mean working group advising with respect compliance issue under health care drug regulation relating promotional matter hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold confidential information font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold continuation notification font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold control font font size style font size mean with respect designated intellectual property right pertaining thereto possession party whether directly ownership either sole joint license from third party indirectly through affiliate having ownership license from third party ability grant other party license sublicense right access other right under such intellectual property intellectual property right provided herein without violating term agreement with third party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promote territory font font size style font size mean united state font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotion font font size style font size mean promoting licensed product under same tradename branding sale representative either party promotion territory when used verb promote shall mean engage promotion font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotion agreement font font size style font size mean agreement entered into between geron affiliate janssen designated affiliate upon geron being granted promotion right pursuant section setting forth term pursuant which party will promote licensed product promotion territory including term forth article nbsp such appropriate term condition typically used janssen such time engage third party contract provider promotional service drug product accordance with compliance program policy applicable copy such term condition used janssen execution date attached exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotion exercise notice font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotion exercise period font font size style font size meaning forth section nbsp font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotion option font font size style font size mean option geron effective upon timely election under section nbsp following exercise right option pursuant section nbsp fulfill obligation support twenty percent promoting cost united state providing twenty percent subject ramp provided section nbsp aggregate detail effort with sale representative employed geron accordance with term condition article nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold corporate integrity agreement font font size style font size mean corporate integrity agreement between office inspector general department health human service johnson nbsp johnson dated october nbsp which publicly available http janssenbiotech company pharmaceutical affiliate corporate integrity agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cost good font font size style font size mean applicable party affiliate reasonable necessary internal pocket paid third party cost incurred manufacturing applicable licensed product component thereof supplied hereunder including avoidance doubt cost acquiring procuring material used manufacturing including purpose synthesizing active substance intermediate precursor formulating active substance into finished licensed product determined accordance with cost accounting policy that accordance with accounting standard consistently applied across such party affiliate manufacturing network other product that they manufacture font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cover font font size style font size mean reference claim patent right particular country other jurisdiction with respect particular subject matter such composition matter product manufacturing other process method that claim interpreted under principle patent such jurisdiction read encompasses such subject matter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold rule font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold credited amount font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contemplated license activity font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cure period font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold currency hedge rate font font size style font size mean weighted average hedge rate used local currency each country other than united state licensed territory calculated janssen based outstanding external foreign currency forward hedge contract nbsp johnson nbsp johnson global treasury service center gtjrc affiliate with third party bank font style margin text indent font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold current manufacturing contract font font size style font size mean material agreement between geron third party relating manufacturing drug substance finished product effect including material provision surviving termination execution date geron hereby represents warrant that contract identified exhibit nbsp constitute current manufacturing contract including amendment which geron aware execution date font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin text indent font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold data font font size style font size mean research data result pharmacology data medicinal chemistry data preclinical data clinical data including investigator report both preliminary final statistical analysis expert opinion report safety other electronic database form including file report data source data including patient medical record original patient report form excluding patient specific data extent required applicable like each case directed used development manufacture commercialization licensed product active substance hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold detail font font size style font size mean with respect licensed product interactive face face visit sale representative such licensed product following regulatory approval field with healthcare professional having prescribing authority able influence prescribing decision within target audience during which approved safety effectiveness contraindication side effect warning other relevant characteristic licensed product discussed effort increase prescribing preference licensed product approved detail include first position detail second position detail defined below avoidance doubt medical affair activity related activity conducted medical support staff such medical science liaison constitute detail detail activity conducted convention similar gathering activity performed market development specialist managed care account director other personnel performing face face sale call specifically trained with respect licensed product will constitute detail first position detail mean detail which applicable product detailed before other product predominant portion time devoted detailing such product second position detail mean detail which applicable product detailed second position more than other product presented discussed with healthcare professional before such product second most predominant portion time devoted detailing such product font font size style font size when used verb detail perform detailing mean engage detail font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold develop font font size style font size mean clinical clinical other research activity study drug candidate product develop toward regulatory approval including such activity conducted after such regulatory approval condition grant such regulatory approval other than post marketing study marketing commercialization field including toxicology adme test analytical method development stability testing process development improvement process validation process scale prior first regulatory approval formulation development delivery system development quality assurance quality control development statistical analysis post approval clinical study trial regulatory affair regulatory activity clarity definition development shall include activity under global development plan exclude commercialization activity developing development shall each have correlative meaning font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development budget font font size style font size mean written budget forth amended from time time written agreement party amended from time time applicable party case conducting development activity described such development plan including budget specifying supply cost clinical supply used connection with applicable development activity font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development cost font font size style font size mean cost development ftes pocket cost incurred party their affiliate developing licensed product field accordance with this agreement global development plan case pursuant development budget therein including such cost directly associated with nbsp development other than manufacturing activity performed direct support clinical study licensed product specified work plan applicable nbsp manufacturing activity supply cost with respect clinical supply licensed product used clinical study forth applicable nbsp purchasing packaging third party comparator drug third party drug device used combination with licensed product each case used clinical study under applicable nbsp disposal clinical sample clinical study under applicable nbsp preparing making regulatory filing such inds ndas licensed product support clinical study other development activity under applicable nbsp performing manufacturing development activity under applicable relating chemistry manufacturing control development know inclusion regulatory filing such such nbsp manufacturing process formulation delivery system development improvement validation scale planning process design nbsp stability testing development nbsp quality assurance quality control development nbsp qualification validation third party contract manufacturer clinical supply licensed product each case extent required regulatory approval licensed product nbsp establishing updating global safety database licensed product based data from clinical licensed product development program anywhere territory nbsp developing vitro companion diagnostics with licensed product accordance with applicable work plan forth applicable avoidance doubt development cost exclude milestone payment hereunder development milestone event capital expenditure such cost scaled manufacturing equipment commercial production cost associated with further scale activity after first regulatory approval under cost included development budget such example cost attributable general corporate activity executive management investor relation treasury service business development corporate government relation external financial reporting legal matter including patent cost other overhead already captured definition rate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development font font size style font size mean employed party affiliate expended directly performing supporting development activity under such scientific medical technical other personnel appropriate applicable development activity including administrative employee dedicating more than fifty percent their time support development activity hereunder clarity such administrative employee include such dedicated personnel compound development team leadership project management exclude back office employee such human resource accounting information technology legal personnel font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development program font font size style font size mean activity performed either both party their respective affiliate third party subcontractor third party sublicensees development licensed product including development activity under global development plan font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development program invention font font size style font size mean invention whether patentable arising development program directly from development activity performed directly behalf affiliate third party sublicensees third party subcontractor either both party arising directly from post marketing study licensed product performed behalf janssen which invention necessary useful manufacturing development active substance licensed product commercialization licensed product including invention made development program pertaining manufacture preparation formulation administration delivery dosing field active substance licensed product notwithstanding foregoing janssen directly through affiliate third party sublicensees performs during term research activity outside scope activity forth global development plan which activity result discovery either novel active substance including through structural modification optimize property novel field then such discovery shall deemed within scope development program invention hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development program font font size style font size mean development program know development program patent right collectively font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development program know font font size style font size mean know generated developed development program from development activity performed directly behalf affiliate third party sublicensees third party subcontractor either both party from post marketing study licensed product performed behalf janssen hereunder which know directly relates active substance licensed product including purpose illustration development program invention data other information relating form active substance licensed product method using active substance licensed product process material manufacturing formulating delivering active substance licensed product active substance combination product companion diagnostic developing commercializing licensed product field material process making active substance licensed product method using testing characterizing active substance licensed product data other information contained regulatory filing relating licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development program patent right font font size style font size mean patent right controlled either both party that includes filed other time during pendency patent office claim covering generally specifically development program invention purpose illustration exemplary development program patent right include more claim covering active substance licensed product form method using active substance licensed product process material manufacturing formulating delivering active substance licensed product combination product extent directly relates active substance hereunder excluding avoidance doubt patent right directed other active ingredient alone companion diagnostic connection with development commercialization licensed product field font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development proposal criterion font font size style font size mean with respect proposed trial general description study design clinical study endpoint clinical methodology font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size monitoring requirement budget estimate pocket cost cost associated therewith together with analysis projected return investment such trial font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold diligent commercialization effort font font size style font size mean with respect effort expended janssen following receipt regulatory approval licensed product major market country other country which janssen obtained regulatory approval licensed product expending commercially reasonable effort behalf janssen through affiliate third party sublicensees collective activity commercialize licensed product such country that consistent with effort typically expended human pharmaceutical industry similarly resourced company under similar circumstance considering example technical challenge market potential regulatory requirement patient population competitive position such country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold diligent development effort font font size style font size mean with respect effort expended designated party regarding development obligation under this agreement expending commercially reasonable effort behalf such party through affiliate third party subcontractor collective activity conduct applicable development activity including event clinical hold imposed regulatory authority particular clinical trial licensed product under global development plan expending effort seek remove such clinical hold extent commercially reasonable that consistent with effort typically expended human pharmaceutical industry similarly resourced company under similar circumstance considering example technical challenge market potential regulatory requirement patient population competitive position font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold dispute font font size style font size mean dispute claim controversy arising from regarding this agreement including interpretation application breach termination validity provision hereof avoidance doubt matter within decision making authority other joint committee shall deemed dispute merely unanimous decision reached party final decision making authority such matter however controversy between party arises regarding interpretation provision hereunder pertaining joint committee decision that made such controversy such controversy shall deemed dispute extent such controversy font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold drug application font font size style font size mean equivalent application submitted regulatory authority particular jurisdiction marketing approval pharmaceutical drug product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold drug regulation font font size style font size mean applicable regulating drug pharmaceutical product such federal food drug cosmetic prescription drug marketing controlled substance policy issued each effect amended from time time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold effective date font font size style font size mean effective date this agreement which shall date following execution date that first business immediately following date which party have actual knowledge that applicable waiting period under with respect transaction contemplated hereunder have expired have been terminated font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean european medicine agency successor agency font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold major market country font font size style font size mean font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold european union font font size style font size mean country european economic area constituted effective date modified from time time after effective date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold excess development cost font font size style font size mean nbsp prior first full janssen calendar year following first regulatory approval first licensed product first major market country portion development cost additional study under given janssen calendar year that aggregate exceeds nbsp total development cost forth initial development budget such additional study such janssen calendar year plus nbsp budget variance limit nbsp thereafter portion development cost additional study under given janssen calendar year that aggregate exceeds nbsp total development cost forth annual development budget additional study such janssen calendar year plus nbsp budget variance limit font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold execution date font font size style font size meaning forth preamble font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold executive officer font font size style font size mean nbsp geron chief executive officer geron nbsp janssen nbsp matter pertains development licensed product global head janssen global therapeutic area head janssen oncology nbsp matter pertains commercialization licensed product worldwide chairman pharmaceutical johnson nbsp johnson president janssen general manager oncology janssen nbsp matter pertains manufacture licensed product vice president supply chain janssen supply group event that position executive officer identified this section nbsp longer exists corporate reorganization corporate restructuring like that result elimination modification identified position applicable executive officer shall replaced with another senior officer with responsibility seniority comparable eliminated modified position font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold existing third party agreement font font size style font size mean nbsp current manufacturing contract nbsp existing license third party nbsp existing license from third party nbsp agreement between geron third party effect execution date other than agreement described clause nbsp through which contain term relating development manufacture commercialization collectively additional existing third party agreement geron represents warrant that exhibit nbsp list material additional existing third party agreement described clause nbsp this section including amendment thereto which geron aware execution date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold existing blocking third party patent right font font size style font size mean issued patent right owned controlled third party included geron product patent right that nbsp include more claim that would infringed development manufacture including font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size with respect claim such patent right that cover manufacturing process used such manufacture those process step feature that accordance with those process step feature manufacturing process utilized behalf geron execution date including under current manufacturing contract excluding process step feature that changed from such manufacturing process commercialization licensed product solely extent inclusion active agent inclusion other active inactive agent ingredient licensed product such development manufacture commercialization activity contemplated license activity nbsp which execution date geron knew reasonably should have known include such claim that would infringed such contemplated license activity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold study font font size style font size mean those clinical study licensed product forth global development plan that study which clarity intended support regulatory approval more country including united state regardless where such study performed font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold expert proxy resolution font font size style font size mean procedure obtaining decision issue within authority that requires unanimous vote expressly provided hereunder event that reach unanimous decision after escalation party executive officer also reach mutual decision escalated issue which procedure forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold fcpa font font size style font size mean foreign corrupt practice amended relevant time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean united state food drug administration successor agency thereto united state font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold field font font size style font size mean prevention treatment diagnosis human disorder medical condition including indication oncology font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold finance working group font font size style font size mean working group advising other joint committee with respect reporting reconciliation development cost promotional cost incurred hereunder font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold first commercial sale font font size style font size mean with respect licensed product country first commercial sale monetary value such licensed product behalf janssen affiliate third party distributor third party sublicensees third party purchaser consumption field following regulatory approval such country avoidance doubt sale licensed product clinical study purpose early access program such provide patient with licensed product prior regulatory approval example pursuant treatment inds protocol named patient program compassionate program similar shall constitute first commercial sale addition clarity sale licensed product between nbsp janssen affiliate nbsp janssen third party sublicensees such contract manufacturer supplier distributor consignment where such sale final sale wholesaler retailer shall constitute font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size first commercial sale each case first commercial sale shall deemed occur upon subsequent resale third party sublicensee third party purchaser clarity only such sale transaction final sale with respect unit licensed product will deemed constitute first commercial sale font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold first indication font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean equivalent work qualified employee agent applicable activity full time year constituting working hour clarity more than hour year equivalent rata portion thereof period than month charged individual contributing work factoring into reimbursable cost hereunder regardless much additional work time contributed such individual during such period individual contributing work than hour year shall deemed fraction rata basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cost font font size style font size mean rate time number ftes expended during applicable financial period cost shall determined based time calculated rated ftes actually spent performing applicable development activity unless another basis expressly specified herein otherwise agreed advance party writing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold rate font font size style font size mean monetary rate which ftes expended party during applicable financial reporting period will accrue toward such party cost hereunder party agree that rate development work shall dollar allocable rate detailing work sale representative sale force rate shall dollar allocable sale representative each such rate shall adjusted annually based change consumer price index quoted department labor bureau labor statistic plus percent with first adjustment taking effect janssen calendar year each party acknowledges that foregoing rate development work been include salary employee benefit routine supply other expense including support staff overhead directly allocable that foregoing sale force rate likewise fully loaded sale representative detailing work font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold gaap font font size style font size mean united state generally accepted accounting principle applied consistent basis font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold generic erosion font font size style font size mean that generic product alone multiple generic product aggregate have attained licensed product licensed product basis country country basis least market share prescription volume janssen calendar quarter applicable licensed product applicable country measured data other marketing data issued reputable data source acceptable both party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold generic product font font size style font size mean licensed product licensed product basis country country basis product that same bioequivalent active substance contained within such licensed product application regulatory approval which submitted through abbreviated foreign equivalent thereof that reference font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size supplemental foreign equivalent thereof licensed product clarity generic product will include authorized janssen generic licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron assay font font size style font size mean geron assay know geron assay patent right collectively font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron assay know font font size style font size mean know owned accordingly controlled geron directly through affiliate execution date during term that pertains assay measuring telomerase activity telomere length geron hereby represents warrant that geron assay know includes assay method material other than reagent generally available commercial purchase without restriction from third party vendor described protocol forth exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron assay patent right font font size style font size mean nbsp patent right owned accordingly controlled geron directly through affiliate execution date during term that include claim covering assay method material measuring telomerase activity telomere length nbsp patent right licensed geron pursuant license agreement dated nbsp between geron mcmaster university geron assay patent right include patent right listed exhibit font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron promotion decision package font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron decision package font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron development program font font size style font size mean geron development program know geron development program patent right collectively font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron development program know font font size style font size mean development program know controlled geron directly through affiliate including geron interest joint development program know font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron development program patent right font font size style font size mean development program patent right controlled geron directly through affiliate including geron interest joint development program patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron election period font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size geron election notification meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron trial cost font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron product font font size style font size mean geron product know geron product patent right collectively font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron product know font font size style font size mean nbsp know related development manufacture commercialization active substance licensed product including active substance licensed product data property development synthesis manufacture formulation administration including contemplated this agreement nbsp know that incorporated geron affiliate into development manufacture commercialization active substance licensed product during term which know each case nbsp nbsp either nbsp controlled geron directly through affiliate effective date nbsp developed outside development program come within control geron directly through affiliate during term case excluding font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron product patent right font font size style font size mean patent right controlled geron directly through affiliate effective date during term that come into control geron directly through affiliate outside development program during term that include time least claim covering generically specifically nbsp geron product know nbsp composition form formulation preparation administration delivery dosing active substance licensed product method using active substance licensed product process material manufacturing formulating preparing administering delivering dosing active substance licensed product each case excluding geron product patent right include patent right listed exhibit font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron promotional funding amount font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron promotional share font font size style font size mean actual percentage maximum twenty percent sale representative pdes expended geron detailing licensed product united state during period during which promoting such licensed product while there innovator protection united state licensed product following regulatory approval font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron reimbursement amount font font size style font size meaning forth section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size mean portion geron reimbursement amount forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron reimbursement downpayment font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold global development plan font font size style font size mean collectively which together shall provide written plan budget overall program development licensed product toward regulatory approval major market country oncology indication other application field including work plan development budget with each party respective allocation cost nbsp clinical trial including party sponsored clinical study investigator initiated clinical study clinical font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size study nbsp regulatory responsibility obtaining regulatory approval applicable country nbsp associated timeline such activity updated amended from time time accordance with term this agreement clarity global development plan shall include clinical study initiated geron affiliate third party contractor under existing third party agreement before execution date conducted extent during term font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold good clinical practice font font size style font size mean current standard clinical trial pharmaceutical forth guideline applicable regulation promulgated thereunder amended from time time such standard good clinical practice required european union other organization governmental agency country which product intended sold extent such standard stringent than united state good clinical practice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold good laboratory practice font font size style font size mean current standard laboratory activity pharmaceutical forth good laboratory practice regulation good laboratory practice principle organization economic operation development amended from time time such standard good laboratory practice required european union other organization governmental agency country which product intended sold extent such standard stringent than united state good laboratory practice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold good manufacturing practice font font size style font size mean current quality assurance standard that ensure that pharmaceutical product consistently produced controlled accordance with quality standard appropriate their intended defined european directive eudralex annex applicable united state european union canadian guidance equivalent other jurisdiction extent stringent font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold government health care program font font size style font size mean medicare program title xviii social security medicaid program title social security tricare federal employee health benefit program other foreign federal state local governmental health care plan program font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold government order font font size style font size mean order writ judgment injunction decree stipulation ruling determination award entered with governmental authority font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold governmental authority font font size style font size mean united state federal state local foreign government political subdivision thereof multinational organization authority authority agency commission entitled exercise administrative executive judicial legislative police regulatory taxing authority power court tribunal department bureau division thereof governmental arbitrator arbitral body font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean thiosphosphoramidate oligonucleotide having structure forth exhibit nbsp which referred geron internally certain publication font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean thiosphosphoramidate oligonucleotide having structure forth exhibit nbsp which reflects covalently linked palmitoyl sodium other salt thereof which also referred imetelstat font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold health care font font size style font size mean applicable relating government health care program private health care plan privacy confidentiality patient health information human biological material including united state federal state applicable pertaining federal medicare medicaid program including medicaid rebate program federal applicable pertaining federal employee health benefit program tricare program other government health care program federal state applicable applicable health care fraud abuse kickback physician self referral false claim including federal civil false claim health insurance portability accountability part nbsp well similar applicable licensed territory each effect amended from time time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold hematological cancer font font size style font size mean cancer arising blood bone forming tissue bone marrow lymph node including leukemia including lymphoma multiple myeloma font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean hart scott rodino antitrust improvement amended rule nbsp regulation promulgated thereunder foreign equivalent thereof under applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold clearance font font size style font size mean pertaining this agreement expiration termination applicable waiting period request information extension thereof under font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold filing font font size style font size mean nbsp filing janssen geron with united state federal trade commission antitrust division united state department justice notification report form nbsp certain merger acquisition that term defined with respect matter forth this agreement together with required documentary attachment thereto nbsp equivalent filing with applicable governmental authority having jurisdiction over request clearance font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean international conference harmonization technical requirement registration pharmaceutical human font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size independent development plan mean written plan prepared behalf party hereunder development licensed product field independently conducted such party directly through affiliate third party sublicensees third party subcontractor expressly permitted hereunder including under section nbsp section nbsp expense including work plan development budget updated amended from time time such party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold imetelstat patent family font font size style font size mean series family geron product patent right which consists nbsp patent nbsp nbsp those other geron product font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size patent right related thereto priority such continuing application thereof parent provisional application serving basis priority therefor claiming common priority right therewith under applicable each case including foreign counterpart foregoing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean investigational drug application filed with similar application filed with regulatory authority outside united state authorization commence clinical study such clinical trial application clinical trial exemption related regulatory submission license authorization font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold transfer agreement font font size style font size mean written agreement between party relating particular clinical study filed before effective date behalf geron third party counterparty existing third party agreement pertaining such ongoing clinical study thereunder which written agreement entered into between party among party such third party after effective date hereof provides transfer janssen responsibility geron under existing third party agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold indemnified party font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold indemnified person font font size style font size shall mean with respect party such party affiliate their respective officer director employee agent font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold indemnifying party font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold independent promotional plan font font size style font size mean written plan prepared janssen setting forth plan detailing supporting janssen commercialization licensed product after applicable regulatory approval nbsp united state geron have right nbsp country other than united state such plan amended updated from time time janssen font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold indication font font size style font size mean specific therapeutic prophylactic indication forth labeling given drug product such licensed product approved regulatory authority identifying application which drug product applicable marketed prevent treat particular disease medical condition product product country country basis first indication specified disease medical condition mean indication such specified disease medical condition forth product label drug product applicable that receives first regulatory approval such country based pivotal clinical study treating patient population second indication mean additional indication same specified disease medical condition forth first indication such drug product applicable which additional indication receives regulatory approval based different pivotal clinical study treating additional patient population distinct from that treated first indication font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold inferior right font font size style font size mean right under geron product patent right licensed janssen under this agreement that after effective date extent font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size prohibited herein geron exercise practice otherwise exploit itself through affiliate grant third party that relate product other than licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold inferior right holder font font size style font size mean holder inferior right whether geron affiliate third party licensee case font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold initial development budget font font size style font size mean initial development budget development activity work plan initial study study that would included forth section nbsp geron were exercise right provided geron geron decision package pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold initial global development plan font font size style font size mean global development plan execution date which attached this agreement exhibit nbsp includes nbsp initial including work plan development budget each initial study nbsp additional study that study planned execution date which shall incorporated into geron exercise right pursuant section nbsp which shall incorporated into janssen geron exercise such right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold initial study font font size style font size mean both lead phase study lead phase risk study font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold licensed geron product patent right font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold innovator protection font font size style font size mean with respect applicable licensed product having regulatory approval given country that either both following protection pertaining active substance licensed product force such country nbsp least valid claim geron product patent right development program patent right such country cover either nbsp active substance contained licensed product composition matter nbsp method using active substance licensed product corresponding first indication approved regulatory authority such country nbsp regulatory exclusivity right protect active substance licensed product chemical entity data exclusivity pediatric exclusivity like first indication orphan drug indication approved licensed product regulatory authority such country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen alternative election period font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen calendar quarter font font size style font size mean financial quarter based janssen calendar year provided however that first janssen calendar quarter last janssen calendar quarter partial quarter applicable under relevant janssen calendar year font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen calendar year font font size style font size mean year based janssen universal calendar that year used janssen internal external reporting purpose copy which year attached hereto exhibit nbsp provided however that first janssen calendar year last janssen calendar year applicable period such royalty term partial year case font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen development program font font size style font size mean janssen development program know janssen development program patent right collectively font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen development program know font font size style font size mean development program know controlled janssen directly through affiliate including janssen interest joint development program know font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen development program patent right font font size style font size mean development program patent right controlled janssen directly through affiliate including janssen interest joint development program patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen election period font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen based regulatory approval font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen trial cost font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen inds font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen parent font font size style font size mean johnson nbsp johnson jersey corporation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen product font font size style font size mean janssen product know janssen product patent right collectively font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen product know font font size style font size mean know that incorporated janssen affiliate into development manufacture commercialization active substance licensed product during term that either nbsp controlled janssen affiliate effective date nbsp developed outside development program come within control janssen affiliate during term font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen product patent right font font size style font size mean patent right controlled janssen affiliate effective date that come into control janssen affiliate outside development program during term that include time least claim covering generically specifically nbsp janssen product know nbsp composition form formulation preparation administration delivery dosing active substance licensed product method using active substance licensed product process material manufacturing formulating preparing administering delivering dosing active substance licensed product each case nbsp extent incorporated into licensed product development manufacture commercialization active substance licensed product janssen affiliate during term font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size joint development committee mean joint development subcommittee further defined section nbsp font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size joint marketing committee mean joint marketing subcommittee further defined section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint committee font font size style font size shall refer nbsp singular each joint steering committee joint development committee joint marketing committee individually nbsp plural joint steering committee joint development committee joint marketing committee collectively font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint development program invention font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint development program know font font size style font size mean development program know owned jointly party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint development program patent right font font size style font size mean development program patent right owned jointly party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint steering committee font font size style font size mean joint steering committee formed representative each party that responsible providing high level oversight decision making regarding collaboration activity further provided article nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold jointly owned geron product patent right font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold know font font size style font size mean technical scientific other know whether patentable data other information well material including invention trade secret research development data plan procedure experimental technique material specification assay test protocol biological chemical pharmacological toxicological pharmaceutical clinical clinical safety quality control data information manufacturing method formula molecule chemical entity reagent starting material reaction intermediate building block synthetic product delivery system excipients ingredient formulation composition matter font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold launched product font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold lead phase risk study font font size style font size mean phase clinical study patient with risk progression based international prognostic scoring system world health organization classification such other classification scheme agreed upon that forth initial font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold lead phase study font font size style font size mean phase clinical study that forth initial font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold lead phase study data package font font size style font size mean identified clinical trial result form protocol specified primary analysis from lead phase study identified font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold lead phase study read font font size style font size mean date delivery lead phase study data package both party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold lead phase study suspension period font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold licensed product font font size style font size mean product field comprising active substance alone combination with other ingredient such excipients other inactive ingredient well other active ingredient font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold licensed territory font font size style font size mean entire world including country their possession territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold loss font font size style font size mean damage loss liability cost including cost investigation defense fine penalty government order expense amount paid settlement each case including reasonable attorney expert expense resulting from claim action third party governmental authority incurred party other indemnified person provided article nbsp xiii result such action font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean nbsp marketing authorization application filed with nbsp under centralized filing procedure nbsp regulatory authority european country centralized filing procedure used nbsp other equivalent related regulatory submission either case gain approval market product country european union each case including avoidance doubt amendment thereto supplemental application font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold major market country font font size style font size mean font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold manufacturing agreement font font size style font size mean written agreement signed both party including agreed upon plan term condition procuring applicable party with respect party with respect case including through engagement third party contract manufacturer supplier starting material reagent active substance licensed product sufficient quality amount adequate meet demand needed conducting clinical study licensed product pursuant global development plan including plan activity aimed promptly transition janssen responsibility manufacturing having manufactured active substance licensed product development purpose under provided that clarity nbsp supply cost procuring such supply each clinical study under shall allocated rata accordance with each party respective percentage share development cost such clinical study provided hereunder such section nbsp nbsp supply cost procuring such supply each clinical study under party shall borne such party subject right reimbursement that arise pursuant term hereof such section nbsp font style margin text indent font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold manufacturing font font size style font size mean reference licensed product activity performed manufacture such licensed product into final form field including producing starting material used manufacture active substance licensed product font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size manufacturing including through multiple synthesis step such starting material into active substance bulk form formulating active substance into licensed product finished dosage form filling finishing packaging labeling performing quality assurance testing release shipping storing packaged licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold mayo contract font font size style font size mean investigator sponsored trial agreement between geron mayo clinic dated october nbsp amended april nbsp june nbsp august nbsp october nbsp nbsp further amended from time time which been superseded clinical trial agreement between geron mayo clinic dated july nbsp amended september nbsp september nbsp further amended from time time under which clinical study entitled pilot open label study efficacy safety imetelstat myelofibrosis other myeloid malignancy been being execution date performed mayo clinic under direction nbsp tefferi nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean myelodysplastic syndrome font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold medical affair font font size style font size mean medical affair activity performed behalf janssen affiliate sublicensees connection with licensed product sold behalf janssen hereunder including providing medical scientific liaison support coordinating distribution medical scientific information material relating licensed product developing conducting medical education program relating licensed product healthcare provider overseeing field based medical science liaison coordinating medical communication field medical education font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean myelofibrosis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold mhlw font font size style font size shall mean ministry health labour welfare japan successor agency thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold named indication font font size style font size mean individually collectively font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean drug application biologics license application submitted purpose obtaining regulatory approval drug united state particular indication including avoidance doubt amendment thereto supplemental application font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold sale font font size style font size mean with respect licensed product following regulatory approval commencing with first commercial sale gross amount invoiced sale approved licensed product behalf specified party directly through affiliate third party sublicensees third party purchaser length transaction following customary deduction determined accordance with accounting standard standard internal policy procedure consistently applied throughout organization party recording such sale calculate revenue financial reporting purpose extent specifically solely allocated sale such licensed product such purchaser actually taken paid accrued allowed included allocated based good font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size faith estimate gross sale price with respect such sale consistently applied forth below font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size normal customary form with respect sale such licensed product extent already reflected amount invoiced font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size extent included specifically excluding clarity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size extent included price separately itemized invoice price font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size sale such licensed product pursuant applicable reason font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size actually granted upon such licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size actually granted font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size associated with font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size aforementioned deduction shall only allowable extent they commercially reasonable shall determined country country basis incurred ordinary course business type amount consistent with party affiliate sublicensee case business practice consistently applied across product line compliance with accounting standard verifiable such discount allowance credit rebate other deduction shall fairly equitably allocated such licensed product other product party affiliate sublicensees such that such licensed product bear disproportionate portion such deduction clarity sale licensed product between party affiliate sublicensees including those that distributor between party their respective affiliate sublicensees sale third party shall excluded from sale calculation purpose long such licensed product subsequently resold third party user avoidance doubt sale licensed product conducting clinical trial such licensed product country order obtain first regulatory approval such licensed product such country shall excluded from sale calculation purpose also notwithstanding anything contrary above sale licensed product compassionate named patient sale shall excluded from sale calculation additionally clarity only single sale transaction with respect particular unit licensed product made time janssen affiliate sublicensees sell such licensed product third party purchaser length transaction will qualify basis determining sale amount such unit calculation sale combination product shall adjusted pursuant section nbsp nbsp below font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold breaching party font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold notice claim font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold oncology font font size style font size mean type form hematological cancer solid tumor cancer font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold ongoing study font font size style font size mean clinical study initiated assumed geron prior execution date identified exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold budget modification font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold pocket cost font font size style font size mean amount paid party affiliate third party subcontractor hereunder service material provided such subcontractor directly support applicable development promoting activity funded extent party clinical supply activity expressly provided hereunder extent such service material apply directly activity under applicable promotional plan manufacturing plan case specific allocation each party share funded pocket cost otherwise specified this agreement clarity pocket cost include payment party affiliate internal salary benefit facility utility general office facility supply insurance information technology capital expenditure like font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold party font font size style font size party have meaning forth preamble font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent controversy font font size style font size mean dispute between party extent that involves issue relating inventorship claim scope interpretation infringement enforceability patentability validity patent right hereunder including such issue relevant prosecution activity hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent cost font font size style font size mean pocket cost reasonably incurred behalf party such designated affiliate prosecuting applicable patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent office font font size style font size mean united state patent trademark office european patent office other governmental authority responsible examination patent application granting patent country region supra national jurisdiction font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent representative font font size style font size mean patent attorney agent representing party described section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent right font font size style font size mean reference designated invention original priority establishing patent application claiming such invention filed anywhere world including provisionals nonprovisionals related application thereafter filed including continuation continuation part division substitute application patent issued granted from such patent application reissue reexamination renewal extension including virtue supplementary protection certificate such patent confirmation patent registration patent patent addition based such patent foreign counterpart equivalent foregoing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent term extension font font size style font size mean extension term issued patent right protection equivalent such extension granted under drug price competition patent term restoration supplementary protection certificate font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size font weight bold nbsp font style margin font size face time roman style font size member state another similar regulation other country jurisdiction clarity pediatric extension obtained application through approval patent office extending term patent shall deemed patent term extension font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent working group font font size style font size mean working group that advises joint committee patent matter more fully forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean primary detailing equivalent contributed sale representative detailing licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold person font font size style font size mean individual entity governmental authority font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold pharmacovigilance agreement font font size style font size mean written pharmacovigilance agreement between party executed hereunder pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold phase high risk study font font size style font size mean phase clinical study licensed product patient with high risk progression based international prognostic scoring system world health organization classification generally outlined font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold phase font font size style font size mean reference clinical study trial licensed product that such study conducted healthy human subject patient generate information product safety tolerability primary purpose applicable pharmacological activity pharmacokinetics more fully described federal regulation nbsp equivalent other jurisdiction purpose illustration phase development licensed product include phase study designed safety pharmacokinetics licensed product single agent combination with other standard care agent used treat particular indication font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold phase font font size style font size mean reference clinical study licensed product following more phase study that such study conducted target patient population indication determining safety efficacy dose ranging licensed product which study prospectively designed generate sufficient data successful commence phase study file accelerated marketing approval more fully described federal regulation nbsp equivalent other jurisdiction clarity lead phase study lead phase risk study shall deemed phase study phase phase study font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold phase font font size style font size mean reference clinical study licensed product following more phase study that such study pivotal study human patient establish safety efficacy licensed product particular indication which study prospectively designed demonstrate with statistical significance that licensed product sufficiently safe effective indication support filing drug application approval market such licensed product such indication jurisdiction more fully described federal regulation nbsp equivalent other jurisdiction font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold post marketing study font font size style font size mean clinical trial study conducted with licensed product after receipt regulatory approval licensed product which font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size conducted voluntarily order enhance marketing scientific knowledge licensed product required regulatory authority intended support regulatory approval licensed product indication other material change product label insert font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold existing license from third party font font size style font size mean agreement between geron third party effect execution date pursuant which third party grant express term whether using word license geron license sublicense other exploitation right under third party patent right know that necessary useful developing manufacturing commercializing active substance licensed product excluding current manufacturing contract geron represents warrant that existing license from third party pertaining which geron aware execution date listed exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold existing license third party font font size style font size mean agreement between geron third party effect execution date pursuant which geron grant express term whether using word license such third party license sublicense other exploitation right under geron product excluding current manufacturing contract geron represents warrant that existing license third party which geron aware execution date listed exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold prior cdas font font size style font size mean collectively nbsp mutual confidential disclosure agreement effective october nbsp entered into between janssen affiliate janssen global service geron amended march nbsp nbsp confidential disclosure agreement dated june nbsp entered into between geron janssen global service nbsp confidential disclosure agreement dated june nbsp entered into between geron janssen global service font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold private health care plan font font size style font size mean governmental third party health care payors plan including insurance company health maintenance organization other managed care organization blue cross blue shield plan self funded employer font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold product infringement font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold product label insert font font size style font size mean with respect licensed product field nbsp display written printed graphic matter upon container which licensed product immediately contained outside container wrapper other packaging licensed product nbsp written printed graphic material within package from which licensed product dispensed including package insert other patient information provided with product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold product trademark right font font size style font size mean trademark right pertaining active substance licensed product controlled party hereunder font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold promoting font font size style font size mean detailing promotion licensed product being sold field excluding avoidance doubt medical affair activity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold promoting cost font font size style font size mean total cost incurred either both party carrying promoting under promotional plan determined nbsp multiplying sale force rate time total sale value applicable party party sale representative nbsp using other accounting methodology accordance with applicable accounting standard establish under advice finance working group font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold promotional budget variance ceiling font font size style font size mean amount that percent geron promotional funding amount janssen calendar year pursuant budget promoting cost forth promotional plan font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold proposed publication font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold proposed resolution font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold proposed trial font font size style font size mean clinical study licensed product oncology indication other than named indication that time proposed supported scope development activity under font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold proposing party font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold prosecuting font font size style font size mean reference designated patent right preparing patent right application form filing patent office performing activity associated with filing prosecuting maintaining defending correcting patent right patent office proceeding with appeal patent office decision therefrom including with respect post grant proceeding supplemental examination post grant review inter parte review reexamination reissue interference opposition proceeding patent office avoidance doubt prosecuting excludes infringement suit other legal action enforce patent right declaratory judgment suit other legal action initiated third party challenge court validity enforceability patent right prosecute prosecution shall each have correlative meaning font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold prosecuting party font font size style font size mean party with current right prosecute applicable patent right forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold prosecution contact font font size style font size mean party designated patent attorney agent identified notice other party updated from time time contact communication between party regarding prosecuting geron product patent right development program patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold publishing party font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold working group font font size style font size mean working group advising with respect quality assurance matter pertaining batch licensed product that manufactured clinical trial forth global development plan font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold regulatory approval font font size style font size mean approval applicable regulatory authority necessary marketing sale pharmaceutical drug product indication field country including approval that required such country pricing reimbursement purpose illustration addition approval drug application regulatory approval includes approval regulatory approval includes regulatory approval includes regulatory approval includes regulatory approval includes font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold regulatory authority font font size style font size mean federal national multinational state provincial local regulatory agency department bureau other governmental entity with authority over marketing sale pharmaceutical product country such united state mhlw japan font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold regulatory exclusivity right font font size style font size mean right protection granted regulatory authority jurisdiction providing with respect licensed product such jurisdiction nbsp marketing exclusivity that prevents regulatory authority from accepting approving drug application whether abbreviated submitted party other than janssen affiliate third party sublicensees generic competing version pharmaceutical product comprising compound that bioequivalent active substance licensed product such through molecular entity orphan drug exclusivity granted exclusive right sell pursuant data exclusivity provision under directive regulation marketing exclusivity granted respect pediatric study under regulation section nbsp nbsp nbsp data protection regulatory data submitted janssen relating licensed product against unfair commercial public release consistent with stringent than trip article nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold regulatory filing font font size style font size mean documentation comprising relating supporting filing application with regulatory authority with respect licensed product potential investigative human including document submitted regulatory authority supporting data including inds supportive document enabling clinical program ndas maas correspondence with regulatory authority with respect licensed product including minute meeting telephone conference discussion with regulatory authority font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold requesting party font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold reverted licensed product font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold reviewing party font font size style font size meaning forth section font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold right reference font font size style font size meaning forth such term nbsp equivalent thereto under applicable jurisdiction outside united state font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold royalty term font font size style font size applicable sale each particular licensed product given country meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold sale force rate font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold sale contribution font font size style font size mean with respect particular sale representative detail licensed product united state during given janssen calendar year total time exceeding full time equal summation each detail visit such sale representative time sale value such detail made during such janssen calendar year font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold sale value font font size style font size mean with respect particular sale representative detail licensed product united state during given janssen calendar year allowance reflected following sentence detailing time expended such sale representative toward aggregate detailing effort pursuant promotional plan such janssen calendar year determine value physician detailing equivalent notwithstanding foregoing determined sale value full time sale representative detail licensed product janssen calendar year united state shall nbsp extent such sale representative detail licensed product first position detail nbsp extent such sale representative detail licensed product second position detail avoidance doubt sale representative detail licensed product different position different detail first position detail portion detail second position detail other detail then rata share foregoing percentage will used determine sale value calculating sale contribution font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold sale representative font font size style font size mean sale representative party case janssen affiliate performs detail licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold second indication font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold solely owned geron product patent right font font size style font size meaning forth section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold solid tumor cancer font font size style font size mean cancer other than hematological cancer font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold supply cost font font size style font size mean nbsp reference clinical supply licensed product bulk finished product form that supplied through third party contract manufacturer with approval party clinical study under global development plan such party pocket cost incurred having such supply manufactured behalf nbsp reference clinical supply licensed product bulk finished product form that manufactured with approval janssen affiliate clinical study under global development plan janssen applicable affiliate cost good such supply plus mark percent font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size mean present future levy impost duty charge assessment nature including interest thereon font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold term font font size style font size mean term this agreement forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold third party product liability action font font size style font size meaning forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold third party font font size style font size mean person entity other party other than party this agreement affiliate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold trademark right font font size style font size mean registered unregistered trademark including common right thereto service mark trade name brand name logo taglines slogan certification mark internet domain name trade dress corporate name business name other indicia origin together with goodwill associated with foregoing application registration extension renewal thereof throughout world right therein provided international treaty convention font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold united state font font size style font size mean united state america including territory possession font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold promotional budget font font size style font size mean written budget developed janssen detailing activity united state described promotional plan font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold promotional plan font font size style font size mean written plan developed janssen detailing activity supporting janssen commercialization licensed product united state after regulatory approval while there innovator protection such licensed product such plan amended supplemented updated from time time initial promotional plan shall include aggregate detail effort number detail conducted janssen where geron exercised promotion option each party consistent with geron promotional share period following regulatory approval licensed product united state through first full janssen calendar year thereafter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold right font font size style font size meaning forth section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold study font font size style font size mean those clinical study licensed product that forth global development plan intended support regulatory approval licensed product united state whether also supportive regulatory approval other country regardless where such study performed font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size mean between font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold valid claim font font size style font size mean claim unexpired patent issued granted patent office that been revoked held unenforceable invalid decision court governmental authority competent jurisdiction from which appeal taken with respect which appeal taken within time allowed appeal that been disclaimed admitted invalid unenforceable through reissue disclaimer otherwise font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold work plan font font size style font size mean portion case constituting written plan including gantt chart development licensed product describing activity performed party their respective responsibility therefor party case font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold working group font font size style font size mean joint team composed representative party with appropriate background experience formed advise other joint committee hereunder matter particular nature such those specified herein font align center style margin text align center text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold license grant geron right font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold geron grant font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold development license font font size style font size subject term condition this agreement geron hereby grant janssen exclusive even geron except extent geron expressly retains expressly granted back right under this agreement worldwide license with right sublicense accordance with section nbsp under geron product geron development program develop have developed active substance licensed product field make manufacture have made manufactured have used import active substance licensed product such purpose license right granted under this section nbsp shall commence effective date throughout royalty term continue thereafter fully paid basis subject termination provision under section nbsp nbsp article nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold commercialization license font font size style font size subject term condition this agreement geron hereby grant janssen exclusive even geron except extent geron expressly retains expressly granted back right under this agreement worldwide license with right sublicense accordance with section nbsp under geron product geron development program commercialize have commercialized offer sale sell have offered sale sold active substance licensed product field make have made have used import active substance licensed product such purpose license right granted under this section nbsp shall commence effective date continue licensed product licensed product country country basis throughout royalty term particular licensed product particular country continue thereafter fully paid basis with respect such licensed product such country subject termination provision under section nbsp nbsp article nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold license under geron assay font font size style font size subject term condition this agreement geron hereby grant janssen exclusive worldwide license with right sublicense accordance with section nbsp under geron assay patent right make import geron assay know perform assay measuring telomerase activity telomere length characterize active substance licensed product nonclinical clinical sample solely connection with janssen development manufacture commercialization active substance licensed product accordance with license granted under section nbsp section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold certain limitation font font size style font size geron represents warrant that geron product patent right existing effective date forth exhibit nbsp jointly owned geron third party identified such exhibit nbsp that subject applicable geron equal undivided interest each such geron product patent right janssen acknowledges that exclusive right granted geron janssen pursuant section font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size under jointly owned geron product patent right only with respect geron joint ownership interest such geron product patent right subject applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold existing license font font size style font size geron represents warrant that provided janssen with true copy existing license third party forth exhibit nbsp that other agreement exist between geron third party which impact right geron able license janssen under geron product janssen acknowledges that exclusive right granted geron with respect geron product patent right under section subject term existing license third party listed exhibit nbsp such agreement effect execution date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold sublicensing font font size style font size event that janssen grant sublicense license right granted janssen under this section nbsp affiliate third party janssen shall remain responsible obligation under this agreement shall responsible performance relevant sublicensee compliance such sublicensee with term condition this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold study data lead phase study data package font font size style font size each party shall provide promptly with identified data other result received from clinical study licensed product conducted under global development plan which affiliate third party subcontractor sublicensee hold upon compilation complete lead phase study data package shall make available copy each party advise each party such availability font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold janssen license continuation election font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold janssen continuation election font font size style font size janssen wish retain license right granted under section nbsp then within period ending earlier font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size date that after lead phase study read font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size date that month after dosing licensed product patient first phase study conducted under global development plan janssen election period font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size janssen shall provide geron with written notice electing continue development licensed product this case continuation notification font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold janssen alternative continuation election event study termination clinical hold font font size style font size event that lead phase study been either terminated early pursuant section nbsp placed clinical hold suspended regulatory authority consecutive month period such month period lead phase study suspension period first phase study been able initiated under global development plan prior termination lead phase study prior during month period that lead phase trial clinical hold suspended then unless such clinical hold suspension lifted prior expiry such font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size month period janssen shall retain license right granted under section nbsp within period such period janssen alternative election period ending font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size date that twenty four month after dosing licensed product patient lead phase study font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size lead phase study commenced nbsp month after termination lead phase study nbsp expiry lead phase study suspension period nbsp date that twenty four month after termination pursuant section nbsp lead phase study commencement lead phase study suspension period font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size janssen provides geron with written notice electing continue development licensed product this case also continuation notification font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold effect election font font size style font size geron shall notify janssen writing date commencement janssen election period janssen alternative election period case event janssen timely delivers continuation notification pursuant section nbsp nbsp geron option exercise right pursuant section nbsp below shall come into effect upon geron receipt such notice event janssen fails provide geron with continuation notification within applicable election period under section nbsp nbsp then absence janssen providing notice termination under section nbsp janssen shall deemed have provided geron with written notification terminate this agreement under section nbsp effective first following janssen election period janssen alternative election period case event that janssen election period janssen alternative election period both running then janssen shall deemed have provided timely continuation notification long provides such notice prior expiry last expire janssen election period janssen alternative election period example lead phase study been placed clinical hold suspended regulatory authority consecutive month period such hold lifted study resume after expiry lead phase study suspension period then janssen provide continuation notice during janssen election period janssen alternative election period font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold geron option united state font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold geron decision package font font size style font size event janssen provides continuation notification under section nbsp above then within thereafter janssen shall provide geron following extent such item possession janssen affiliate date delivery continuation notification have been provided geron directly through nbsp preliminary interim case under applicable trial protocol identified data result analysis from lead phase risk study nbsp proposed work plan setting forth design synopsis associated development budget those additional study which study that would included pursuant section nbsp under geron were exercise right whether such additional study have been initiated janssen such time nbsp font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size then projected date first commercial sale licensed product being developed under along with preliminary estimate average annual promoting cost licensed product nbsp following development cost information associated with development activity under global development plan only extent that such activity have been initiated janssen such time additional study that study that pursuant section nbsp would become incorporated into upon geron exercise right nbsp total development cost incurred through last full janssen calendar quarter immediately preceding date geron decision package nbsp good faith estimate development cost incurred since last last full janssen calendar quarter immediately preceding date geron decision package nbsp good faith projection development cost anticipated incurred during period between date geron decision package geron election period each case under development budget associated with such additional study collectively geron decision package avoidance doubt initial development budget such additional study that study referenced clause nbsp above shall become subject annual budget variance limit geron shall janssen part development cost incurred thereunder part development cost described clause nbsp above unless until geron exercise right thereupon such study initial development budget incorporated into font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold geron election right font font size style font size within after receiving complete geron decision package geron election period geron shall notify janssen writing geron election notification whether geron elect nbsp fund with janssen further development licensed product beyond initial study licensed product including additional study that study toward regulatory approval united state with geron responsible twenty percent total development cost including supply cost party such development activity including study forth nbsp support twenty percent promoting activity under promotional plan licensed product united state either through contribution twenty percent sale representative detail upon geron exercise promotion option under section nbsp qualification promote under section nbsp reimbursement promoting cost incurred janssen under promotional budget case with reconciliation such ramp time during which such percentage detail described clause nbsp than forth section nbsp such right obligation under clause nbsp nbsp collectively right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold promote decision package font font size style font size order facilitate geron determination whether exercise promotion option granted under section nbsp below within janssen receipt geron election notice exercising right under section nbsp above janssen shall provide geron with nbsp update geron decision package information provided under section nbsp nbsp preliminary promotional plan such licensed product summarizing high level promotional activity planned such licensed product united state including estimate average annual aggregate detailing effort promoting licensed product following then projected date first commercial sale geron promotion decision package font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold geron promote option font font size style font size only geron provided geron election notification exercising right accordance with section nbsp above then upon such exercise janssen shall hereby grant geron promotion option exercisable notice janssen time during period running from date such geron election notification through date that from date receipt geron promotion decision package pursuant section nbsp promotion exercise period promote licensed product promote territory during period innovator protection united state such licensed product subject term condition article nbsp hereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold geron right development program promotion font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold development program font font size style font size janssen hereby grant geron exclusive worldwide license under applicable geron product geron development program janssen development program janssen product each case during term development program hereunder develop have developed have used import licensed product field pursuant global development plan make manufacture have made manufactured licensed product pursuant manufacturing agreement development activity pursuant global development plan pursuant manufacturing agreement pharmacovigilance agreement transfer agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold promotion font font size style font size effective only event geron exercise promotion option pursuant section nbsp below other term condition article nbsp hereof janssen shall grant back geron exclusive limited license under applicable geron product geron development program janssen shall grant geron exclusive limited license under applicable janssen development program janssen product each case without right sublicense third party affiliate solely geron promote licensed product following janssen receipt regulatory approval therefor united state providing aggregate detail effort promote territory during period innovator protection therein pursuant promotional plan subject term condition article nbsp hereof promotion agreement notwithstanding anything contrary herein foregoing limited promotion right granted geron under this section nbsp shall assignable otherwise transferable geron clarity shall subject section nbsp event change control geron font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold license constitute under bankruptcy code font font size style font size right license granted under pursuant section this agreement including section nbsp hereof right intellectual property defined section nbsp bankruptcy code each party hereby acknowledges behalf itself affiliate embodiment intellectual property pursuant bankruptcy code include following nbsp data from research development licensed product nbsp active substance licensed product sample inventory nbsp licensed product formulation nbsp laboratory notebook record from either party research relating active substance licensed product including from development program nbsp result from clinical study licensed product nbsp regulatory filing regulatory approval relating licensed product nbsp marketing advertising promotional material relating licensed product font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin text indent font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold trademark license font font size style font size geron represents warrant that effective date otherwise control product trademark right pertaining janssen therefore acknowledges that this agreement grant janssen license right under trademark right geron font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold other right font font size style font size right other than those expressly forth this agreement granted party other party hereunder additional right shall deemed granted either party implication estoppel otherwise with respect patent right know other intellectual property right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold geron covenant font font size style font size except expressly permitted under this agreement geron shall directly through affiliate third party during term hereof nbsp make have made import grant third party right under geron product geron interest development program make have made import licensed product containing except development purpose hereunder transitional manufacturing activity accordance with article nbsp nbsp develop commercialize offer sale sell grant third party right under geron product geron interest development program develop commercialize offer sale sell licensed product containing whether inside outside field alone combination with other product nbsp commercialize grant third party right commercialize active substance that covered time claim imetelstat patent family nbsp commercialize grant third party right commercialize under geron product geron interest development program active substance that identified literature generally known based telomerase inhibitory activity otherwise through same predominant primary mechanism action licensed product nbsp conduct fund otherwise support third party conduct clinical trial outside development program involving active substance licensed product font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold oversight collaborative activity font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold establishment subcommittee font font size style font size promptly after effective date party shall establish joint steering committee well joint development committee that shall report each composed three nbsp representative from geron three nbsp representative from janssen which include clarity employee agent affiliate quorum member event geron exercise right under section nbsp then party shall promptly thereafter establish joint marketing committee that shall also report composed three nbsp representative from geron three nbsp representative from janssen quorum member necessary appropriate agreed establish additional subcommittee delegate task within authority expressly provided hereunder such subcommittee such additional subcommittee shall constitute joint committee hereunder each necessary appropriate establish more working group assign task such working group develop advice facilitate such joint committee decision making within authority avoidance doubt working group shall have font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size decision making authority member joint committee shall appropriately qualified experienced order make meaningful contribution meeting render decision within scope authority hereunder each party replace representative joint committee written notice other party addition specific working group referenced hereunder establish additional working group composed representative party with appropriate functional expertise advise matter within authority hereunder avoidance doubt decision within authority another joint committee delegated working group font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold responsibility font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold development licensed product font font size style font size with respect development licensed product hereunder directly through delegation joint development committee shall subject section nbsp have authority font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size oversee monitor collaboration activity party with respect lead phase study lead phase risk study under other study funded party pursuant term hereof respective percentage share ratio under including additional study under support development toward maintain regulatory approval united state event geron exercise right pursuant font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size monitor activity each party under respective font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size review result progress development program under global development plan including periodic review preliminary interim final data result analysis from study under global development plan including clinical regulatory safety data result report analysis including those contained janssen global safety database font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size review approve from time time modification amendment work plan associated development budget funded study whether initial study additional study within budget variance limit font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size other desired modification within scope authority such modification that would increase development budget funded study excess budget variance limit substantial modification design lead phase study lead phase risk study propose party consideration potential agreement party amendment font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size recommend party development program invention claiming development program patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size discus potential publication strategy with respect development program result subject subcontractual obligation third party subcontractor pertaining publication their result font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size under advice working group monitor oversee manufacture active substance licensed product clinical study under global development plan order audit manufacturing site clinical supply intended development program monitor implementation capa plan subject section nbsp accept reject source licensed product manufactured clinical supply based suitability clinical study under font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold promoting licensed product font font size style font size with respect promoting licensed product hereunder following geron exercise right directly through delegation joint marketing committee shall have authority font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size oversee monitor promoting activity janssen party geron been granted promoting right pursuant section under promotional plan font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size monitor activity janssen under independent promotional plan font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size recommend party proposed modification promotional plan font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size geron been granted promoting right perform other oversight function with respect promotion licensed product promote territory specifically delegated promotion agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size review discus janssen promotional plan licensed product other major market country which licensed product obtains regulatory approval font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size where geron exercised promote option review discus janssen medical affair plan promote territory including nbsp field based medical education activity grant based medical education program nbsp post marketing study nbsp scientific presentation publication strategy relating licensed product font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size notwithstanding anything contrary herein neither shall have authority modify promotional plan promotional budget developed pursuant section nbsp janssen shall have sole responsibility commercialization decision including with respect designing approving promotional material licensed product used sale representative detail such licensed product other promotional activity programming support licensed product medical affair activity design implementation post marketing study font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold patent working group font font size style font size each party shall establish appoint member patent working group comprising three five representative from each geron janssen patent working group including patent attorney agent designated such party lead contact patent representative discussing patent matter coming before joint committee pertaining development manufacture promoting licensed font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size product hereunder joint committee other working group shall discus issue relating geron product patent right development program patent right patent right third party relevant development manufacture promoting licensed product including with respect their scope patentability validity prosecution infringement unless both party patent representative present patent working group hold meeting separate from connection with meeting joint committee working group appropriate discus such issue relating such patent right party patent representative shall solely responsible documenting their discretion issue discussed joint committee other working group relating patent right which document content such discussion shall held strict confidence party protect their common interest preserve privileged status attorney client communication advice legal opinion reflected therein party acknowledge that patent working group established purpose advising joint committee that article nbsp governs responsibility prosecuting enforcing geron product patent right development program patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold joint committee meeting font font size style font size shall meet quarterly long party conducting collaboration activity under this agreement such other time party agree shall determine frequency schedule other joint committee meeting provided that established shall meet every quarter more frequently party otherwise agree first meeting shall held soon reasonably practicable event later than after effective date meeting shall held such place place mutually agreed teleconference videoconference provided that least quorum member each party present joint committee meeting each party from time time invite reasonable number participant addition representative joint committee such working group member attend joint committee meeting which additional participant shall member shall attend joint committee meeting basis voting capacity joint committee meeting will chaired janssen chairperson shall agenda joint committee meeting advance provided that agenda will include matter within authority joint committee hereunder reasonably requested geron addressed party will rotate responsibility recording preparing within reasonable time issuing draft minute each joint committee meeting each party member review chairperson shall issue party final minute signed otherwise approved writing such electronic signature janssen joint committee representative geron joint committee representative font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold meeting expense font font size style font size each party shall bear cost including travel expense incurred joint committee member additional member participant such party connection with their attendance joint committee meeting other activity related joint committee avoidance doubt such cost shall included development cost font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold decision making font font size style font size decision joint committee within scope authority hereunder shall made unanimous vote with janssen representative joint committee collectively having nbsp vote geron representative joint committee collectively having nbsp vote decision joint committee reporting shall memorialized font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size meeting minute become effective until ratified unanimous vote decision shall memorialized meeting minute fails reach unanimous decision matter within authority that been pending excess such other period party agree writing matter shall referred applicable executive officer party shall attempt reach mutual decision event that executive officer reach mutual decision with regard such matter then janssen shall have deciding vote subject section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold certain limitation decision making font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold modification work plan budget budget variance limit font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold ongoing study initial study font font size style font size work plan development budget ongoing study initial study effective date part under initial global development plan proposed modification work plan development budget ongoing study initial study whether prior after decision geron exercise right shall subject approval decision making authority forth section nbsp provided however that janssen shall have deciding vote thereon provided that nbsp geron shall unreasonably withhold consent modification proposed janssen good faith work plan development budget with respect initial study nbsp party decision making with respect initial study subject section font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold additional study font font size style font size work plan development budget additional study effective date part initial global development plan prior geron exercise right janssen shall have right modify work plan related development budget with respect additional study forth section nbsp upon geron exercise right initial development budget associated work plan nbsp provided geron decision package additional study that study shall part development budget work plan nbsp under subsequently approval proposed modification other than budget modification which subject section nbsp work plan development budget with respect additional study including modification study then current addition study required deemed advisable regulatory approval named indication including proposed trial decision making mechanism which forth section nbsp shall subject approval decision making authority forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold budget modification additional study font font size style font size upon geron exercise right initial development budget provided geron decision package additional study that study shall development budget under going forward thereafter subject annual budget variance limit pertains decision making hereunder proposed modification then current work plan associated development budget with respect additional study that effect increasing aggregate budgeted amount such additional study under development budget allocated particular janssen calendar year more than budget variance limit shall deemed budget modification shall outside font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size decision making authority pursuant section nbsp upon either party request shall prepare party consideration draft amendment work plan development budget reflect such proposed budget modification enable party better understand evaluate such proposed budget modification such budget modification shall become effective however unless until memorialized writing signed both party notwithstanding foregoing geron shall unreasonably withhold consent janssen proposed budget modification development budget that nbsp increase projected development cost based more current information updated assumption incurred normal course completing additional study related activity forth then current work plan excess development cost development budget such activity nbsp study required deemed advisable regulatory approval licensed product nbsp more named indication nbsp addition work plan associated development budget perform supplemental activity proposed janssen that reasonably necessary ancillary activity conduct completion additional study accordance with then current protocol each case forth then current provided that full janssen calendar year following regulatory approval licensed product major market country only geron discretion withhold consent sole determination such proposed budget modification during such janssen calendar year either nbsp cause aggregate budget modification such janssen calendar year excess dollar aggregate clarity such dollar shall apply budget modification proposed before full janssen calendar year following regulatory approval licensed product such major market country font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold material modification protocol initial study font font size style font size material modification protocol initial study regarding study design including with respect patient enrollment criterion statistical analysis plan clinical pharmacology bioanalytical method assessment endpoint size timing readout excluding change dosage licensed product shall made only unanimous decision which decision shall subject janssen final decision making authority under section nbsp event failure party executive officer reach unanimous decision provided however that geron representative shall unreasonably withhold consent including with respect such material modification which required regulatory authority party executive officer fail reach unanimous decision with respect other proposed material modification required regulatory authority excluding licensed product dosage change protocol initial study party shall refer such issue expert proxy resolution accordance with section nbsp clarity nbsp section nbsp this section nbsp shall apply proposed required discontinuation early termination initial study nbsp foregoing provision this section nbsp shall construed otherwise limiting janssen final decision making authority event unanimous decision reached other matter within scope authority clarity change dosage licensed product protocol initial study shall constitute material modification protocol janssen shall retain final decision making authority under section nbsp event failure party executive officer reach unanimous decision with respect such dosage change font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold discontinuation initial study font font size style font size except provided section nbsp proposed discontinuation early termination initial study party other than clinical hold suspension study regulatory authority including ceasing enrollment additional patient required protocol shall made only unanimous decision which decision shall unreasonably withheld delayed subject escalation executive officer pursuant section nbsp event failure party executive officer reach unanimous decision notwithstanding section nbsp such unresolved issue shall subject janssen final decision making authority except case where either nbsp such discontinuation required regulatory authority nbsp continuation continued enrollment additional patient particular initial study would unethical unreasonable safety related reason such that based good faith assessment janssen relevant data continuation such initial study resulted significant risk resulting occurrence safety tolerability finding that would raise material concern regarding clinical benefit licensed product target population such initial study example harm significantly excess acceptable side effect profile nbsp continuation continued enrollment additional patient such initial study would unethical insufficient efficacy based futility analysis such initial study forth applicable protocol with respect unresolved issue regarding proposed discontinuation initial study which other than that described foregoing clause nbsp executive officer agree upon such discontinuation then such issue regarding proposed discontinuation initial study shall subject expert proxy resolution under section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold prosecution geron product patent right development program patent right governed article nbsp font font size style font size notwithstanding other provision this agreement contrary decision regarding prosecution geron product patent right development program patent right shall within authority provision article nbsp this agreement shall govern prosecution such patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold accounting methodology promoting cost font font size style font size notwithstanding other provision this agreement contrary failure referred them under section nbsp party executive officer reach unanimous decision regarding particular accounting methodology used determine promoting cost forth section nbsp nbsp shall subject janssen final decision making authority under section nbsp provided that particular accounting methodology determined result application such final decision making under advice finance working group compliant with accounting standard applicable consistent with accounting methodology similar promotional cost consistently applied janssen font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold acceptability existing clinical font font size style font size notwithstanding other provision this agreement contrary failure party executive officer reach unanimous decision regarding acceptability unexpired batch licensed product that were manufactured behalf geron before effective date compliance with gmps other applicable remain within specification shall subject janssen final decision making authority under section nbsp event such failure party shall refer such issue expert proxy resolution pursuant section nbsp font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold authority modify agreement font font size style font size notwithstanding anything contrary herein neither other joint committee working group shall have authority nbsp modify provision forth body this agreement including payment condition term obligation party which provision modified only written agreement party nbsp resolve dispute font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold dissolution font font size style font size notwithstanding anything contrary above event geron exercised right under section nbsp provided that upon lead phase study lead phase risk study have been completed otherwise terminated then nbsp subcommittee including shall dissolve nbsp party shall form joint oversight committee composed from three representative each party which will meet least quarterly basis until first commercial sale licensed product united state thereafter semi annual basis nbsp janssen shall provide geron confidence each such meeting such joint oversight committee reasonable overview result plan janssen development commercialization activity hereunder nbsp janssen shall provide geron confidence with quarterly written progress report summarizing janssen development commercialization activity hereunder reasonable request geron more than once year during term janssen shall supplement such report providing reasonable information facilitate geron assessment whether janssen complying with diligence obligation under this agreement information provided joint oversight committee meeting report under this section nbsp shall treated janssen confidential information hereunder font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold alliance manager font font size style font size each party shall designate single alliance manager coordinating interaction between party regarding activity contemplated under this agreement alliance manager such alliance manager will responsible worldwide coordination collaboration activity will serve facilitate routine communication between party such alliance manager shall have experience knowledge appropriate manager with such project management responsibility each party change designated alliance manager from time time upon written notice other party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold expert proxy undecided matter requiring unanimous vote font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size issue within decision making authority that subject janssen final decision making authority under section nbsp requires unanimous vote expressly provided section nbsp which fails reach unanimous decision further which party executive officer fail reach mutual decision escalated issue pursuant section nbsp shall resolved pursuant procedure forth this section nbsp expert proxy resolution font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size decision made behalf party expert proxy resolution will made follows upon failure party executive officer reach decision applicable issue described section nbsp shall notify party issue submitted expert proxy resolution following receipt such notice party shall confer attempt good faith mutually select engage single external expert resolve issue such expert shall neutral independent both party their font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size respective affiliate shall have significant experience expertise clinical development product manufacturing regulatory affair pertaining pharmaceutical product appropriate considering unresolved issue party agree such single expert within notice then each party shall select nbsp such expert nbsp expert selected party shall appoint third expert decision shall rendered expert panel provided that such three nbsp expert must meet foregoing criterion shall mutually engaged party under written contract acceptable both party within each expert selection appointment within after expert nbsp selected appointed case each party will deliver expert nbsp other party written memorandum setting forth unresolved issue proposed decision relevant information supporting argument rationale each proposed resolution applicable party such memorandum exceed page nbsp length with double spaced typeface least point font party will also provide expert nbsp with copy this agreement amended such time within after receipt other party proposed resolution each party submit expert nbsp with copy other party response other party proposed resolution such response exceed page nbsp length with double spaced type face least point font neither party have other communication either written oral with expert nbsp other than expressly permitted this section provided that expert nbsp convene hearing expert nbsp choose nbsp question party within after appointment selection required expert expert nbsp will render written decision selecting proposed decision forth proposed resolution without modification unless party mutually agree decision expert nbsp shall final memorialized party shall share equally pocket cost incurred engaging expert font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size avoidance doubt expert proxy resolution apply resolution dispute expert nbsp shall have power authority award either party relief render decision other than expressly provided section nbsp font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold development font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold clinical development plan font font size style font size development licensed product shall conducted pursuant either initial global development plan effective date attached hereto exhibit nbsp includes nbsp work plan development budget initial each initial study nbsp proposed work plan development budget additional study which study intended execution date support regulatory approval licensed product containing more named indication planned future implementation depending party evaluation clinical data other result from ongoing study nbsp certain work plan development budget ongoing study which shall remain sole financial responsibility geron unless party expressly agree writing fund development cost incurred after effective date conduct complete close such ongoing study specified associated development budget nbsp applicable ongoing study forth nbsp work plan development budget study intended support further development licensed product regulatory approval united state regardless whether geron ultimately elect exercise right party acknowledge that initial global development plan preliminary font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size provides high level work plan estimated development budget both initial study certain additional study party through shall commercially reasonable effort agree upon updated more detailed global development plan course after effective date prior beginning geron election period further information develops subject section clarity until such time ever that geron exercise right janssen shall have sole discretion update modify work plan associated development budget additional study under global development plan provided that keep apprised such update modification font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold development diligence font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size janssen shall diligent development effort develop least licensed product toward regulatory approval each named indication such development successful seek regulatory approval each such named indication each major market country janssen shall also diligent development effort initiate have initiated commercially reasonable time additional study licensed product each other indication extent specified then current considering such time circumstance such evolving data other result from prior ongoing clinical study licensed product other data pertaining developability licensed product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size without limiting section nbsp each party shall diligent development effort perform respective development activity under each party affiliate third party subcontractor shall conduct development activity good scientific manner compliance with applicable including regulation regarding environmental safety industrial hygiene good laboratory practice good clinical practice nbsp informed consent nbsp institutional review board requirement pharmacovigilance applicable requirement relating protection human subject clinical study notwithstanding anything contrary herein party shall obligated undertake continue development activity with respect licensed product such party reasonably determines that performance such development activity would violate applicable pose unacceptable safety risk clinical study subject font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size without limiting obligation forth section nbsp promptly following effective date finalization protocol initial study janssen shall commence each party shall diligent development effort conduct each initial study material accordance with including associated development budget clarity each party acknowledges that timeline reflected initial study good faith approximation only shall construed imposing obligation strictly adhere such timeline subject foregoing this section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold transfer know font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold from geron prior work font font size style font size after effective date notwithstanding anything contrary written plan party whether appended this agreement exhibit geron shall provide janssen reasonable rolling font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size basis copy access mutually agreed time during normal business hour business upon reasonable notice permit janssen make copy janssen expense geron product know relating arising from geron affiliate third party contractor activity before effective date recorded form including laboratory notebook entry database entry monograph report slide presentation provided that nbsp geron shall prioritize transfer particular geron product know forth written plan party that appended hereto otherwise agreed upon nbsp copy laboratory notebook entry such geron product know provided promptly after janssen delivers continuation notification provided that until such time geron shall provide copy such laboratory notebook entry relating certain such know reasonably requested janssen thereafter during term geron shall reasonable effort promptly provide janssen upon reasonable request with copy other geron product know font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold from work development program font font size style font size extent that geron performing otherwise involved development activity hereunder including through nbsp janssen shall provide geron directly through meeting joint development committee copy development program know developed behalf janssen that necessary useful performance development activity performed behalf geron under geron nbsp geron shall provide janssen directly through meeting joint development committee copy development program know developed behalf geron including development program know that necessary useful making using developing under janssen manufacturing commercializing licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold responsibility regulatory filing responsibility development font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold inds other regulatory filing font font size style font size provision this section nbsp shall apply clinical development program font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold existing geron held inds font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold ongoing clinical study font font size style font size with respect each ongoing study listed exhibit nbsp party shall commercially reasonable effort enter into mutually acceptable transfer agreement enable janssen assume responsibility performing activity forth exhibit nbsp such activity hereafter agreed party transfer agreement geron shall remain responsible case cost liability arising connection with performance failure perform activity obligation with respect ongoing study nbsp prior effective date thereafter until transfer such ongoing study nbsp regardless date such transfer specified assigned exhibit nbsp geron performance both case nbsp nbsp relation each ongoing study listed exhibit nbsp unless party agree otherwise transfer agreement geron shall reimburse janssen development cost expended janssen connection with performance activity obligation forth exhibit nbsp transfer agreement unless such transfer agreement provides otherwise until such time that party able enter into mutually acceptable transfer agreement with respect such described this subsection geron request janssen font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size shall commercially reasonable effort expend resource necessary assist geron geron designee performing activity specified exhibit nbsp geron performance such preparing regulatory filing review submission geron geron shall nbsp remain responsible cost liability arising from failure relation such geron held inds nbsp shall reimburse janssen development cost expended janssen connection with performance such requested activity clarity exhibit nbsp intended assign party their respective internal operational responsibility hereunder allocate transfer liability cost event inconsistency between term exhibit nbsp body this agreement body this agreement shall control font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold publication result from ongoing study other study font font size style font size clarity section nbsp shall apply clinical study listed exhibit nbsp exhibit nbsp exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold inds clinical study font font size style font size unless otherwise agreed writing party janssen shall responsible filing maintaining directly through affiliate third party subcontractor inds maintaining directly through affiliate third party subcontractor inds transferred janssen pursuant transfer agreement clinical study licensed product initiated after effective date under including initial study janssen inds geron shall commercially reasonable effort upon janssen request cooperate have geron applicable third party contractor subject applicable existing third party agreement cooperate facilitate janssen establishment sponsorship assumption responsibility transferred electronic updating clinical study under unless decides otherwise transfer agreement otherwise provides party having shall responsible filing maintaining directly through affiliate third party subcontractor inds clinical study licensed product initiated after effective date under such party extent necessary geron janssen shall provide geron right cross reference janssen inds between party except expressly provided otherwise hereunder transfer agreement effective date janssen shall solely responsible interaction with regulatory authority with respect licensed product under janssen clinical study licensed product initiated after effective date under clinical study transferred geron janssen pursuant transfer agreement filing maintaining directly through designated affiliate third party subcontractor where necessary geron regulatory filing licensed product under such janssen inds janssen shall regulatory filing made connection with development seeking regulatory approval licensed product under janssen janssen shall hold regulatory approval licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold ownership inds font font size style font size clarity with regard inds licensed product filed sponsored party conduct development activity hereunder such party shall deemed each such filed name except otherwise forth transfer agreement additionally accordance with section nbsp geron hereby grant janssen janssen shall have directly through affiliate right reference with respect each such held behalf geron janssen font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size development purpose hereunder accordingly regulatory authority considering regulatory filing relating licensed product being developed hereunder shall permitted rely otherwise applicable information such geron held inds font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development font font size style font size janssen shall have responsibility managing collaboration activity relating development chemistry manufacturing control technology associated know manufacture licensed product which activity clarity include actual production testing clinical supply which manufacturing activity governed section nbsp below except otherwise provided herein geron role performing such collaboration activity excluding obligation under current manufacturing contract other existing third party agreement shall provide janssen upon janssen reasonable request pursuant work plan associated development budget assistance design conduct troubleshooting such chemistry manufacturing control know development activity related development study cost incurred account geron connection with such assistance shall deemed development cost under reimbursed rate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold regulatory meeting font font size style font size janssen shall responsible directly through affiliate sublicensees where necessary through geron interaction with regulatory authority connection with regulatory filing hereunder subject applicable however geron shall have right designate silent observer attend material meeting conference discussion janssen affiliate with regulatory authority pertaining development licensed product field under such observer shall treat information observed discussed therein relating licensed product janssen trade secret confidential information janssen shall provide geron with reasonable advance notice such meeting conference with regulatory authority font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold regulatory reporting safety database font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold responsibility font font size style font size after filing janssen transfer geron janssen applicable initial study licensed product under between party report including adverse event report made regulatory authority connection with development activity conducted sponsored behalf either both party hereunder licensed product shall made exclusively janssen accordance with term condition pharmacovigilance agreement case that geron contributed information data report being submitted regulatory authority janssen shall provide geron with copy such report comment advance unless time reasonably permit considering circumstance janssen font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold adverse event reporting font font size style font size promptly such within business after party becomes informed serious adverse event clinical trial involving licensed product shall notify other party such notifying party shall thereafter continue provide additional information other party relevant such including extent necessary such other party comply with applicable including security regulation applicable rule nbsp public stock exchange geron acknowledges agrees that janssen party having right hold drug application licensed product hereunder required submit information file font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size report various regulatory authority licensed product under clinical investigation licensed product proposed promoting marketed licensed product including such information typically required time initial filing investigational human time request regulatory approval licensed product addition janssen required provide supplemental information licensed product periodic interval report adverse event drug experience more frequent interval depending severity experience whether event unexpected with respect development activity conducted behalf geron under global development plan upon reasonable request janssen geron shall nbsp provide janssen with adverse event information safety related data available within control geron from clinical laboratory animal toxicology pharmacology study clinical study reasonably necessary expected necessary janssen comply with applicable pertaining licensed product nbsp report provide such information janssen such manner time enable janssen comply with applicable font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold global safety database font font size style font size janssen shall establish global safety database such licensed product including storing safety data from clinical study licensed product under inds held janssen storing safety data within geron product know each licensed product developed under janssen janssen shall maintain global safety database information relating adverse event pregnancy report such licensed product which shall include serious adverse event data other information relating other adverse event janssen decides include reasonable discretion which janssen regulatory reporting responding safety query from regulatory authority promptly after effective date during term extent geron conducting conducted development activity under geron geron shall shall cause affiliate third party contractor disclose information relating adverse event pregnancy report from clinical licensed product their possession control janssen inputting into global safety database within mutually agreed period time each party shall handle serious adverse event information other safety data that come into possession during development commercialization licensed product hereunder accordance with applicable during time geron regulatory sponsor under global development plan continuing obligation forth exhibit nbsp with respect licensed product upon geron good faith request janssen shall promptly make available geron such information from janssen global safety database licensed product geron deems necessary good faith fulfill geron pharmacovigilance reporting other compliance obligation under applicable applicable regulatory authority connection with such sponsorship enable geron fulfill obligation forth exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold pharmacovigilance agreement font font size style font size within effective date each party shall identify safety representative other party lead negotiation between party regarding process procedure sharing adverse event information which process procedure shall documented written pharmacovigilance agreement signed party pharmacovigilance agreement later than party identification their respective safety representative such other time party otherwise agree pharmacovigilance agreement shall define safety data exchange procedure concerning adverse event including adverse drug reaction with respect font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size licensed product sufficient permit each party affiliate subcontractor sublicensees case comply with requirement applicable pertaining drug safety pharmacovigilance including extent applicable those obligation contained health care imposed regulatory authority pharmacovigilance agreement shall reflect that janssen shall maintain comprehensive global safety database adverse event pregnancy report other safety data reported anywhere world from human licensed product anywhere licensed territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold conditional subcontracting font font size style font size party subcontract development activity hereunder third party provided that nbsp such party executes written subcontract agreement with such third party that contains material respect applicable obligation covenant hereunder nbsp party subcontract third party sponsorship clinical study including investigator initiated study licensed product under without prior written approval except expressly provided nbsp geron subcontract third party sponsorship clinical study including investigator initiated study licensed product under geron without prior written approval party engaging subcontractor shall responsible performance subcontractor hereby warrant compliance with material term hereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold division study based geron decision font font size style font size event geron exercise right within geron election period pursuant section nbsp then work plan development budget additional study which study such time included global development plan shall deemed have been included effective purpose allocating responsibility cost under section nbsp initiation activity under such work plan avoidance doubt work plan development budget study that such time included global development plan other than forth geron shall included janssen font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold effect failure exercise font font size style font size event geron elect exercise right fails make timely election within geron election period then work plan development budget study that such time included global development plan other study forth such time other than initial study shall deemed have been incorporated into janssen addition study global development plan intended conducted behalf janssen affiliate sublicensees shall also included more nbsp janssen avoidance doubt geron exercise right provided section nbsp then nbsp janssen license right commercialize licensed product united state under section nbsp above shall become remain exclusive even geron janssen shall solely responsible activity cost associated therewith forth section nbsp nbsp geron shall have right undertake development licensed product other than provided geron font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen independent development activity font font size style font size avoidance doubt nothing herein shall restrict janssen from independently undertaking development font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size activity licensed product including initiating clinical study repeating clinical study previously conducted under that failed meet primary endpoint provided that nbsp event janssen independently undertakes such activity they shall deemed within scope development program term this agreement shall continue apply thereto nbsp event geron exercise right janssen shall first propose activity proposed trial already subject pursuant section nbsp nbsp janssen development activity under this agreement shall performed pursuant more regardless whether geron exercise right font style margin text indent font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold additional development proposed trial font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold additional development proposal font font size style font size nbsp janssen before geron exercise right nbsp either party after geron exercise right desire undertake proposed trial licensed product then such party shall submit written proposal addition such trial additional development proposal each additional development proposal shall include development proposal criterion proposed trial such other general content require provided however that party proposing such proposed trial proposing party have information required complete development proposal criterion package shall submit such information then available connection with additional development proposal elect form preclinical working group evaluate proposed trial licensed product such oncology indication direct such working group complete information lacking from such development proposal criterion thereafter completed additional development proposal shall submitted review shall promptly consider additional development proposal later than receipt forward along with consensus comment including decision whether belief that there high degree confidence that conduct proposed trial result will adversely affect other development commercialization licensed product shall within business such other time agreed party receipt additional development proposal comment render decision party whether unanimously recommends that party amend including development budget include proposed trial font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold adoption additional development proposal font font size style font size unanimously recommends adoption additional development proposal ratifies such recommendation party shall thereafter enter into good faith negotiation modify written amendment this agreement development budget based such additional development proposal associated budget allocation development cost such proposed trial between party with unless otherwise agreed amendment twenty percent such development cost being allocated geron geron exercised right under section nbsp upon party executing such written amendment proposed trial shall deemed additional study within scope development activity thereunder development cost such trial shall allocated between party specified such written amendment font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold effect failure agree font font size style font size unanimously recommend adoption additional development proposal recommends against inclusion proposed trial party unable reach written agreement amend include proposed trial within recommendation under section nbsp then provided that each have decided that there high degree confidence that conduct proposed trial considering potential result outcome proposing party will adversely affect other development commercialization licensed product proposing party upon notice other party elect conduct proposed trial independently expense proposed trial shall deemed within scope development program global development plan clarity term this agreement shall continue apply thereto nbsp proposing party shall provide other party with such trial updated from time time nbsp shall have decision making authority with respect conduct such proposed trial although shall have authority monitor proposing party progress review result from proposed trial under avoidance doubt this section nbsp provides only mean which geron conduct development activity with respect active substance licensed product independent geron conduct clinical trial active substance licensed product except pursuant geron hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron additional development font font size style font size case that geron proposing party under section nbsp successfully conduct proposed trial under geron clarity excluding clinical trial identified exhibit expense shall notify janssen writing provide reasonably detailed accounting geron pocket cost cost reasonably incurred conducting proposed trial under geron collectively geron trial cost upon receipt such notice notwithstanding anything contrary herein janssen shall promptly seek regulatory approval major market country which registration supported final data available upon completion proposed trial under geron based data from such geron trial such expand licensed product labeling include oncology indication supported proposed trial shall geron amount equal percent difference resulting from nbsp geron trial cost minus nbsp cost pocket cost incurred janssen seeking regulatory approval which amount will upon janssen receipt regulatory approval such expanded licensed product labeling payable within thereafter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold janssen additional development font font size style font size event geron exercise right under section nbsp case that janssen proposing party under section nbsp successfully conduct proposed trial which clarity would include study under janssen expense obtains regulatory approval based data from such trial such expand licensed product labeling include oncology indication supported trial such regulatory approval janssen based regulatory approval shall notify geron writing such janssen based regulatory approval provide reasonably detailed accounting janssen pocket cost cost reasonably incurred conducting such proposed trial clarity other than study under janssen janssen trial cost which event geron shall janssen amount equal percent janssen trial cost geron reimbursement font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold amount font font size style font size which geron reimbursement amount will upon janssen receipt janssen based regulatory approval payable follows geron election notice janssen provided within geron receipt notice janssen based regulatory approval particular additional study under janssen geron shall within such notice janssen provision invoice amount geron reimbursement downpayment that lesser nbsp full geron reimbursement amount nbsp amount equal greater dollar percent total amount paid janssen geron prior month form upfront milestone payment royalty with such payment geron reimbursement downpayment geron shall hereby grant janssen credit right offset assessed pursuant section nbsp which credit janssen thereafter apply accordance with section nbsp notwithstanding anything contrary herein geron right under this section nbsp shall subject section nbsp including balance ceiling under section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold suspension independent trial font font size style font size time after commencement proposed trial under party other party determines reasonably good faith that such trial reasonably likely adversely affect development commercialization licensed product field such party shall notify party conducting trial shall promptly thereafter discontinued subject such ethical obligation continue support patient already enrolled clinical trial under party conducting good faith determine unless until decides that such trial should permitted resume continue font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold progress report font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold responsibility font font size style font size each party shall responsible implementation development activity which affiliate otherwise assigned responsibility under shall keep other party reasonably informed progress such activity result including development program know therefrom font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development report font font size style font size each meeting joint development committee each party will report development activity such party affiliate performed caused performed since last meeting including periodic review preliminary interim final data result analysis from study under global development plan addition each party shall provide with such other information reasonably requested other party with respect such development activity party fails adequately provide such report meeting joint development committee other time upon reasonable request either party other party request such party will provide such other party written progress report that includes information regarding development activity support clinical study such regarding accrual site initiation progress protocol writing meeting request briefing document other information within control reasonably necessary convey reasonably comprehensive understanding status result applicable development activity font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold auditing font font size style font size font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold compliance inspection font font size style font size with respect facility site which party affiliate third party contractor subcontractor conduct manufacturing clinical regulated under development activity pursuant this agreement other party shall have right permitted subject term condition applicable existing third party agreement otherwise expressly permitted applicable third party manufacturer expense upon reasonable written notice such party applicable such affiliate contractor subcontractor during normal business hour inspect such site facility record relating thereto once year more often with cause verify other party compliance with term this agreement with applicable including current standard pharmacovigilance practice such inspection shall subject confidentiality provision forth article nbsp each party agrees commercially reasonable effort include contract other written arrangement with subcontractor clause permitting other party exercise right under this section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold site audit font font size style font size janssen through janssen global research nbsp development quality assurance successor organization responsible quality assurance janssen affiliate will responsible establishing audit plan each clinical study assigned party provision section nbsp below shall govern audit site manufacturing clinical supply licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold regulatory audit font font size style font size party shall cooperate good faith event regulatory authority inspects site where clinical study manufacturing clinical supply licensed product conducted behalf party pursuant this agreement whether such audited site such party affiliate contractor such case geron under existing third party agreement subcontractor hereunder permitted subject term condition applicable existing third party agreement otherwise expressly permitted applicable third party each party shall notify other party within business after receiving notification regulatory authority inspection site where clinical study manufacturing clinical supply active substance licensed product conducted each party shall given reasonable opportunity taking into account timing notice provided applicable regulatory authority term applicable existing third party agreement assist preparation other party audited site inspection where appropriate attend inspection regulatory authority other party audited site summary wrap meeting with regulatory authority conclusion such inspection such attendance would result disclosure other party audited site confidential information unrelated subject matter this agreement party shall enter into confidentiality agreement covering such unrelated subject matter event that audited site found compliant with more applicable good laboratory practice good clinical practice good manufacturing practice current standard pharmacovigilance practice compliant party case geron applicable contractor under existing third party agreement shall submit other party capa plan within business after receiving notification such compliance from compliant audited site shall commercially reasonable effort cause such compliant audited site implement such capa plan promptly after submission each party agrees commercially reasonable effort include agreement other written arrangement font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size including amendment applicable existing third party agreement entered into after effective date with applicable contractor subcontractor case clause permitting other party exercise right under this section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold right reference access data font font size style font size janssen shall have right reference geron affiliate drug master file other regulatory filing whether made before during term hereof controlled geron anywhere world related licensed product janssen shall also have right review access request copy such regulatory filing know including data therein such know connection with performance janssen obligation exercise right under this agreement including inclusion such know regulatory filing licensed product provided however that with respect know obtained from trial conducted under geron expense accordance with section nbsp above janssen right cross reference include such know obtained geron expense shall subject satisfaction payment obligation forth section nbsp applicable geron hereby grant janssen right reference that term defined nbsp united state equivalent exclusive right access reference other country region world regulatory filing including geron affiliate clinical dossier controlled geron that relates licensed product janssen exploitation development commercialization right relating licensed product field pursuant this agreement geron affiliate shall provide signed statement this effect requested janssen accordance with nbsp equivalent required other country region world otherwise provide appropriate notification such right janssen applicable regulatory authority event geron conduct development activity under geron geron shall have similar right reference regulatory filing controlled janssen know therein solely extent needed purpose conducting geron activity under geron same manner such right granted janssen under this section nbsp this section nbsp shall apply party with respect thereto mutatis mutandis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold sharing cost development program font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cost allocation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold sharing font font size style font size subject section below development cost including supply cost incurred collectively party connection with lead phase study lead phase risk study pursuant shall borne fifty percent janssen fifty percent geron clarity should janssen elect conduct additional study forth global development plan prior geron election period janssen shall bear hundred percent development cost including supply cost incurred connection with conduct such additional study subject reimbursement portion such cost forth section nbsp nbsp event geron exercise right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold sharing font font size style font size upon geron exercise right under section nbsp then subject section nbsp development cost including supply cost incurred party connection with additional study other development font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size activity described whether initiated before date geron exercise right clarity excluding study other study under shall borne eighty percent janssen twenty percent geron accordingly development activity under work plan additional study that become incorporated into geron exercise right were initiated janssen prior such exercise janssen paid development cost incurred under development budget associated therewith including manufacturing cost related initial study then janssen shall provide geron with report such development cost part geron decision package forth section nbsp finance working group shall review such janssen development cost incurred through time geron exercise advise true payment which such payment shall owed janssen within invoice therefor order satisfy geron obligation contribute twenty percent such development cost incurred prior such exercise clarity date upon which such true payment from geron becomes payable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cost font font size style font size provided section nbsp above subject section nbsp nbsp below party performing development program activity under shall solely responsible cost associated therewith subject janssen payment with respect proposed trial under geron under section nbsp geron payment janssen with respect proposed trial under janssen under section nbsp clarity event geron exercise right while party shall share development cost under forth section nbsp janssen shall bear hundred percent development cost including supply cost study such cost incurred under more janssen further clarity geron exercise right janssen shall bear hundred percent development cost incurred connection with activity conducted behalf janssen affiliate sublicensees further development activity such activity conducted under janssen font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development budget update cost reporting font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size party shall commercially reasonable effort update annual basis development budget upcoming year development program approved agreed writing party case under section nbsp later than december nbsp font font size style font size position relative font font size style font size each applicable year font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size finance working group shall advise shall establish reasonable financial procedure consistent with accounting standard applicable party determine estimated development cost updating development budget under each janssen calendar quarter before enable each party appropriately accrue share development cost financial reporting purpose each party shall record itemized development cost incurred affiliate maintain such record accordance with accounting standard manner permit party comply with financial reporting procedure established joint development committee under advice finance working group which procedure shall consistent with financial reporting requirement party applicable font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size finance working group shall also review advise potential discrepancy other finance accounting matter related development cost under within after each applicable janssen calendar quarter each party shall submit finance working group joint development committee report accordance with established financial procedure development cost under incurred such party during such janssen calendar quarter within following receipt such report each party shall have right request reasonable additional information documentation related other party affiliate development cost during such janssen calendar quarter order confirm that such other party spending conformance with then current development budget font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size notwithstanding anything contrary herein license payment including milestone royalty from geron third party under existing license from third party additional existing third party agreement including such payment resulting from modified term under written amendment such agreement entered into after effective date hereof provided that janssen provided express written approval advance geron enter into each such amendment including modified term thereof further provided that such payment expressly included shared development cost under under this agreement account development licensed product hereunder shall sole expense geron deemed development cost allocable extent janssen hereunder addition license payment including milestone royalty under unblocking license agreement shall sole expense geron treated credited amount pursuant section nbsp deemed development cost allocable extent janssen hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold reconciliation allocate development cost geron excess development cost font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size party with affiliate incurs janssen calendar quarter more than share provided section nbsp after considering applicable financial report provided section nbsp total actual development cost under development budget forth then such party shall provide other party with invoice portion development cost incurred that allocable hereunder other party other party shall reimburse invoicing party reconcile allocation development cost incurred such janssen calendar quarter consistent with section nbsp such amount shall payable from receipt invoice applicable amount addition validation batch licensed product made under later sold janssen affiliate sublicensees commercial supply then janssen shall refund geron share development cost previously allocated under development budget manufacture such batch later used commercialization font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size notwithstanding provision section nbsp nbsp above excess development cost accrue with regard approved budget modification development budget additional study then geron shall have right upon notice janssen within geron receipt invoice development cost that include excess development cost which event clarity right granted geron under this section nbsp nbsp shall limited notwithstanding anything font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size contrary herein geron right under this section nbsp nbsp shall subject section nbsp including balance ceiling under section nbsp further clarity provision this section nbsp shall apply development cost associated with initial study font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold suspension clinical study safety reason font font size style font size notwithstanding anything contrary herein independent safety board determines that clinical study licensed product ongoing development program would pose unacceptable safety risk subject patient participating such study then neither party shall obligated continue such clinical study notwithstanding section nbsp either party delay suspend development activity with respect ongoing clinical study licensed product such party reasonably belief that such clinical study would pose such unacceptable safety risk clarity permanent discontinuance initial study including after such study been delayed suspended accordance with this section nbsp shall subject section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold record font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold maintenance research record font font size style font size each party shall maintain cause maintained record respective collaboration activity conducted material compliance with applicable including requirement each case extent applicable requirement corporate record retention policy consistent therewith such record shall complete accurate shall fully properly reflect work done result achieved performance foregoing activity manner appropriate regulatory purpose when applicable permitted under this agreement connection with filing patent right prosecution patent right such record shall retained longer either nbsp such period required such retaining party corporate record retention policy nbsp such period required applicable nbsp term this agreement unless party first offer deliver such record other party keeping delivers such party record reasonably request before destroying disposing such record font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold access record font font size style font size subject term condition this section each party shall have right mutually agreed time during normal business hour business upon reasonable notice obtain from other party access copy cost record maintained other party pursuant section nbsp solely extent relating active substance licensed product development manufacturing commercialization activity hereunder intellectual property associated right licensed obtained hereunder including nbsp enable requesting party conduct reasonable diligence matter potentially giving rise liability part requesting party according applicable requirement this agreement conduct defense itself with respect such liability extent that fact circumstance event arisen that give requesting party reasonable basis believe that incur such liability nbsp meet obligation regulatory authority with respect licensed product nbsp prosecute enforce patent right hereunder nbsp otherwise exploit right hereunder font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold optional promotion font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron determination exercise promotion option font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size term this article nbsp shall apply party promoting licensed product hereunder following geron exercising promotion option granted under section nbsp promote licensed product providing aggregate detail effort promote territory during period innovator protection therein pursuant section nbsp below font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size time during promotion exercise period which clarity shall expire from receipt geron promotion decision package unless extended written agreement party geron shall have right provide janssen with written notification promotion exercise notice electing exercise geron promotion option under section nbsp which notice election shall include written certification that geron affiliate geron such time posse have option obtain right market promote pharmaceutical ingredient drug substance which constitutes competing oncology product time such election clarity written certification under foregoing sentence shall deemed warranty geron hereunder that best knowledge time geron exercise promotion option neither geron affiliate that geron such time posse option obtain right market promote pharmaceutical ingredient drug substance which constitutes competing oncology product time such election further clarity party acknowledge that relevant time determining whether particular product which geron then option other right license outright license under agreement with third party qualifies competing oncology product under this section nbsp effective date rather date upon which geron provides janssen with such promotion exercise notice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size following receipt promotion exercise notice from geron provided section nbsp janssen geron shall good faith commercially reasonable effort promptly negotiate mutually acceptable promotion agreement consistent with provision this article nbsp term condition exhibit nbsp reasonably updated janssen upon party execution promotion agreement following janssen receipt regulatory approval licensed product promote territory geron shall have right promote licensed product promote territory pursuant promotional plan including timeline forth therein geron commencement detailing activity accordance with section nbsp accordance with term forth this article nbsp promotion agreement provided however that geron shall permit sale representative contribute detail promote territory until such time that janssen determines which determination shall unreasonably withheld delayed that such geron sale representative appropriately trained otherwise qualified promote accordance with applicable policy standard government order applicable janssen detailing activity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron promotional share ramp font font size style font size geron exercise promotion option then following janssen determination that geron sale representative qualified forth section nbsp geron shall subject this section nbsp commercially reasonable effort according timeline plan forth promotion plan which shall reasonably developed janssen after good faith discussion with geron janssen consideration geron comment ramp number geron sale representative font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size twenty percent aggregate detail effort licensed product promote territory such percentage given time constituting geron promotional share event geron promotional share given period while geron promotion right than twenty percent aggregate detail effort under promotional plan then section nbsp shall apply reconciliation purpose clarity lieu ramp geron promotional share with geron consent which shall unreasonably withheld delayed promotional plan provide geron commencement share aggregate detail effort some time other than actual date first commercial sale licensed product promote territory example event geron capable providing adequate proportion aggregate detail effort promote territory upon regulatory approval therein licensed product indication then date geron promotion exercise notice than year before projected first commercial sale licensed product promote territory promotional plan provide that such commencement occur date that month after such regulatory approval indication that follows regulatory approval licensed product indication promote territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold booking sale font font size style font size avoidance doubt janssen affiliate third party sublicensee applicable will book sale generated through geron promoting activity promote territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold governance promotion promotional plan font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size shall have oversight responsibility party detailing activity promote territory under promotion agreement promotional plan shall composed senior sale manager marketing manager healthcare compliance representative from each party having knowledge about promoting drug product promote territory including with respect compliance with health care promptly after party execute promotion agreement shall establish each party shall appoint equal number representative compliance working group reporting advise health care drug regulation pertaining promotional activity party including with respect implementation measure adherence janssen compliance program policy font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size following execution promotion agreement joint marketing committee shall course review discus promotional plan developed janssen shall subject term condition hereof recommend party amendment update thereto including purpose reasonably allocating responsibility toward aggregate detail effort between party respective sale representative based geron promotional share promotional plan given janssen calendar year following geron exercise promotion right first commercial sale licensed product promote territory shall include aggregate detailing effort well share number detail contributed each party accounting ramp geron promotional share pursuant section nbsp promotional plan shall further address allocation detail promote territory based reasonable factor strategic otherwise such geographic regional consideration list healthcare provider targeted detailing with janssen using reasonable effort font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size provide geron sale representative with reasonable opportunity detailing high value prescribers subject janssen overall sale deployment strategy font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold allocation payment promoting cost font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold allocation without promotion font font size style font size geron exercised right have promotion right hereunder because exercise such promotion right qualify such promotion because such promotion right have terminated then janssen shall remain responsible eighty percent geron shall remain responsible twenty percent promoting cost incurred janssen promoting licensed product united state pursuant promotional plan while there innovator protection therein geron promotional funding amount janssen shall invoice geron such geron promotional funding amount each janssen calendar quarter geron shall such invoice within receipt thereof notwithstanding foregoing janssen make change promotional plan that aggregate result percentage increase geron promotional funding amount given janssen calendar year above promotional budget variance ceiling then geron shall have right upon notice janssen within geron receipt such invoice which case notwithstanding anything contrary herein geron right under this section nbsp shall subject section nbsp including balance ceiling under section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold reimbursement with full promotion font font size style font size where geron exercising promotion right hereunder janssen calendar quarter which geron promotional share twenty percent aggregate promotion effort under promotional plan janssen shall responsible promoting cost other cost incurs providing requisite eighty percent aggregate promotion effort under promotion agreement geron shall responsible promoting cost cost incurs providing requisite twenty percent aggregate promotion effort under promotional plan clarity each nbsp geron nbsp janssen except geron obligation reimburse promoting cost under section nbsp geron promotional share than shall have sole responsibility cost expense incurred connection with activity other work performed such party sale representative hereunder including salary travel expense other expense providing benefit deducting federal state local payroll fica contribution similar paying worker compensation premium unemployment insurance contribution other payment required applicable made behalf such party employee nothing agreement shall construed conclude that party sale representative agent employee other party without limiting obligation hereunder each party shall have sole authority over term condition employment sale representative including their hiring supervision compensation including from incentive plan discipline discharge font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold responsibility compensating sale representative font font size style font size avoidance doubt geron timely delivers promotion exercise notice geron janssen each shall solely responsible additional cost incurred support geron sale representative janssen sale representative which other than those promoting cost that consistent with promotional budget including sale representative training supply approved material each party shall solely responsible compensation that font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size sale representative connection with their work hereunder each party hereby represents warrant that compensation program sale representative will during time promotion licensed product hereunder provide financial incentive that knowledge facilitate promotion detailing licensed product violation applicable geron shall materially different compensation structure sale representative than janssen compensation structure respective sale representative detailing licensed product promote territory hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold reconciliation promoting ramp shortfall font font size style font size geron shall provide janssen with report each janssen calendar quarter during which geron sale representative performed detail hereunder accordance with detailing reporting procedure established under advice finance working group itemizing detail contributed geron under promotional plan finance working group shall review geron quarterly detail report given janssen calendar year while there innovator protection promote territory advise true promoting cost owed janssen satisfy geron obligation contribute equivalent sale representative detail during such year which promoting occurs hereunder subject section nbsp janssen shall invoice geron such promoting cost each such janssen calendar year which shall payable geron within receipt thereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold subcontracting font font size style font size geron right promote providing sale representative detailing under right hereunder personal limited geron delegated otherwise performed under contract third party except otherwise agreed upon party promote agreement otherwise font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotion diligence projected detail shortfall font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size each party shall commercially reasonable effort perform detailing activity including those involving approved material product sample promote territory according requirement promotional plan promotion agreement accordance with applicable including health care detail carried hereunder geron shall nbsp employee payroll geron nbsp quality equivalent that provided janssen measured same performance standard employer employee relationship shall exist between janssen geron sale representative font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size party belief expects that will unable provide through sale representative detail meeting share aggregate detailing effort required provided janssen calendar year pursuant promotional plan shall promptly notify other party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold training font font size style font size location mutually selected party janssen shall provide geron expense training including provision training material geron sale representative detailing licensed product promote territory level comparable training provided janssen sale representative promoting such licensed product promote territory geron shall responsible ensuring that sale representative able perform detailing trained able comply with this font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size agreement promote agreement applicable industry code conduct janssen policy regarding detailing before permitting them engage detailing licensed product licensed territory notwithstanding foregoing janssen shall have right have geron suspend detailing licensed product sale representative janssen sole good faith reasonable judgment concern regarding their performance with respect such compliance matter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotional material font font size style font size janssen shall provide geron geron expense with sufficient quantity approved material enable geron sale representative perform promotional detail promote territory accordance with promotional plan provided however that janssen shall obligated provide quantity approved material beyond those quantity that sufficient provide each sale representative geron with same quantity such material provided each janssen sale representative janssen shall have sole responsibility developing approved material used under promotional plan compliance with applicable geron shall only approved material provided janssen geron shall alter modify approved material shall supplement substitute such approved material with material font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold product sample font font size style font size janssen shall provide geron with sufficient quantity licensed product sample enable geron sale representative perform promotional detail accordance with promotional plan provided however that janssen shall obligated provide quantity sample beyond those quantity that sufficient provide each sale representative geron with same quantity sample provided each janssen sale representative janssen shall have sole responsibility manufacturing such sample compliance with applicable including cgmp requirement geron shall alter modify sample including their packaging labeling shall supplement substitute such janssen sample with sample each party shall distribute sample promotional material compliance with applicable furtherance thereof each party shall establish maintain adhere written procedure detailing promote territory assure that such party sale representative comply with legal requirement geron shall notify janssen promptly upon learning that sample shipped janssen have been lost have been received scheduled geron shall maintain promotion record required applicable shall allow representative janssen inspect such record request upon written notice geron janssen shall entitled conduct inspection audit geron sample distribution practice sale representative facility where sample stored geron such inspection audit shall made accordance with applicable more than once year janssen shall responsible supplying sale representative with approved material sample detailing under promotional plan font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promoting limitation font font size style font size each party shall instruct sale representative shall monitor sale representative that such personnel following nbsp limit claim efficacy safety licensed product those claim that consistent with approved promotional claim delete modify claim efficacy safety promotion licensed product respect from those claim efficacy safety that contained product labeling licensed product approved applicable font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size regulatory authority nbsp make change approved material provided janssen approved material manner that consistent with both applicable with product labeling licensed product approved applicable regulatory authority nbsp promote detail licensed product adherence material respect with applicable extent consistent therewith corporate policy applicable detailing applicable industry standard promote territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold risk management return customer support compliance matter font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold risk management system font font size style font size each party shall cause sale representative strict adherence with applicable risk management system maintained janssen licensed product extent geron made aware such risk management system janssen including through meeting compliance work group font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold return customer support font font size style font size avoidance doubt janssen directly through affiliate third party sublicensees shall responsible handling return licensed product being commercialized behalf janssen hereunder such licensed product returned geron then geron shall promptly ship such licensed product with other information material received janssen designated affiliate geron requested janssen shall inform customer returning such licensed product that been returned janssen janssen directly through affiliate third party sublicensees shall responsible providing customer support handling medical query responding product medical complaint relating licensed product commercialized behalf janssen hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold effort font font size style font size each party shall commercially reasonable effort execute perform cause performed promotion activity assigned under promotional plan diligent manner compliance with applicable including health care then current standard pharmacovigilance practice notwithstanding anything contrary contained herein party shall obligated undertake continue promotion activity with respect licensed product such party reasonably determines that performance such promotion activity would violate applicable which event shall promptly notify other party shall thereafter convene meeting presence compliance working group discus potential remedial measure including amendment promotional plan font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold compliance with applicable font font size style font size each party shall cause sale representative comply with applicable related performance obligation under this agreement promote agreement including drug regulation federal state anti kickback statute applicable regulation thereunder applicable phrma guideline well relevant code practice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotion progress report font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold responsibility font font size style font size each party shall responsible implementation promotion activity which with respect janssen only font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size affiliate otherwise assigned responsibility under promotional plan shall keep other party reasonably informed progress such activity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold report font font size style font size each party shall provide report each janssen calendar quarter during which such party sale representative performed promoting hereunder accordance with detailing reporting procedure established under advice compliance working group finance working group itemizing detail contributed party under promotional plan party fails adequately provide such report meeting joint marketing committee other party request such party will provide such other party written progress report that includes information regarding promotion activity support janssen commercialization promote territory other information within control reasonably necessary convey reasonably comprehensive understanding status result promotion activity compliance with term hereof promote agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold medical affair responsibility font font size style font size janssen shall have sole responsibility medical affair activity including responding medical question inquiry related licensed product directed party personnel such that arise during performance geron promotion detailing hereunder janssen shall ensure that field based medical science liaison each licensed product equally distributed party respective sale representative rata basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold voluntary termination promotion font font size style font size geron elect cease detailing licensed product terminate promotion agreement upon hundred eighty advance written notice janssen after such election geron shall cooperate with janssen janssen reasonable request transition responsibility providing then current geron promotional share such detailing licensed product promote territory from geron janssen thereafter geron will longer have right obligation detail such licensed product promote territory instead geron shall reimburse janssen twenty percent promoting cost incurred janssen provided section nbsp after geron discontinues detailing activity such time geron exercised promotion option only exercised right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold termination promotion cause font font size style font size without limitation right recourse otherwise provided under this agreement remedy that available under applicable janssen shall have right terminate upon written notice geron geron right promote promote territory promotion agreement follows each case upon each occurrence specified event with respect geron permitted successor font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size event there occurred material breach geron obligation under article nbsp hereof including regard promotional detailing promotion agreement provided that janssen shall have provided promptly after becoming aware such breach notice thereof geron identifying such breach geron shall have failed cure such breach default curable within from date geron received such notice font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin text indent font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size event there change control geron permitted successor interest controlling affiliate thereof except event that either nbsp time such change control geron contributing least successive month been contributing twenty percent aggregate sale effort promotional detailing licensed product promote territory nbsp such change control geron involves acquisition merger consolidation share exchange business combination recapitalization sale majority asset similar transaction with affiliated entity acquiror that together with such entity affiliate existing time immediately preceding change control fewer than sale representative detailing human pharmaceutical product behalf itself affiliate third party provided that such event described subsection geron shall continue carry promoting obligation under promotion plan promote territory using previously qualified sale representative employed geron immediately before such change control until party whether geron aquiror employing such sale representative upon change control enters into promotion agreement with janssen which upon execution shall supersede prior promotion agreement assumes geron obligation under this article nbsp whether through such previously qualified sale representative newly qualified sale representative provided that addition exception forth above event such change control result from event described section nbsp janssen exercise termination right under this section nbsp only director constituting majority seat other than vacant seat board director similar governing body geron immediately after such change control event affiliated with employed pharmaceutical biotechnology company font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size event geron bankruptcy font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size event geron affiliate thereof nbsp developing phase later clinical trial competing oncology product field more indication nbsp which licensed product then being developed obtained regulatory approval nbsp offering sale selling marketing promoting competing oncology product nbsp collaborating with assisting third party develop commercialize such competing oncology product each case nbsp including conduct such activity geron affiliate with respect particular product which first qualifies competing oncology product change identification primary predominant mechanism action such product causing such product qualify competing oncology product provided that such case geron affiliate shall have least cease activity forth nbsp nbsp before janssen shall have right terminate geron right promote promote territory promotion agreement hereunder font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size event that after geron fails contribute least percent share aggregate detail effort toward detail target specified promotional plan more consecutive janssen calendar quarter janssen notifies geron writing such detail shortfall geron fails remedy such detail shortfall within janssen notice geron detail shortfall font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold record font font size style font size monthly basis geron shall provide janssen with comprehensive electronic medium record detail during prior month reflecting geron district font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size regional configuration promote territory detail actually delivered performed compared detail required under promotional plan each such monthly promotion report shall janssen within after each month while there innovator protection promote territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold oversight promotion font font size style font size promptly after delivery promotion exercise notice shall establish each party shall appoint equal number representative working group reporting joint marketing committee which shall have oversight responsibility party detailing activity promote territory under promotion agreement promotional plan shall composed senior sale manager marketing manager healthcare compliance representative from each party having knowledge about promoting drug product promote territory including with respect compliance with health care font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold commercialization font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold commercial diligence font font size style font size country country basis until expiration royalty term commencing upon janssen obtaining regulatory approval licensed product country janssen shall diligent commercialization effort commercialize such licensed product such country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold responsibility font font size style font size subject geron promotion option except otherwise expressly forth this agreement including article nbsp promotion agreement janssen shall solely responsible directly through affiliate sublicensees commercialization activity territory with respect licensed product exploitation license right granted under section nbsp well business decision connection therewith subject term this agreement including geron promote option right including those relating manufacturing distribution price packaging licensed product subject section nbsp each decision whether when commercially launch licensed product particular country jurisdiction territory shall within discretion janssen acting directly through affiliate sublicensees janssen directly through affiliate third party sublicensees will book sale licensed product made hereunder geron acknowledges that nothing herein prohibits janssen from donating supply licensed product humanitarian charitable purpose font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold trademark font font size style font size janssen directly through affiliate sublicensees will select trademark under which will market licensed product hereunder will trademark right associated therewith font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotional plan marketing plan font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotional plan where geron exercised right font font size style font size event geron exercised right then nbsp joint marketing committee shall course review discus promotional plan developed janssen subject term condition hereof nbsp country other than united state which regulatory approval licensed product obtained janssen directly through affiliate third party sublicensees janssen shall develop independent promotional font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size plan summary which shall provided geron annual basis geron exercised right then case that geron exercised promotion option then initial promotional plan shall include aggregate detail effort number detail conducted janssen case that geron exercised promotion option then initial promotion plan shall include aggregate detail effort number detail conducted each party consistent with geron promotional share each case period following regulatory approval licensed product united state through full janssen calendar year thereafter follows unless otherwise agreed party writing nbsp least percent detail licensed product united state year following first commercial sale licensed product therein will first position detail remaining percent will second position detail nbsp least percent detail such licensed product united state year following such first commercial sale will first position detail remaining percent will second position detail avoidance doubt foregoing sentence prohibit either party sale representative from detailing product other than licensed product third position detail font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold promotional plan where geron exercised right font font size style font size event geron exercised right then nbsp both united state country other than united state which regulatory approval licensed product obtained janssen directly through affiliate third party sublicensees janssen shall develop independent promotional plan summary which shall provided geron annual basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold marketing plan font font size style font size regardless whether geron exercised right following regulatory approval licensed product major market country janssen shall provide geron report annual basis summarizing high level extent permitted applicable janssen marketing plan licensed product such country pertaining medical affair launch preparation branding font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold shared promoting cost united state font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold allocation font font size style font size upon geron exercise right where geron timely delivered promotion exercise notice during such time that geron providing sale representative toward detailing promote territory exercised promotion option then promoting cost incurred thereafter janssen connection with detailing under promotional plan pursuant promotional budget shall borne eighty percent janssen twenty percent geron while there innovator protection thereafter upon expiration geron promotion right exercised borne solely janssen font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold reporting promoting cost font font size style font size upon geron exercise right finance working group shall advise shall establish reasonable financial procedure consistent with accounting standard applicable determination estimated promoting cost updating promotional budget under promotional plan each janssen calendar quarter before enable each party appropriately accrue share promoting cost financial reporting purpose janssen font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size shall record itemized promoting cost incurred janssen directly through affiliate maintain such record accordance with accounting standard applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold payment font font size style font size amount owed geron janssen under this section nbsp shall payable from geron receipt invoice from janssen applicable amount font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold clinical supply product manufacture font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold responsibility manufacture font font size style font size between janssen geron janssen shall responsible directly through affiliate sublicensees overseeing managing licensed product manufacturing activity hereunder including with respect nbsp manufacturing having manufactured including geron through third party contractor under current manufacturing contract third party under subcontract hereunder clinical supply licensed product clinical study under global development plan nbsp manufacturing having manufactured supply licensed product otherwise development subject section nbsp commercialization during term geron shall reasonably cooperate with janssen secure cooperation geron third party contractor under current manufacturing contract other existing third party agreement further provided below provided that geron obligation procure supply licensed product including through third party contractor shall event cease month period after effective date avoidance doubt party responsibility clinical supply cost included development cost shall remain event provided section nbsp section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold existing manufacturing subcontractor font font size style font size promptly after effective date geron shall commercially reasonable effort assign otherwise transfer janssen material right obligation avoidance doubt excluding obligation make payment third party accrued geron prior such assignment transfer under those current manufacturing contract selected party under term condition mutually agreed party forth manufacturing agreement subject agreement applicable counterparties current manufacturing contract such assignment transfer such term condition mutually acceptable party such counterparty after effective date upon written agreement party applicable counterparty current manufacturing agreement assign janssen supersede with replacement agreement with term condition mutually acceptable party janssen shall party solely responsible managing manufacture licensed product with such counterparty under applicable agreement including with respect audit manufacturing site utilized such counterparty under applicable agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold technical transfer font font size style font size promptly after effective date geron shall promptly transfer shall commercially reasonable effort cause third party contractor under applicable existing third party agreement including current manufacturing contract promptly transfer permitted subject term condition applicable existing third party agreement otherwise expressly permitted applicable third party janssen designated affiliate third party subcontractor record copy know within geron product know font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size geron assay know extent such know geron possession obtained geron expending commercially reasonable effort obtain such know possession such third party contractor such know transferred hereunder developed development program shall treated each party other party trade secret confidential information under article nbsp this agreement shall oversee such transfer manner that ensures timely efficient transition janssen affiliate subcontractor such know whether such know geron assay know relating manufacture developed effective date necessary useful manufacture characterization such licensed product accordance with applicable development commercialization other purpose contemplated hereunder geron shall bear internal expense incurred geron transferring such know including payment counterparties under current manufacturing contract existing license from third party clarity such cost associated with know transfer under this section nbsp shall deemed development cost font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold termination manufacturing subcontractor font font size style font size time after janssen directly through affiliate having supply licensed product manufactured third party subcontractor including virtue assignment superseding agreement with respect current manufacturing contract once held geron meet development need hereunder janssen elect terminate such subcontract negotiate required amendment wind down terminate such subcontract unless otherwise agreed party writing including manufacturing agreement pocket cost cancellation cancellable payment obligation resulting from such termination winding down current manufacturing contract shall deemed development cost associated with initial study borne party equally provided however that before party take action terminate wind down current manufacturing contract shall first provide other party with estimate such pocket cost expected become result taking such action opportunity comment thereon which comment shall provided within business receipt such estimate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold clinical supply clinical study under development plan font font size style font size font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cost clinical supply clinical trial under font font size style font size unless agreed otherwise party manufacturing agreement pursuant section nbsp supply cost clinical supply licensed product clinical study under shall allocated same other development cost provided section nbsp clarity nbsp reflected section nbsp each party shall responsible fifty percent supply cost clinical supply licensed product needed conducting lead phase study lead phase risk study pursuant nbsp janssen shall bear eighty percent geron shall bear twenty percent supply cost clinical supply licensed product needed conducting additional study under pursuant development budget such study geron exercised right geron shall solely responsible license payment including milestone royalty third party under unblocking license agreement font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cost clinical supply clinical trial under font font size style font size party conducting clinical study licensed product under independent development plan shall solely responsible supply cost associated with acquisition clinical supply licensed product such study clinical trial under geron party shall enter into clinical supply agreement that shall include term related compensation janssen supply management distribution clinical supply licensed product such trial prioritizing supply ongoing trial under ahead clinical trial either janssen geron event shortage clinical supply licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold manufacturing supply agreement font font size style font size party shall commercially reasonable effort within month effective date develop transitional manufacturing plan supply cost budget initial study within month thereafter such other time party agree enter into written manufacturing agreement reflect status negotiation reference proposed transfer amendment current manufacturing contract under section nbsp which also include amendment necessary update manufacturing plan supply cost budget initial study provide manufacturing plan supply cost budget additional study subject section nbsp such amendment result increase development budget greater than budget variance limit other study janssen geron font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold commercial supply font font size style font size except expressly provided otherwise herein including under section nbsp janssen shall solely responsible sole cost expense manufacture have manufactured otherwise supply licensed product commercialization purpose hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold quality assurance font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold compliance with font font size style font size supply licensed product human development commercialization activity hereunder shall manufactured compliance with nbsp applicable relating nbsp applicable relating safety preservation protection human health environment including workplace safety ambient surface water groundwater land subsurface stratum relating handling treatment transportation disposal waste nbsp policy janssen affiliate employment young person attached exhibit nbsp such policy updated notice geron following transition manufacturing responsibility janssen pursuant section nbsp janssen quality assurance personnel shall primarily responsible ensuring compliance with this section nbsp including through inspection provided section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold inspection font font size style font size with respect manufacturing facility site which party affiliate third party sublicensees third party contractor including under current manufacturing contract whether they transferred janssen manufacturing clinical supply licensed product whether bulk active ingredient finished product form under this agreement other party shall have right expense upon reasonable written notice provided party manufacturing having manufactured such supply audited party audited site third party during normal business hour permitted subject term condition applicable existing third font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size party agreement otherwise expressly permitted third party contractor inspect such audited site record relating thereto once year more often with cause verify compliance with term this agreement applicable which inspection shall subject confidentiality provision this agreement such inspection would result disclosure audited site confidential information unrelated subject matter this agreement party applicable third party shall enter into confidentiality agreement covering such unrelated subject matter after such inspection auditing party shall provide written observation audited party shall within thereafter provide cause applicable affiliate third party sublicensee contractor subcontractor provide written response such observation including proposed capa plan such response shall include observation provided auditing party shall promptly review proposed capa plan decide upon final capa plan implementation audited site provide such final capa plan audited party audited party shall thereafter promptly provide such capa plan audited site commercially reasonable effort cause audited site implement capa plan promptly after receipt font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp viii font font size style font size font weight bold financial provision font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold upfront continuation payment font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold upfront font font size style font size partial consideration right granted janssen under this agreement upfront payment amount thirty five million dollar shall from janssen geron upon effective date payable within thereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold continuation font font size style font size consideration janssen continuation license right granted under section nbsp continuation amount sixty five million dollar shall from janssen geron upon janssen delivery continuation notification geron deemed receipt thereof pursuant section nbsp nbsp nbsp payable within thereafter notwithstanding foregoing such payment sixty five million dollar shall clarity equal sixty five million dollar font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold full right font font size style font size consideration geron waiving right during geron election period additional amount seventy million dollar shall from janssen geron upon geron delivery geron election notification exercising right pursuant section nbsp after janssen provision continuation notification pursuant section nbsp nbsp which shall payable within janssen receipt such geron election notification font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold milestone payment font font size style font size janssen shall each milestone payment identified this section nbsp geron time only upon first achievement specified milestone event with respect first licensed product attain avoidance doubt further payment shall from janssen upon achievement same milestone event another licensed product font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold clinical development milestone font font size style font size clarity provision only milestone clause nbsp nbsp this section nbsp will apply phase clinical study licensed product under global development plan depending whether geron exercised right pursuant section nbsp further provided below event that combined phase clinical study conducted respect licensed product irrespective whether that study initially established combined study transition into combined study once under where phase part that study satisfies definition phase clinical study phase part that trial satisfies definition phase clinical study hereunder milestone payment forth section nbsp nbsp applicable shall payable upon first dosing licensed product human subject phase part such clinical study font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron font font size style font size only geron notified janssen geron exercise right prior expiration geron election period each following milestone payment shall from janssen geron time only upon first achievement specified milestone event licensed product font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin text indent font size face time roman style font size font weight bold milestone nbsp event nbsp nbsp geron nbsp nbsp nbsp have nbsp nbsp nbsp right font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold milestone nbsp payment nbsp nbsp dollar font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron font font size style font size only geron notified janssen geron exercise right prior expiration geron election period each following milestone payment shall from janssen geron time only upon first achievement specified milestone event licensed product font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin text indent font size face time roman style font size font weight bold milestone nbsp event nbsp nbsp geron nbsp nbsp nbsp nbsp right font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold milestone nbsp payment nbsp nbsp dollar font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold drug application filing milestone major market font font size style font size clarity milestone event specified this section nbsp will apply regardless whether geron exercised right each following milestone payment shall from janssen geron time only upon first achievement specified milestone event licensed product font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold milestone nbsp event font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold milestone nbsp payment nbsp nbsp dollar font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold approval milestone first indication major market font font size style font size clarity milestone event specified this section nbsp will apply regardless whether geron exercised right each following milestone payment shall from janssen geron time only upon first achievement specified milestone event licensed product font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold milestone nbsp event nbsp nbsp first nbsp indication font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold milestone nbsp payment nbsp nbsp dollar font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold approval milestone second indication major market font font size style font size clarity provision only milestone clause nbsp nbsp this section nbsp will apply with respect second indication avoidance doubt each case following achievement corresponding milestone with respect first indication depending whether geron exercised right further provided below font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron font font size style font size only geron notified janssen geron exercise right prior expiration geron election period each following milestone payment shall time only from janssen geron upon first achievement specified milestone event licensed product provided that font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size corresponding milestone first indication licensed product provided section nbsp above been achieved font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold second nbsp indication nbsp milestone nbsp event nbsp without nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold milestone nbsp payment nbsp nbsp dollar font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron font font size style font size only geron notified janssen geron exercise right prior expiration geron election period each following milestone payment shall time only from janssen geron upon first achievement specified milestone event licensed product provided that corresponding milestone first indication licensed product provided section nbsp above been achieved font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold second nbsp indication nbsp milestone nbsp event nbsp with nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold milestone nbsp payment nbsp nbsp dollar font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold time only sale milestone font font size style font size solely upon first occurrence aggregate annual worldwide sale licensed product sold behalf janssen directly through affiliate sublicensees hereunder time during term first attaining sale threshold specified milestone described below janssen shall corresponding milestone payment geron within following janssen calendar quarter which such sale milestone event attained avoidance doubt same janssen calendar quarter multiple sale milestone event described below font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size first attained then payment such milestone event attained specified below shall payable same time font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold sale nbsp milestone nbsp event font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold milestone nbsp payment nbsp nbsp dollar font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size dollar font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size dollar font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size dollar font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size dollar font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size dollar font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold each milestone nbsp attained time only font font size style font size avoidance doubt milestone event specified this section nbsp achieved same distinct licensed product additionally should licensed product replaced backed another licensed product additional milestone payment shall under section nbsp milestone event completed replacement back licensed product which corresponding milestone payment were previously made geron with respect such replaced licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold notice payment milestone event font font size style font size applicable party first becoming aware achievement milestone event hereunder shall inform other party writing soon practicable event later than business after achievement such event thereafter geron submit janssen invoice applicable milestone payment milestone payment from janssen geron shall payable from janssen receipt invoice from geron applicable amount font style margin font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold royalty payment font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold royalty base term font font size style font size determination which particular sale licensed product janssen affiliate third party sublicensees will form base royalty obligation under this section nbsp shall made licensed product licensed product country country basis period during which royalty will accrue sale janssen affiliate third party sublicensees particular licensed product given country royalty term shall from date first commercial sale such particular licensed product janssen affiliate third party sublicensee given country until later nbsp expiration last expire innovator protection given country particular licensed product nbsp nbsp year from first commercial sale particular licensed product given country avoidance doubt only royalty rate obligation make royalty payment shall apply particular unit licensed product font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold royalty rate country with innovator protection font font size style font size applicable royalty rate calculating royalty applicable incremental amount aggregate worldwide annual janssen calendar year portion thereof falling within applicable royalty term sale licensed product janssen affiliate third party sublicensees country with innovator protection provided section nbsp shall determined provided under applicable clause nbsp nbsp below this section nbsp royalty shall calculated multiplying applicable increment aggregate worldwide sale licensed product made country during janssen calendar year portion thereof during applicable royalty term such country against applicable royalty rate nbsp identified below subject applicable adjustment reduction provided section nbsp below with each royalty rate referred below applying only that increment annual sale that fall within incremental sale bracket such royalty rate avoidance doubt only royalty rate obligation make royalty payment shall apply particular unit licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron font font size style font size only geron notified janssen geron exercise right prior expiration geron election period there innovator protection country where sale licensed product janssen affiliate third party sublicensee occur following incremental royalty rate shall apply such sale font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold incremental nbsp sale nbsp bracket nbsp aggregate nbsp worldwide nbsp annual nbsp nbsp sale nbsp licensed nbsp product nbsp nbsp country nbsp with nbsp innovator nbsp protection nbsp nbsp nbsp dollar font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty nbsp rate font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size percent font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal than font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size percent font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal than font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size percent font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size percent font table style margin font size face time roman style font size nbsp font style margin font size face time roman style font size illustrate calculation royalty hypothetical janssen calendar year example cumulative annual worldwide sale licensed product upon which royalty accrue provided this section nbsp nbsp totaled janssen calendar year then absent adjustment reduction pursuant section nbsp royalty would calculated follows font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron font font size style font size only geron notified janssen geron exercise right prior expiration geron election period there innovator protection country where sale licensed product janssen affiliate third party sublicensee occur following incremental royalty rate shall apply such sale font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold incremental nbsp sale nbsp bracket nbsp aggregate nbsp worldwide nbsp annual nbsp nbsp sale nbsp licensed nbsp product nbsp nbsp country nbsp with nbsp innovator nbsp protection nbsp nbsp nbsp dollar font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty nbsp rate font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size percent font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal than font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size percent font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal than font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size percent font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size percent font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold royalty rate step down country with innovator protection font font size style font size applicable royalty rate calculating royalty applicable incremental amount aggregate worldwide annual janssen calendar year portion thereof falling within applicable royalty term sale licensed product janssen affiliate third party sublicensees country without innovator protection provided section nbsp shall determined provided under applicable clause nbsp nbsp below this section nbsp royalty shall calculated multiplying applicable increment aggregate worldwide sale licensed product made country during janssen calendar year portion thereof during applicable royalty term such country against applicable royalty rate nbsp identified below subject applicable adjustment reduction provided section below with each royalty rate referred below applying only that increment annual sale that fall within incremental sale bracket such royalty rate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron font font size style font size only geron notified janssen geron exercise right prior expiration geron election period there innovator protection country where sale licensed product janssen affiliate third party sublicensee occur following incremental royalty rate shall apply such sale font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold incremental nbsp sale nbsp bracket nbsp aggregate nbsp worldwide nbsp annual nbsp nbsp sale nbsp licensed nbsp product nbsp nbsp country nbsp without nbsp innovator nbsp protection nbsp nbsp nbsp dollar font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty nbsp rate font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size percent font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal than font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size percent font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal than font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size percent font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size percent font table style margin text indent font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron font font size style font size only geron notified janssen geron exercise right prior expiration geron election period there innovator protection country where sale licensed product font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size janssen affiliate third party sublicensee occur following incremental royalty rate shall apply such sale font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold incremental nbsp sale nbsp bracket nbsp aggregate nbsp worldwide nbsp annual nbsp nbsp sale nbsp licensed nbsp product nbsp nbsp country nbsp without nbsp innovator nbsp protection nbsp nbsp nbsp dollar font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty nbsp rate font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size percent font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal than font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size percent font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal than font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size percent font width valign style padding width style margin font size face time roman style font size font weight bold font font size style font size font weight bold nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font font size style font size greater than equal font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size percent font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold adjustment royalty font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold compulsory license font font size style font size time country third party shall under government order competent governmental authority granting compelling granting license under valid claim geron product patent right covering licensed product sold behalf janssen such country offer sale sell product competition with licensed product marketed behalf janssen with respect which royalty become from janssen pursuant section nbsp above then janssen reduce royalty rate calculating royalty geron based janssen affiliate third party sublicensees sale licensed product such country under section nbsp equivalent royalty rate payable third party geron under compulsory license granting third party right market competing product provided that janssen shall have right apply additional royalty adjustment under rest this section nbsp section nbsp janssen elect adjust royalty pursuant this section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold generic competition font font size style font size event generic product sold third party given country where licensed product sold janssen directly through affiliate third party sublicensee during royalty term only duration that generic erosion persists such licensed product such country applicable royalty rate such country under section nbsp case shall reduced percent reduced royalty rate will applied retrospect necessary sale applicable licensed product janssen calendar quarter immediately following janssen calendar quarter during which generic erosion first occurs such reduced royalty rate shall thereafter continue janssen calendar quarter janssen calendar quarter basis during royalty term long such generic erosion continues exist font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold combination product font font size style font size event licensed product combination product royalty base used calculate royalty shall sale combination product multiplied adjustment factor determined follows nbsp there list price country where each active ingredient including active substance combination product also marketed separate product containing respective active ingredient single active ingredient then adjustment factor where product font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size active ingredient shall fraction where actual average list price wholesaler licensed product sold separately such country containing active substance single active ingredient actual average list price product each sold separately such country containing other active ingredient combination product single active ingredient nbsp there list price list price country where only active substance combination product also marketed separate product containing active substance single active ingredient then adjustment factor shall fraction where defined above actual list price wholesaler combination product provided that value fraction greater than nbsp country where there list price then party shall negotiate good faith determine appropriate adjustment factor font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold royalty floor font font size style font size notwithstanding anything contrary except royalty adjustment forth section nbsp event shall total royalty adjustment under this section nbsp reduce applicable royalty rate under section nbsp case more than percent compared rate forth section result adjustment combined avoidance doubt royalty adjustment under this section nbsp nbsp shall limit application credited amount under section nbsp offset royalty that become hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold third party obligation font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold subcontractor font font size style font size party designated affiliate entering into subcontract with third party performance subcontracted collaboration activity hereunder including jurisdiction which employee agent such third party have right compensation remuneration payment their invention under applicable shall commercially reasonable effort obligate third party subcontractor written subcontract agreement solely responsible compensation remuneration payment third party employee agent account their performance such activity under subcontract agreement including payment obligation that arise operation applicable particular country account either party exercise right hereunder with respect licensed product that were invented whole part such third party employee agent performance such activity party fails include such obligation subcontract agreement with third party such party shall bear expense incurred connection with such payment obligation that arise font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold payment under existing license from third party existing third party agreement font font size style font size during term this agreement between party geron shall solely responsible royalty obligation milestone payment remittance sublicensing income other payment type that become under font font size style font size existing license from third party other existing third party agreement including such payment resulting from modified term under written amendment such agreement entered into after effective date hereof provided that janssen provided express written approval advance geron enter into each such amendment including modified term thereof further provided that such payment expressly included shared development cost under under this agreement account activity font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size behalf party accordance with this agreement including commercialization licensed product behalf janssen hereunder janssen will obligated reimburse geron such payment owed under such agreement amended except party otherwise expressly agree writing such manufacturing agreement written agreement signed both party under which janssen expressly agrees share such payment under particular existing third party agreement reimburse geron share such payment made thereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold unblocking license agreement font font size style font size notwithstanding indemnification obligation geron with respect existing blocking third party patent right under section nbsp clause after delivery continuation notice janssen during term janssen belief that obtaining right under existing blocking third party patent right necessary contemplated license activity janssen shall call meeting patent representative designated patent counsel each party shall discus such matter confidence including whether license under such existing blocking third party patent right would necessary whether such existing blocking third party patent right valid whether what extent other defense potential infringement such existing blocking third party patent right exist following such meeting geron determines reasonable discretion seek obtain such license which exclusive under such existing blocking third party patent right from relevant third party with right sublicense janssen affiliate sublicensees subcontractor unblocking license agreement geron shall make reasonable good faith effort obtain such unblocking license agreement connection with seeking unblocking license agreement geron will where possible provide janssen designated patent counsel draft such proposed unblocking license agreement reasonably advance providing such draft applicable third party will consider good faith reasonable comment janssen regarding such draft geron enters into unblocking license agreement nbsp shall hereby grant janssen sublicense thereunder purpose performing contemplated license activity subject term condition such unblocking license agreement clause nbsp this section nbsp nbsp license payment including milestone royalty third party under such unblocking license agreement arising from such contemplated license activity janssen affiliate sublicensees subcontractor hereunder shall sole expense geron treated credited amount pursuant section nbsp shall deemed development cost allocable extent janssen hereunder event geron elect after request janssen obtain unblocking patent license with respect existing blocking third party patent right term indemnification geron under section nbsp clause nbsp shall continue apply with respect such existing blocking third party patent right font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold securing exclusive right solely owned geron product patent right joint interest arises font font size style font size event that notwithstanding representation warranty geron under section nbsp third party obtains ownership interest imetelstat patent right other solely owned geron product patent right that include claim covering field then nbsp upon janssen request geron shall obtain exclusive worldwide license with right sublicense perform contemplated license activity under such third party ownership interest such patent right upon geron entering into agreement with such third party granting geron such font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size license geron shall hereby grant janssen exclusive even geron sublicense with right further sublicense under such license purpose performing contemplated license activity under such patent right subject term condition geron license agreement with such third party clause nbsp this section nbsp nbsp license payment including milestone royalty such third party under such license agreement arising from performance such contemplated license activity janssen affiliate sublicensees subcontractor hereunder shall sole expense geron treated credited amount pursuant section nbsp shall deemed development cost allocable extent janssen hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cross reference obligation relating font font size style font size font weight bold payment development cost promoting cost font font size style font size applicable party allocated responsibility paying share portion development cost promoting cost incurred hereunder shall bear such payment responsibility pursuant section nbsp above case font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp general payment term font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold invoice font font size style font size payment amount geron under this agreement shall payable except otherwise expressly provided herein within after janssen receipt invoice from geron such amount each invoice shall specifically refer this agreement janssen purchase order number provided geron shall provide other information specified form invoice attached exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold royalty reporting payment font font size style font size royalty payment shall payable united state dollar after each janssen calendar quarter during term each payment royalty under this agreement will accompanied with royalty report setting forth licensed product licensed product country country basis nbsp amount sale licensed product janssen affiliate sublicensees nbsp united state only nbsp conversion such sale from currency sale into dollar accordance with section nbsp applicable nbsp calculation aggregate amount royalty owed based such sale including methodology used order determine appropriate royalty tier royalty payable showing application reduction made accordance with term section nbsp credit granted geron janssen hereunder applied janssen offset such royalty accrued font style margin text indent font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold remittance font font size style font size payment geron hereunder shall made immediately available fund electronic transfer janssen affiliate behalf bank account identified below such other bank account geron designate writing janssen payment payable under this agreement date that business made next business time legal restriction prevent prompt remittance part royalty hereunder with respect country where licensed product sold janssen shall have right option make such payment depositing amount thereof local currency geron account bank depository such country directed geron using such lawful mean method remitting payment janssen reasonably determine font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign style padding width style margin font size face time roman style font size name bank font width valign style padding width style margin font size face time roman style font size font width valign style padding width style margin font size face time roman style font size bank address font width valign style padding width style margin font size face time roman style font size font width valign style padding width style margin font size face time roman style font size routing transit font width valign style padding width style margin font size face time roman style font size font width valign style padding width style margin font size face time roman style font size credit font width valign style padding width style margin font size face time roman style font size font width valign style padding width style margin font size face time roman style font size account name font width valign style padding width style margin font size face time roman style font size font width valign style padding width style margin font size face time roman style font size further credit font width valign style padding width style margin font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold currency font font size style font size payment under this agreement shall payable united state dollar with respect sale licensed product invoiced currency other than dollar such amount amount payable hereunder shall expressed their united state dollar equivalent calculated using method described remainder this section nbsp each janssen calendar year during which royalty become hereunder janssen shall provide nbsp currency hedge rate used local currency each country licensed territory nbsp calculation each such currency hedge rate writing geron later than business after currency hedge rate country other than where royalty bearing sale licensed product hereunder occur available from janssen applicable affiliate each currency hedge rate given country will remain constant throughout entire janssen calendar year janssen shall currency hedge rate convert sale united state dollar purpose calculating royalty font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size each party shall solely responsible payment imposed share income arising directly indirectly from collaborative effort party under this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size each party will make payment other party under this agreement without deduction withholding except extent that such deduction withholding required applicable effect time payment party agree commercially reasonable effort consult good faith before taking action that reasonably expected result under this agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size required withheld amount payable payor party under this agreement will paid payor behalf payee party appropriate governmental authority payor will furnish payee with proof payment such such required withheld will expense borne payee such assessed against paid payor then payee shall indemnify hold harmless payor from such font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size party will cooperate with respect documentation required taxing authority reasonably requested either party secure reduction rate applicable withholding within business execution date this agreement each party will deliver other party accurate complete internal revenue service form nbsp such form shall updated renewed required applicable font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold record audit right font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold maintenance record font font size style font size each party shall keep shall cause affiliate applicable third party subcontractor sublicensees keep complete true accurate book record accordance with accounting standard sufficient detail other party determine payment cost incurred under this agreement each party will keep such book record accordance with applicable least year following date payment which they pertain font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold audit right font font size style font size upon written request party applicable auditing party more than once each calendar year other party audited party shall permit independent certified public accounting firm nationally recognized standing selected auditing party reasonably acceptable audited party have confidential access during normal business hour such record audited party applicable affiliate third party sublicensees subcontractor reasonably necessary verify accuracy payment made under this agreement period ending more than year prior date such request accounting firm shall provide each party correct complete copy report summarizing final result such audit which shall treated audited party confidential information auditing party shall obligate accounting firm keep audited party information confidential shall request audited party cause auditing party accounting firm execute reasonable confidentiality agreement prior commencing such audit font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold audit font font size style font size charged accounting firm engaged party accordance with section nbsp shall paid auditing party provided however that audit uncovers underpayment overpayment favor audited party exceeding percent total amount accordance with this agreement then such accounting firm shall paid audited party underpayment overpayment discovered such audit otherwise will paid refunded promptly applicable party within date auditing party delivers audited party such accounting firm written report otherwise agreed upon party plus interest calculated accordance with section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold party making payment font font size style font size geron acknowledges agrees that delegated janssen from time time affiliate janssen acting paying agent janssen make certain payment geron under this agreement behalf janssen provided that janssen shall remain primarily responsible such payment geron under this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold treatment credit font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold credit owed geron font font size style font size janssen deduct portion nbsp under accordance with section nbsp nbsp under accordance with section nbsp nbsp nbsp under accordance with section nbsp each case which janssen received from geron pursuant section nbsp under section nbsp each such amount credited amount until janssen recouped provided that janssen recouped percent particular credited amount before earliest nbsp termination this agreement nbsp geron change control nbsp invoice invoice credit notification credit notification basis anniversary later original invoice font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size credit notification such particular invoiced notified credited amount then remaining unpaid balance such credited amount will become payable upon such date provided that geron shall have until date that after receipt invoice from janssen such unpaid amount remit such payment outstanding balance such particular invoiced notified credited amount event janssen applies credited amount nbsp janssen shall apply such credited amount then nbsp janssen shall font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold maximum balance credited amount payment acceleration font font size style font size notwithstanding anything contrary herein geron shall obligated down that portion cumulative balance credited amount annual basis that exceeds dollar balance ceiling during applicable janssen calendar year accordingly event that outstanding balance credited amount exceeds balance ceiling janssen shall invoice geron portion cumulative balance credited amount that exceeds balance ceiling amount equal such portion exceeding balance ceiling will payable geron within receipt geron invoice from janssen such amount font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold interest late payment font font size style font size interest assessed payee party amount payable under this agreement which paid payor party before date payment hereunder credited amount which such interest shall accrue calculated daily basis rate percent annum above then current prime rate quoted citibank york city event excess maximum rate permissible under applicable period from date payment date janssen receives right credit offset font font size style font size credited amount case until date actual payment payment such interest shall limit payee party from exercising other right have consequence lateness payment from payor party font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold intellectual property matter font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold reporting development program invention font font size style font size each party shall promptly report well each party patent representative each material development program invention after reduction practice affiliate third party subcontractor employee agent performing development activity under global development plan font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold ownership font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size governs ownership each development program invention shall follow inventorship determined pursuant principle united state patent accordingly nbsp development program invention invented solely more employee agent party affiliate third party subcontractor shall owned solely such party nbsp development program invention invented jointly more employee agent party affiliate third party subcontractor more employee agent other party affiliate third party subcontractor joint development program invention shall owned jointly party subject term this font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size agreement including exclusive license other right such development program invention expressly granted hereunder ownership each development program patent right right afforded party having ownership interest therein subject term condition hereof including under article nbsp shall determined accordance with principle united state patent taking into account inventorship properly determined claim claim under ownership each item development program know constituting development program invention shall also determined pursuant font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold confirmatory assignment font font size style font size each party shall take reasonable action requested other party responsible prosecuting development program patent right that includes nbsp claim covering joint development program invention nbsp claim covering development program invention owned solely party along with claim covering development program invention owned solely other party hereunder perfect separately document other party ownership interest right such development program patent right provided this agreement including causing applicable affiliate third party subcontractor employee agent execute appropriate assignment document requesting party shall required remuneration other party affiliate third party subcontractor their employee agent execution assignment other paper pursuant this section clarity each party directly through applicable affiliate third party subcontractor shall solely responsible compensation affiliate third party subcontractor employee agent connection with assignment their respective right development program invention associated development program patent right pursuant this agreement exploitation party affiliate third party sublicensees hereunder such development program invention associated development program patent right including required operation applicable account commercialization such development program invention behalf janssen hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold prosecution patent right font font size style font size font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold communication font font size style font size each party shall reasonable effort handle communication between party under this section nbsp through their prosecution contact keep such communication strict confidence protect their attorney client privileged status font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold reporting filing font font size style font size party planning filing priority establishing original each case with respect claim matter described patent specification patent application within development program patent right hereunder shall reasonable effort provide other party with reasonable advance time such least prior proposed prosecution filing patent office such draft application response official action provide other party opportunity comment thereon through prosecution contact each party shall provide other promptly after filing copy each priority establishing original whether provisional nonprovisional patent application within development program patent right filed patent office each other substantive prosecution filing including other patent application filed within development program patent right font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold prosecution responsibility coordination font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold geron product patent right font font size style font size with respect geron product patent right geron shall primarily responsible through outside patent counsel mutually acceptable party engaged geron prosecute third party right control prosecution geron product patent right under existing license from third party represent geron prosecution geron product patent right provided that long agreement remains effect geron shall follow instruct outside patent counsel follow reasonable direction janssen provided designated prosecution contact prosecuting geron product patent right including with respect filing continuation divisional other continuing application notwithstanding foregoing providing such prosecution direction janssen shall consider incorporate nbsp reasonable comment geron designated prosecution contact regarding filing divisional without introduction matter pending application within geron product patent right within imetelstat patent family which application filed patent office provides support under applicable claim proposed divisional application that specifically focus subject matter disclosed specification pending application other than subject matter covering active substance licensed product invention related thereto including with respect thereof manufacture material manufacture active substance licensed product nbsp reasonable comment geron designated prosecution contact regarding further prosecution such divisional application provided each case nbsp nbsp that janssen shall obligated adopt geron proposal reasonable opinion janssen patent counsel prosecution action with respect such divisional proposed geron could detrimentally impact patentability validity enforceability geron product patent right country consistent with applicable avoidance doubt foregoing sentence shall construed granting geron back right active substance licensed product granted janssen under section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold prosecution cost geron product patent right font font size style font size subject foregoing section nbsp geron shall solely responsible patent cost incurred prosecuting geron product patent right before effective date including those payable third party under existing license from third party each party shall bear fifty percent patent cost incurred prosecuting geron product patent right including those payable third party under existing license from third party after effective date notwithstanding foregoing geron intends permit particular geron product patent right that pending patent office lapse become abandoned including failure validate allowed multi jurisdictional patent application such pending european patent office possible country geron shall notify janssen such intention least within such other practicable time before date upon which such patent right will lapse become abandoned janssen shall thereupon have right obligation assume responsibility further prosecution such patent right continuing application based thereon patent cost associated therewith such event nbsp geron shall reasonably cooperate promptly effect transfer prosecution such patent right janssen assign geron interest such geron product patent right janssen nbsp such transferred patent right shall longer deemed geron product patent right purpose determining duration font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size innovator protection royalty obligation janssen hereunder unless geron continues fifty percent patent cost incurred prosecuting such patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold development program patent right font font size style font size party having sole ownership interest development program patent right shall primarily responsible through outside patent counsel mutually selected party prosecuting such development program patent right provided that such party shall nbsp follow reasonable direction under advice patent working group selection country patent office licensed territory filing validating application form family related development program patent right nbsp provide other party through designated prosecution contact reasonable opportunity review comment upon proposed prosecution paper filed patent office including draft response official action joint development program patent right both party shall share primary responsibility through outside patent counsel mutually selected engaged party prosecuting such joint development program patent right provided that party shall nbsp follow reasonable direction under advice patent working group selection country patent office licensed territory filing application form family related development program patent right nbsp escalate prosecution decision which party agree decision under advice patent working group consultation with prosecution contact direct outside counsel with respect such prosecution matter involving joint development program patent right subject foregoing janssen shall bear patent cost incurred prosecuting development program patent right owned solely janssen each party shall bear fifty percent patent cost incurred prosecuting development program patent right owned solely geron joint development program patent right font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold prosecution cooperation font font size style font size each party shall provide reasonable assistance requested other party prosecuting geron product patent right development program patent right consistent with term hereof including with respect timely completion filing prosecution paper compliance with applicable recording assignment reflect ownership consistent with term hereof party prosecuting patent right hereunder shall reasonable effort provide other party with copy material prosecution paper filed received from patent office party prosecuting patent right hereunder shall annual basis during term provide other party with report identifying status geron product patent right development program patent right which primarily responsible prosecution provided however that joint development program patent right party shall cooperate jointly prepare such status report font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent enforcement font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold notice font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size each party shall notify other promptly apparent threatened actual infringement third party geron product patent right development program patent right misappropriation geron product know development program know which party becomes aware notifying party shall font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size promptly furnish other with known detail evidence such infringement misappropriation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size each party shall promptly notify other third party communication pertaining geron product patent right development program patent right that party receives pursuant drug price competition patent term restoration similar such notice including notice pursuant such from person have filed abbreviated anda paper font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold enforcement action font font size style font size long janssen license right commercialize licensed product under section nbsp janssen shall have initial right expense name name geron required under applicable bringing infringement suit other enforcement action account third party infringement geron product patent right development program patent right based alleged making using selling offering sale importing other exploitation active substance licensed product infringement such patent right misappropriation geron product know development program know providing regulatory exclusivity right active substance licensed product each product infringement counsel choice geron will cooperate with janssen janssen reasonably request connection with such action including becoming party such action janssen cost provided that janssen shall reimburse geron pocket cost reasonably incurred connection with rendering such assistance janssen decline initiate such enforcement action against unabated product infringement shall notify geron shall thereafter have right obligation geron expense name initiate such action counsel choice janssen shall cooperate with geron geron reasonably request including becoming party such action geron cost geron shall reimburse janssen pocket cost reasonably incurred connection with rendering such assistance settlement consent judgment other voluntary final disposition action brought party under this section nbsp entered into without consent other party provided that such settlement consent judgment other disposition admit invalidity unenforceability patent right owned controlled other party provided further that right granted third party continue activity upon which such action based such settlement consent judgment other disposition shall limited third party product activity that subject action damage recovered other amount awarded action product infringement under this section nbsp shall allocated party brought action after reimbursement each party actual expense incurred such action provided hereunder provided that janssen shall geron royalty determined accordance with section nbsp based damage amount recovered janssen product infringement such form lost profit reasonable royalty assessed account third party sale infringing product after reimbursement cost incurred such action font style margin text indent font size face time roman style font size font weight bold nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold other enforcement action font font size style font size geron acknowledges that outcome infringement suit other enforcement action account third party infringement other than product infringement geron product patent right development program patent right licensed janssen under section nbsp detrimentally impact scope validity enforceability such patent right with respect potential product infringement accordingly font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size party shall reasonably cooperate with each other with respect infringement suit other enforcement action account third party infringement geron product patent right development program patent right other than product infringement clarity geron will required enforce geron product patent right against third party infringement other than product infringement provided that geron decline initiate enforcement action reasonably requested janssen abate third party infringing activity other than product infringement within scope janssen exclusive right under geron product patent right development program patent right granted hereunder then extent permitted existing third party agreement concerning such geron product patent right applicable upon janssen request geron shall reasonably cooperate with janssen that janssen initiate expense such enforcement action same manner described under section nbsp above with respect product infringement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold maintenance freedom operate font font size style font size party shall commercially reasonable effort avoid infringing third party patent right conducting development activity under global development plan each party shall promptly notify through patent representative event such party becomes aware third party patent right that pertain development activity party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent term extension font font size style font size long janssen retains commercialization right licensed product under section nbsp upon janssen written request which shall notice identifying date applicable regulatory approval licensed product deadline filing patent term extension prosecuting party shall reasonable effort each country jurisdiction where regulatory approval licensed product been obtained applicable such country jurisdiction permit application patent term extension apply reasonable direction janssen designated patent counsel patent term extension patent within geron product patent right including valid claim covering such licensed product which patent shall selected janssen reasonable judgment after considering opinion janssen patent counsel regarding eligibility patent term extension janssen shall have right nbsp identify list patent drug application applicable geron product patent right nbsp development program patent right janssen reasonably belief appropriate nbsp commence suit product infringement such geron product patent right nbsp development program patent right nbsp under applicable permitted under section nbsp nbsp exercise right that exercisable patent owner including applying patent term extension geron product patent right nbsp development program patent right nbsp pertaining approved licensed product commercialized janssen hereunder geron agrees cooperate with janssen affiliate third party sublicensees licensed product applicable upon janssen reasonable request exercise authorization granted under this section geron shall execute such document take such additional action janssen reasonably request connection therewith including requested janssen permitting geron joined party suit product infringement brought janssen hereunder term condition forth section nbsp provided that janssen shall reimburse geron reasonable pocket cost incurred geron taking such action geron agrees cooperate with janssen affiliate third party sublicensees licensed product applicable upon janssen reasonable request exercise authorization granted under this section subject surviving right granted geron third party geron obligation remaining under font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size applicable existing third party agreement then effect pursuant their term execution date except such amended geron with janssen prior written consent geron shall execute such document take such additional action janssen reasonably request connection therewith including using reasonable effort procure cooperation inferior right holder such that janssen shall have nbsp first superior right relation inferior right holder select from geron product patent right development program patent right particular country jurisdiction particular patent right which will pursue patent term extension such country application nbsp first superior right enforce defend patent within geron product patent right development program patent right against infringement pertaining third party licensed product generic product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold inferior right subordinate janssen font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size notwithstanding anything contrary herein geron shall commercially reasonable effort ensure that nbsp prosecution enforcement other activity inferior right holder pertaining geron product patent right under inferior right done reasonable manner avoid detrimentally impacting validity enforceability geron product patent right pertaining active substance licensed product country nbsp prosecution including with respect patent term extension enforcement right granted geron inferior right holder remain subordinate right janssen hereunder font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size consideration foregoing this section nbsp provision section nbsp inferior right holder develops composition matter exercise inferior right during term then geron shall commercially reasonable effort procure cooperation inferior right holder permit geron with janssen consent segregate divisional application claiming priority pending geron product patent right each applicable country where possible under applicable more narrow claim covering specifically such composition matter specie type claim such that each such divisional application within geron product patent right include claim covering active substance licensed product their janssen shall unreasonably withhold consent filing such divisionals provided that between party geron assumes responsibility patent cost associated with prosecuting such divisional geron follows reasonable comment janssen with respect prosecution font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold product trademark font font size style font size geron represents warrant that effective date otherwise control product trademark right relating including trademark application registration domain name janssen shall have directly through affiliate third party sublicensees commercializing licensed product right brand discretion licensed product using trademark trade name selected discretion file obtain maintain discretion cost product trademark right name font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold confidentiality publicity font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold confidential information font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size facilitate activity hereunder party disclosing party provide other party receiving party party this case receiving party otherwise through activity contemplated this agreement come into possession confidential information material controlled licensed developed possessed other party this case disclosing party such item confidential information material individually collectively constituting confidential information information identified being confidential that disclosed geron janssen under prior cdas shall considered confidential information geron under this agreement used purpose permitted hereunder receiving party shall keep such confidential information disclosing party confidential other than expressly permitted herein shall disclose directly indirectly such confidential information whether tangible intangible form disclosing party shall take reasonable measure identify confidential information material provided other party with confidential trade secret marking similar notation clarity janssen shall deemed disclosing party with respect information global development plan promotional plan independent promotional plan data other information from development commercialization licensed product exploitation support janssen license right under section including discussed joint committee meeting disclosed report provided geron hereunder such information shall treated janssen confidential information hereunder geron shall deemed disclosing party with respect information geron such information shall treated geron confidential information hereunder moreover effective date long janssen retains commercialization right licensed product hereunder geron product know unpublished effective date relating active substance licensed product including with respect discovery development preparation testing manufacture formulation delivery administration development program know relating licensed product shall treated janssen confidential information regardless ownership such information during applicable period confidentiality specified section nbsp below each receiving party shall shall cause affiliate keep confidence disclose third party purpose except pursuant order carry term objective this agreement including exercise such party right performance such party obligation under this agreement each case including those surviving expiration termination this agreement forth article nbsp confidential information other disclosing party font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size receiving party obligation confidentiality restriction disclosing party confidential information except those constituting trade secret shall last during term period seven nbsp year thereafter receiving party obligation confidentiality restriction with respect disclosing party confidential information identified trade secret typically held pharmaceutical industry trade secret such applicable know promotional marketing information shall font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size continue perpetually long such confidential information unpublished disclosing party provision section nbsp nbsp nbsp nbsp applies such confidential information font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size restriction receiving party disclosure disclosing party confidential information forth above this section nbsp shall apply particular confidential information extent that such confidential information font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size known receiving party affiliate prior disclosure disclosing party affiliate hereunder evidenced receiving party such affiliate written record other competent evidence font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size becomes part public domain through fault receiving party affiliate violation this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size disclosed receiving party affiliate third party having legal right make such disclosure without violating confidentiality obligation that such third party disclosing party affiliate thereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size independently developed personnel receiving party affiliate without reliance access confidential information evidenced receiving party such affiliate written record other competent evidence font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size avoidance doubt each receiving party disclose other party confidential information under appropriate confidentiality obligation substantially equivalent those this agreement receiving party affiliate forth written subcontract otherwise provided herein third party licensee sublicensees subcontractor other third party extent such disclosure reasonably necessary perform obligation exercise right granted reserved under this agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold exception confidentiality obligation font font size style font size receiving party disclose confidential information disclosing party receiving party obtains disclosing party prior written consent disclose identified information moreover receiving party disclose confidential information disclosing party solely extent required disclosed receiving party comply with applicable including security regulation applicable rule nbsp public stock exchange defend prosecute litigation comply with order court other government order provided that receiving party notifies disclosing party such order insofar possible font font size style font size provides reasonable assistance obtaining protective order confidential treatment preventing limiting disclosure requiring that confidential information disclosed used only purpose which regulation required which order issued avoidance doubt nbsp janssen disclose geron confidential information reasonably necessary making regulatory filing connection with development licensed product hereunder nbsp geron disclose janssen confidential information reasonably necessary making regulatory filing connection with development licensed product pursuant geron obligation specified exhibit nbsp under geron font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size hereunder nbsp geron event early termination which geron obtains right develop reverted product pursuant section nbsp disclose janssen confidential information reasonably necessary making regulatory filing connection with development such reverted licensed product after such early termination this agreement applicable nbsp party controlling prosecution patent right pursuant this agreement disclose other party confidential information patent office connection with such permitted prosecution font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold requirement cooperate enable accurate public disclosure font font size style font size extent either party discloses other party confidential information which fact result event relating development commercialization licensed product collaboration activity that receiving party good faith reasonably belief insufficient either nbsp allow receiving party fully understand materiality such confidential information purpose determining whether receiving party required disclose government authority publicly such confidential information order comply with applicable including security regulation applicable rule nbsp public stock exchange nbsp meet need receiving party keep investor informed regarding receiving party business investor information defined section nbsp pursuant section nbsp disclosing party agrees discus such confidential information with receiving party provide additional information reasonably requested receiving party enable receiving party materiality case nbsp above accuracy completeness case nbsp nbsp above such information such public disclosure purpose case which additional information shall treated disclosing party additional confidential information shall treated accordance with term hereof including section nbsp above below case font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold confidentiality agreement term font font size style font size subject section each party agrees cause affiliate disclose third party term this agreement without prior written consent other party hereto except each party affiliate disclose term this agreement nbsp advisor including financial advisor attorney accountant actual potential acquisition partner private investor others need know basis each case under appropriate confidentiality provision substantially equivalent those this agreement nbsp extent necessary comply with applicable court order including security regulation applicable rule nbsp public stock exchange font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold publicity font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold initial press release font font size style font size after effective date each party issue respective press release regarding this agreement attached hereto exhibit nbsp including existence certain term hereof provided such exhibit font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold further publicity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold investor information font font size style font size each disclosing party acknowledges that other party receiving disclosing party confidential information hereunder from time time nbsp desire publicly disclose through nbsp press release nbsp medium appearance font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size public announcement presentation such presentation analyst shareholder collectively investor presentation nbsp required publicly disclose applicable regulation rule nbsp stock exchange required filing such form each such disclosure nbsp public disclosure term this agreement significant result development regarding licensed product keep investor reasonably informed achievement milestone significant event development regulatory process licensed product commercialization activity like that such public disclosure pertain confidential information other party that otherwise permitted disclosed under this article nbsp which beyond what required disclosed applicable collectively investor information clarity investor information includes solely those item that beyond what required disclosed under applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold public disclosure review procedure font font size style font size with respect public disclosure except initial press release described section nbsp receiving party requesting party shall provide other party reviewing party with nbsp draft content defined next sentence draft press release required filing nbsp summary content investor presentation review least business practicable under circumstance practicable such shorter time advance issuance press release filing required filing scheduled date investor presentation word content this section nbsp nbsp mean information relating activity contemplated this agreement including investor information include other business information requesting party information pertaining safe harbor provision private security litigation reform relating forward looking statement reviewing party notify requesting party reasonable objection suggestion that other party have regarding content public disclosure provided review under this section requesting party shall reasonably consider such objection suggestion that provided timely manner principle observed with respect disclosure investor information shall include accuracy compliance with applicable regulatory guidance document reasonable sensitivity potential negative reaction regulatory authority reasonable sensitivity commercial information value competitor need keep investor informed regarding requesting party business reasonable sensitivity avoid requesting party shall commercially reasonable effort adopt reasonable request reviewing party with respect confidential information font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold publication font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold publication strategy font font size style font size directly through joint development committee shall develop under advice patent working group strategy provide guidance party appropriate timing scientific publication either both party relating result from development licensed product hereunder party acknowledge that appropriate party from time time enter into agreement with third party subcontractor performing development work such academic institute conducting clinical study under that include contractual provision permitting such third party make publication regarding result their subcontract work party font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size through appropriate joint committee shall reasonably cooperate facilitate such third party publication permitted under such third party subcontract font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold publication review font font size style font size publication presentation result from development program party publication activity relating thereto licensed product shall conducted accordance with term hereof guidance prior publishing presenting result development activity related licensed product party desiring submit such publication publishing party shall provide other party reviewing party least prior planned submission publication presentation such other time reasonably practicable circumstance draft proposed abstract poster manuscript slide summary oral presentation other material that such publishing party affiliate subcontractor intends publish publicly present proposed publication later than after receipt proposed publication reviewing party shall notify publishing party writing whether reviewing party objection proposed publication whether inclusion confidential information allow time applicable party party file patent protection invention within development program know upon such notice from reviewing party publishing party shall delay submission permit filing such desired patent application appropriate based advice patent working group related provisional application within year thereof such development work relating invention described proposed publication improvement thereof still ongoing reviewing party notifies publishing party that such objection proposed publication publishing party shall reasonably cooperate with reviewing party address such concern publishing party shall reasonably consider other suggestion reviewing party that provided timely manner after doing proceed with proposed publication subject term condition hereof clarity proposed publication material that subcontractor investigator other third party propose publish present such material shall subject review under this section nbsp extent that geron janssen case right time font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold authorship font font size style font size party shall comply proposed publication made pursuant this section nbsp during term with standard academic practice regarding authorship scientific publication recognition contribution party notwithstanding foregoing extent that reviewing party either provided funding activity relating development licensed product incurring reimbursing development cost with respect thereto reviewing party contribution shall acknowledged proposed publication that relates such activity unless reviewing party request acknowledged clarity nothing contained this section nbsp shall alter affect party confidentiality obligation pursuant this article nbsp obligation comply with applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold publication progress clinical study font font size style font size party agree that nothing herein shall prohibit either party from publishing confidential information pertaining progress such clinical study licensed product under global development plan required applicable geron acknowledges agrees that nothing herein shall prohibit janssen affiliate from publishing confidential information reasonably required janssen compliance with then current policy registration reporting result font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size pharmaceutical company sponsored clinical study policy copy which execution date janssen provided geron geron further agrees provide cause applicable subcontractor provide janssen such assistance reasonably requested connection with fulfilling requirement forth such policy subject foregoing this section party shall commercially reasonable effort comply with review procedure section nbsp prior posting other publication proposed publication under this section nbsp extent consistent herewith font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold third party clinical data font font size style font size geron acknowledges that janssen ascribes certain industry group position such those phrma advamed adopted policy each case regarding disclosing clinical data certain third party including without limitation certain research accordingly data information obtained from clinical study licensed product conducted under this agreement disclosed janssen third party consistent with janssen policy regulatory authority requirement applicable provided that janssen provides geron prior written notice such disclosure reasonably advance such disclosure nothing this agreement will prohibit such disclosure janssen font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold representation warranty font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold representation authority font font size style font size geron janssen each represents warrant other party that execution date through effective date shall retain full right power authority enter into this agreement perform respective obligation under this agreement that right grant other license sublicenses granted pursuant this agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold consent font font size style font size each party represents warrant other party that except provided section nbsp regarding clearance except approval from regulatory authority including pricing reimbursement approval manufacturing approval similar approval necessary development manufacture commercialization licensed product necessary consent approval authorization government authority other person required obtained effective date connection with execution delivery performance this agreement have been obtained effective date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold conflict font font size style font size each party represents warrant other party that notwithstanding anything contrary this agreement execution delivery this agreement such warranting party performance such party obligation hereunder contemplated effective date license sublicenses granted such party pursuant this agreement nbsp conflict with violate requirement applicable existing effective date applicable such party nbsp conflict with violate breach constitute default under contractual obligation such party affiliate existing effective date each party shall shall cause affiliate comply with applicable pertaining development manufacture commercialization licensed product including applicable drug regulation clinical investigation health care font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold enforceability font font size style font size each party represents warrant other party that effective date this agreement legal valid obligation binding upon warranting party enforceable against accordance with term font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold additional representation warranty geron font font size style font size geron represents warrant janssen that execution date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size geron nbsp aware claim made against asserting invalidity misuse unregisterability unenforceability infringement geron product patent right nbsp aware claim made against challenging geron ownership license right geron product patent right making adverse claim ownership whether sole joint thereof license thereto except license expressly forth existing license third party identified exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size other than exclusive license granted geron third party under existing license third party identified exhibit nbsp which grant preclude janssen from exploiting full scope license granted janssen under section hereof geron granted license third party under geron product patent right geron product know offer sale sell otherwise commercialize licensed product field which license expired been terminated prior execution date shall have granted such right effective date font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size geron product patent right through effective date shall remain free clear lien charge encumbrance other than exclusive license granted geron third party which grant preclude janssen from exploiting full scope license granted janssen contemplated hereunder neither geron affiliate their respective current former employee best geron knowledge misappropriated geron product know from third party geron aware claim third party that such misappropriation occurred font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size except expressly forth applicable existing license from third party identified exhibit nbsp neither geron geron knowledge third party licensors geron product been party agreement with federal government agency thereof pursuant which federal government such agency provided funding such under grant contract research development work relating licensed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size best geron knowledge written claim infringement patent right third party been made threatened writing directly indirectly against geron affiliate best geron knowledge third party contractor under existing third party agreement with respect development manufacture commercialization active substance licensed product there other judgment settlement against owed geron affiliate which geron affiliate party best geron knowledge pending litigation litigation threatened writing each case relating active substance licensed product font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size geron made available janssen review material information geron possession control execution date that best geron knowledge pertains development manufacture commercialization thereof including complete correct copy following extent there geron possession control execution date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size adverse event data report font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size clinical study report study data including identified data observation analysis conclusion summary report resulting from clinical study initiated under mayo contract nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size regulatory authority inspection report notice adverse finding warning letter regulatory filing letter other correspondence with regulatory authority font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size geron knowledge study test clinical clinical trial licensed product conducted prior being conducted execution date have been execution date being conducted material compliance with applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size best geron knowledge exhibit nbsp list geron product patent right owned solely geron execution date collectively solely owned geron product patent right exhibit nbsp list geron product patent right owned jointly geron with third party identified such exhibit execution date geron equal undivided interest each such geron product patent right collectively jointly owned geron product patent right exhibit nbsp list geron product patent right licensed geron from third party execution date collectively licensed geron product patent right best geron knowledge based record that geron possessed were reasonably available geron time before execution date inventorship named execution date each issued geron product patent right correct font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size best geron knowledge exhibit nbsp list geron assay patent right execution date best geron knowledge none know described contained exhibit nbsp includes derived from know licensed geron under existing license from third party confidential information proprietary third party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size geron product patent right subject font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size each patent right within imetelstat patent family owned solely geron font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold further representation warranty geron regarding existing license from third party font font size style font size best geron knowledge exhibit nbsp list existing license from third party execution date that pertain geron represents warrant that best knowledge execution font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size date geron entered into geron agrees that through effective date during term shall enter into agreement with third party virtue which royalty milestone payment other payment would owed janssen such third party account commercialization licensed product behalf janssen contemplated hereunder geron represents warrant that exhibit nbsp forth existing license from third party which geron obtained right licensed geron product patent right geron represents warrant that prior execution date geron provided janssen with opportunity review complete correct copy existing license from third party including amendment thereof including term condition thereof execution date geron represents warrant that knowledge such existing license from third party remain full force effect execution date except where noted otherwise exhibit nbsp knowledge geron each third party counterparty been compliance material respect with term thereof geron covenant that shall commercially reasonable effort take omit take action that would constitute breach existing license from third party through effective date during term hereof geron agrees enter into amendment existing third party agreement through effective date during term hereof each case which breach amendment would have material adverse effect development commercialization licensed product contemplated hereunder during term geron shall provide janssen promptly with notice occurrence such breach receipt notice allegation such breach font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold warranty font font size style font size except otherwise expressly forth this agreement neither party make representation extends warranty kind either express implied other party each party hereby disclaims implied warranty merchantability fitness particular purpose noninfringement with respect collaboration activity each party hereby disclaims representation warranty that development manufacture commercialization licensed product pursuant this agreement will successful that particular sale level with respect licensed product will achieved font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold debarment font font size style font size except with regard janssen reflected subject term corporate integrity agreement each party represents warrant that effective date neither affiliate been debarred subject debarment neither party affiliate will capacity connection with development manufacture commercialization licensed product product field person been debarred pursuant section nbsp united state federal food drug cosmetic subject conviction described such section each party agrees inform other party writing immediately person performing service hereunder debarred subject conviction described section nbsp united state federal food drug cosmetic action suit claim investigation legal administrative proceeding pending best such party knowledge threatened relating debarment conviction such party person used capacity such font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size party affiliate connection with development manufacture commercialization licensed product product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold compliance with anti corruption applicable font font size style font size each party shall shall cause each affiliate third party subcontractor sublicensees conducting activity hereunder comply with anti corruption provision exhibit nbsp attached hereto connection with performance activity under this agreement font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp xiii font font size style font size font weight bold indemnification insurance font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold indemnification obligation font font size style font size each party indemnifying party shall indemnify hold harmless other party font font size style font size indemnified person font font size style font size collectively indemnified party font font size style font size from against loss resulting from action brought third party against indemnified party extent such loss font font size style font size arise from based claim claim font font size style font size nbsp negligence wilful misconduct indemnifying party indemnified person third party sublicensees subcontractor each case connection with exercise such indemnifying party right performance such party obligation under this agreement nbsp indemnifying party indemnified person third party sublicensees subcontractor failure comply with perform more such party such affiliate applicable obligation this agreement breach inaccuracy more such indemnifying party such indemnified person applicable warranty this agreement nbsp indemnifying party indemnified person third party sublicensees subcontractor font font size style font size making using selling offering sale importation distribution disposition other exploitation development program outside development program font font size style font size nbsp violation applicable indemnifying party indemnified person third party sublicensees subcontractor connection with exercise such indemnifying party right performance such party obligation under this agreement nbsp performance development activity indemnifying party indemnified person third party sublicensees subcontractor hereunder nbsp case janssen indemnifying party commercialization manufacture promoting including detailing sale distribution licensed product employee agent including sale representative janssen affiliate third party sublicensees hereunder except each case extent resulting from inaccuracy omission safety information regulatory documentation that relates licensed product provided geron reasonably relied upon janssen affiliate indemnified person hereunder nbsp case geron indemnifying party promoting licensed product employee agent including sale representative geron pursuant exercise geron promotion option hereunder except extent resulting from inaccuracy omission approved material detailing licensed product product label insert safety information regulatory documentation relating licensed product that provided janssen reasonably relied upon geron indemnified person hereunder nbsp case geron indemnifying party infringement existing blocking third party patent right based upon resulting from font font size style font size contemplated license activity unless until such time with respect given existing blocking third party patent right unblocking license agreement entered into geron accordance with section nbsp font font size style font size font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold claim indemnification font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold notice font font size style font size case action which indemnifying party liable indemnified person under section nbsp indemnified party shall soon practicable notify indemnifying party writing such action notice claim failure delay notifying indemnifying party shall relieve indemnifying party liability have indemnified party except only extent that such failure delay cause actual harm indemnifying party with respect such action notice claim shall specify reasonable detail action with respect which such indemnified party indemnified person intends base request indemnification reimbursement under section nbsp failure provide such reasonable detail will relieve indemnifying party liability have indemnified party except only extent that such failure cause actual harm indemnifying party with respect such action indemnified party shall enclose with notice claim copy paper served with respect such action indemnifying party shall have right assume defense such action unless provides notice within from date which indemnifying party received notice claim that indemnifying party waif right assume defense such action litigation resulting therefrom with counsel choice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold control defense font font size style font size provided that indemnifying party waived right assume defense action pursuant section nbsp then subject section indemnifying party shall have right defend settle otherwise dispose such action font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold cooperation font font size style font size party shall good faith responding defending against settling otherwise dealing with such action pursuant term hereof provided that nbsp indemnified party shall obligated enter into consent entry judgment settlement relation action provided section nbsp nbsp event indemnifying party shall relieved obligation under this section nbsp result failure indemnified party cooperate provided this section nbsp except extent that indemnifying party actually prejudiced such breach party shall also cooperate such defense giving each other reasonable access privileged information relevant thereto extent permitted applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold control indemnifying party font font size style font size indemnifying party assumes control action accordance with section nbsp nbsp indemnified party retain separate counsel sole cost expense participate defense action indemnifying party shall continue control investigation defense settlement thereof nbsp indemnifying party will without prior written consent indemnified party consent entry judgment enter into settlement with respect action extent such judgment settlement nbsp provides equitable relief other relief other than solely money damage against indemnified party indemnified person liability obligation that assumed performed indemnifying party full without recourse indemnified party indemnified person nbsp provides monetary relief that will fully discharged indemnifying party without recourse indemnified party indemnified person concurrently with effectiveness such judgment settlement provided that indemnified party consent shall unreasonably font align center style margin text align center font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size withheld conditioned delayed extent that sole relief monetary nbsp effect full unconditional release indemnified party indemnified person with respect claim such action portion thereof which judgment settlement relates nbsp that contains admission wrongdoing part indemnified party indemnified person notwithstanding anything contained herein contrary indemnifying party shall entitled assume defense action that seek injunction other equitable relief other relief other than solely money damage against indemnified party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold interim control font font size style font size unless until indemnifying party determined with respect particular action party subject such action shall have right defend control such action shall have right consent entry judgment enter into settlement with respect action which would seeking indemnification reimbursement hereunder without prior written consent other party which consent shall unreasonably withheld conditioned delayed font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold election control font font size style font size indemnifying party waif control action accordance with section nbsp then indemnified party will entitled assume control action upon delivery notice such effect indemnifying party provided that indemnifying party shall have right participate action sole cost expense indemnified party shall control investigation defense settlement thereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold unauthorized settlement font font size style font size whether indemnifying party assumed control action indemnified party will consent entry judgment enter into settlement with respect action which seeking indemnification hereunder without prior written consent indemnifying party which consent shall unreasonably withheld conditioned delayed such indemnifying party shall obligated indemnify reimburse indemnified party hereunder settlement entered into judgment that consented indemnified party without indemnifying party prior written consent font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold allocation font font size style font size action under this article nbsp xiii indemnified party incurs amount consisting both loss which indemnifying party obliged indemnify indemnified party loss covered such indemnification then extent otherwise determined court competent jurisdiction party agree good faith their reasonable endeavour determine fair reasonable allocation such loss allocation between party such loss otherwise determined court competent jurisdiction shall party reach agreement writing such allocation determined arbitration pursuant section nbsp party arbitrator case shall make such allocation based indemnification reimbursement principle forth this article nbsp xiii notwithstanding foregoing party shall entitled refer dispute with respect loss arising under action pursuant this section nbsp arbitration extent that liability either party such loss being contested such action other action that would binding with respect such first action font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold mitigation font font size style font size indemnified party shall shall procure that indemnified person shall each instance take reasonable step mitigate loss they suffer arising font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size connection with action respect which they seek indemnity from other party under this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold conduct product liability claim font font size style font size provision this section nbsp shall govern with respect third party product liability action which party seek indemnification pursuant section nbsp provision this section nbsp below shall control event conflict between such provision those section nbsp above font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold product liability action font font size style font size party becoming aware action involving product liability claim connection with human licensed product whether clinical study development program through commercialization janssen hereunder shall promptly notify other party event that third party asserts file product liability claim action based thereon relating alleged defect licensed product whether design defect manufacturing defect defect sale promoting third party product liability action against party event third party product liability action initiated against single party which seek indemnification from other indemnifying party under section nbsp indemnifying party shall have control over such action such case indemnified party shall have right discretion expense join otherwise participate such third party product liability action with legal counsel selected indemnified party reasonably acceptable indemnifying party indemnifying party shall have right control defense such action shall notify keep indemnified party apprised writing such action shall consider take into account indemnified party reasonable interest request suggestion regarding defense such action event third party product liability action initiated against both party janssen shall control response such third party product liability action with each party responsible legal expense incurred such action font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold cooperation font font size style font size controlling party third party product liability action shall reasonably cooperate with controlling party preparation formulation defense such third party product liability action taking other step reasonably necessary respond such third party product liability action controlling party shall have sole exclusive right select counsel defense such third party product liability action required under applicable order controlling party maintain suit response such third party product liability action controlling party shall join party suit controlling party shall assume pocket cost incurred connection with litigation proceeding related such third party product liability action including expense counsel selected well reasonable pocket cost controlling party associated with providing assistance requested controlling party joining suit requested controlling party required maintain suit controlling party shall also have right participate represented such suit counsel expense controlling party shall settle compromise third party product liability action without consent other party which consent shall unreasonably withheld font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold insurance font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size during term period five year thereafter janssen will secure maintain full force effect adequate insurance coverage against liability under this agreement including commercial general liability product liability insurance amount than occurrence annual aggregate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size prior initiation clinical study related development activity under global development plan party responsible applicable activity shall secure maintain full force effect clinical trial insurance compliance with applicable those territory where clinical study conducted font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size upon written request each party shall provide other with certificate insurance evidencing required coverage hereunder notwithstanding foregoing either party failure maintain adequate insurance shall relieve that party obligation forth this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold limitation liability font font size style font size notwithstanding provision section nbsp nothing herein intended shall limit restrict indemnification right obligation party under this article nbsp xiii font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font font size style font size font weight bold term termination font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold agreement term font font size style font size unless terminated earlier accordance with this article nbsp term this agreement term shall commence effective date shall expire upon expiration last expire geron product patent right development program patent right royalty term licensed product sold hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold early termination default font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold notice default cure period font font size style font size upon material breach this agreement party breaching party other party breaching party shall have right give breaching party notice specifying nature such material breach breach this agreement curable then breaching party shall have period from date receipt notice cure period cure such material breach manner that effectively remedy harm breaching party caused material breach notwithstanding foregoing such breach nature curable reasonably curable within cure period then provided that such breach payment obligation hereunder such cure period shall extended breaching party provides written plan curing such breach breaching party diligent effort cure such breach accordance with such written plan provided that such extension shall exceed extended cure period totaling without consent breaching party clarity this provision shall restrict either party right notify other party other breach demand cure other breach font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold termination right default font font size style font size breaching party shall have right terminate this agreement upon written notice breaching party nbsp event font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size breaching party notify breaching party within notice under section that breaching party dispute that committed material breach that intends cure such breach accordance with section event that breaching party cured material breach within cure period party good faith raise dispute regarding such termination including with respect existence materiality breach sufficiency cure pursuant dispute resolution procedure under section such termination shall effective only upon conclusion dispute resolution procedure section resulting determination that there been uncured material breach earlier abandonment dispute breaching party avoidance doubt exercise termination right under this section breaching party shall without prejudice right seek damage other remedy account breaching party material breach that available equity subject term hereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold early termination bankruptcy font font size style font size font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size event bankruptcy party successor interest event this agreement assigned permitted hereunder other party terminate this agreement notice bankrupt party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license other right granted pursuant this agreement party other will otherwise deemed purpose section bankruptcy code comparable provision other jurisdiction license right intellectual property defined under section bankruptcy code comparable provision applicable other jurisdiction notwithstanding anything contrary herein party agree that lieu party licensed sublicensed right from party bankruptcy terminating this agreement entirety provided section above party licensee such right from other party under this agreement shall upon such other party bankruptcy retain fully exercise right election under bankruptcy code comparable applicable other jurisdiction event commencement bankruptcy proceeding against party under bankruptcy code comparable provision applicable other jurisdiction party that party such bankruptcy proceeding shall entitled complete duplicate complete access appropriate such intellectual property embodiment such intellectual property which granted license other right hereunder same already possession will promptly delivered upon such commencement bankruptcy proceeding upon written request therefor unless party subject such proceeding elect continue perform obligation under this agreement delivered under subsection above following rejection this agreement behalf party subject such proceeding upon written request therefor subject party right power remedy granted hereunder party licensee intellectual property right provided this section addition substitution other right power remedy hereafter existing equity event commencement bankruptcy action against granting party under applicable licensee party addition right power remedy expressly provided herein shall entitled exercise other such right power resort other such remedy hereafter exist equity such event font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold termination janssen safety concern font font size style font size janssen terminate this agreement written notice geron event that janssen determines good faith judgment that continued development commercialization licensed product would unethical unreasonable safety related reason such janssen belief based good faith assessment relevant data that continuation human licensed product resulted significant risk resulting occurrence safety tolerability finding that would raise material concern regarding clinical benefit licensed product target population example harm significantly excess acceptable side effect profile such termination shall effective immediately upon janssen written notice geron font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold discretionary termination janssen font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold prior lead phase study read font font size style font size time before occurrence lead phase study read janssen unilaterally terminate this agreement written notice geron which termination shall effective from date such notice irrespective whether lead phase study read occurs during such font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold during janssen election period font font size style font size during janssen election period janssen unilaterally terminate this agreement written notice geron effective after expiration janssen election period alternatively janssen timely deliver geron continuation notification under section during janssen evaluation period shall deemed have exercised right terminate under this section effective immediately after expiration janssen evaluation period font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold after delivery continuation notice font font size style font size time after janssen delivered continuation notification janssen unilaterally terminate this agreement notice geron which termination shall effective month from date such notice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold consequence early termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold geron breach bankruptcy font font size style font size event early termination this agreement janssen under section geron material breach geron bankruptcy then upon effective date such termination following provision shall apply addition those provision forth section font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license other right granted geron janssen under section shall terminate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license granted geron under section shall terminate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold safety janssen breach bankruptcy janssen font font size style font size event early termination janssen under section safety geron under section janssen material breach janssen bankruptcy then effective date such termination following provision shall apply addition those provision forth section font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license granted janssen under section shall terminate except that applicable license shall survive exclusive basis solely purpose duration wind down activity conducted janssen accordance with clause this section font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license granted geron under section shall terminate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size janssen will assign geron regulatory filing regulatory approval specific licensed product being developed such time previously developed during term commercialized hereunder janssen affiliate third party sublicensees effective date termination reverted licensed product janssen development program know contained such regulatory filing regulatory approval shall subject license grant forth section such event janssen shall grant hereby grant geron right reference master file within possession control janssen directly through affiliate date notice such termination provided that janssen covenant intentionally relinquish control prior such notice termination reverted licensed product active substance therein janssen shall take such reasonable action execute such other instrument assignment document reasonably requested geron effect transfer right under such regulatory filing regulatory approval geron applicable prevents delay transfer ownership such regulatory filing regulatory approval geron janssen shall grant hereby grant geron exclusive irrevocable right access reference such regulatory filing regulatory approval licensed product shall cooperate with geron make benefit such regulatory filing regulatory approval available geron designee addition providing copy regulatory filing regulatory approval pursuant clause this section janssen shall promptly provide geron with copy other material janssen development program know including clinical regulatory data result report analysis know pertaining reverted licensed product possession control font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size geron request janssen shall promptly transfer safety data from clinical development commercialization reverted licensed product janssen possession including those contained janssen global safety database geron geron shall accept such transfer such data assume pharmacovigilance responsibility such product including with respect serious adverse event pregnancy reporting accordance with applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size janssen shall grant hereby grant effective upon date such termination geron worldwide exclusive paid janssen subject term condition hereof perpetual license with right sublicense under applicable janssen development program subject geron agreeing assume janssen obligation third party solely extent reasonably necessary useful geron make sell offer sale import reverted licensed product provided however that geron shall agree assume payment obligation third party arising from geron affiliate third party sublicensees exploitation such right clarity such janssen development program shall treated janssen well geron confidential information regardless ownership font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size such information subject confidentiality provision article geron request janssen shall enter into good faith negotiation grant geron corresponding royalty bearing exclusive worldwide license under janssen product provided that janssen shall obligated enter into such license party fail reach mutually acceptable license term font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size janssen shall geron request commercially reasonable effort provided that clarity such effort shall require janssen make payment unless geron agrees writing reimburse janssen such payment facilitate negotiation between geron janssen third party subcontractor sublicensees performing ongoing development manufacturing commercialization activity with respect reverted licensed product geron reasonable request extent permissible under agreement between janssen such third party subcontractor sublicensee provided that such agreement relates only reverted product subject geron agreement bear associated cost assign such agreement related solely reverted licensed product geron font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size janssen shall geron request transfer geron remaining inventory licensed product except forth clause this section below manufactured development accordance with geron shall janssen such inventory amount cost good plus percent which shall payable within geron receipt invoice janssen such amount janssen shall geron request commercially reasonable effort facilitate orderly prompt transition manufacturing clinical supply reverted licensed product active substance then being conducted janssen affiliate geron designee while such manufacturing capability transitioned supply geron designee with such active substance reverted licensed product development price equivalent cost good therefor plus percent percent provided that janssen shall obligated continue supply such active substance reverted licensed product after earlier janssen sole manufacturing source active substance reverted licensed product date falling twenty four month from effective date termination provided that twelve month from effective date termination geron using commercially reasonable effort procure alternative manufacturing source active substance reverted licensed product date geron able procure alternative manufacturing source reverted licensed product sufficient meet development need event that twelve month from effective date termination geron using commercially reasonable effort procure alternative manufacturing source reverted licensed product then janssen shall have further obligation continue supply such active substance reverted licensed product event that third party manufacturing active substance reverted licensed product then janssen shall obligated continue supply such active substance reverted licensed product provided that material manufacturing agreement between janssen such third party assigned geron further provided that pocket cost cancellation cancellable payment obligation resulting from assignment from janssen geron such material manufacturing agreement shall borne party equally font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size janssen affiliate sublicensees selling having sold effective date termination licensed product country which regulatory approval been obtained launched product then geron designee shall have optional right purchase part remaining stock launched product warehouse factory janssen affiliate price equivalent cost good such stock launched product plus percent geron exercise optional right take over janssen affiliate stock launched product under this clause then janssen shall have right continue sell have sold residual salable usable stock launched product period month from effective date such termination provided that royalty payment obligation under section accruing geron account janssen sale such remaining stock during such period shall made accordingly case janssen shall obligated promote launched product after effective date termination janssen shall geron request commercially reasonable effort facilitate orderly prompt transition manufacturing launched product then being conducted janssen affiliate geron designee while such manufacturing capability transitioned supply geron designee with launched product price equivalent cost good therefor plus percent provided that janssen shall obligated continue supply launched product after earlier janssen sole manufacturing source launched product date falling twenty four month from effective date termination provided that twelve month from effective date termination geron using commercially reasonable effort procure alternative manufacturing source launched product date geron able procure alternative commercial manufacturing source launched product sufficient meet commercialization need provided however that event that twelve month from effective date termination geron using commercially reasonable effort procure alternative manufacturing source launched product then janssen shall have further obligation continue supply such launched product event that third party manufacturing launched product then janssen shall obligated continue supply such launched product provided that material manufacturing agreement between janssen such third party assigned geron further provided that pocket cost cancellation cancellable payment obligation resulting from assignment from janssen geron such material manufacturing agreement otherwise transitioning manufacturing geron shall borne party equally font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold janssen prior lead phase study read font font size style font size event early termination janssen under section prior lead phase study read then effective date such termination following provision shall apply addition those provision forth section font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license granted janssen under section shall terminate except that applicable license shall survive exclusive basis solely purpose duration transitional wind down activity conducted janssen accordance with this section font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license granted geron under section shall terminate font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size provision section shall apply font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size janssen shall have following transitional wind down obligation clarity except forth clause below janssen shall longer have obligation fund development cost incurred under development budget after effective date such termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size with respect lead phase study whether initiated provided that time termination there prohibition initiating continuing such study applicable regulatory authority janssen shall continue fund janssen share development cost under development budget such initial study incurred after effective date such termination through completion such initial study font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size with respect lead phase risk study only initiated with patient dosed provided that time termination there prohibition continuing such study applicable regulatory authority janssen shall continue fund janssen share development cost under development budget such initial study incurred after effective date such termination through date which lead phase study then targeted complete reflected date notice such termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size extent such initial study ongoing date notice such termination being continued pursuant clause this section unless geron request earlier wind down study transfer responsibility from janssen geron which event janssen shall reasonably cooperate with such request janssen shall continue execute collaboration activity such initial study pursuant until earlier date completion collaboration activity lead phase study date that twelve month from date notice such termination under oversight which shall connection therewith render decision within authority hereunder consensus vote party representative during such time notwithstanding anything contrary herein oversee transfer responsibility geron during such time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size with respect additional study under clinical study under janssen each case only such study whether under janssen initiated with patient dosed provided that time termination there prohibition continuing such study applicable regulatory authority janssen shall continue fund development cost allocable under this agreement janssen under development budget janssen applicable such study incurred during period running month from date notice such termination extent such other clinical study under this clause ongoing date notice such termination being continued pursuant this clause unless geron request earlier wind down study transfer responsibility from janssen geron which event janssen shall reasonably cooperate with such request janssen shall continue execute operational activity such study under janssen applicable until date that twelve month from date notice such termination under oversight font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size which shall connection therewith render decision within authority hereunder consensus vote party representative during such time notwithstanding anything contrary herein oversee transfer responsibility geron during such time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold janssen during janssen election period font font size style font size event early termination janssen under section during janssen election period notice termination failure deliver continuation notification then effective date such termination following provision shall apply addition those provision forth section font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license granted janssen under section shall terminate except that applicable license shall survive exclusive basis solely purpose duration transitional wind down activity conducted janssen accordance with this section font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license granted geron under section shall terminate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size provision section shall apply font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size janssen shall have following transitional wind down obligation clarity except forth clause janssen shall longer have obligation fund development cost under development budget initial study incurred after effective date such termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size with respect additional study under only initiated with patient dosed provided that time termination there prohibition continuing such additional study applicable regulatory authority janssen shall continue fund janssen share development cost under development budget continuing such additional study during month period running from effective date termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size extent lead phase risk study such additional study under ongoing effective date termination being continued pursuant clause this section unless geron request earlier wind down such study transfer responsibility from janssen geron which event janssen shall reasonably cooperate with such request janssen during twelve month period running from effective date such termination shall continue perform collaboration activity each applicable study during such time under oversight which shall connection therewith render decision within authority hereunder consensus vote party representative during such time notwithstanding anything contrary herein oversee transfer responsibility geron during such month period font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size with respect additional study under clinical study under janssen each case only such study whether under janssen initiated with patient dosed provided that time termination there prohibition continuing such study applicable regulatory authority janssen shall continue fund share development cost under development font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size budget janssen applicable such study incurred during period running month from date notice such termination extent such other clinical study under this clause ongoing date notice such termination being continued pursuant this clause unless geron request earlier wind down study transfer responsibility from janssen geron which event janssen shall reasonably cooperate with such request janssen shall continue execute operational activity such study under janssen applicable until date that twelve month from date notice such termination under oversight which shall connection therewith render decision within authority hereunder consensus vote party representative during such time notwithstanding anything contrary herein oversee transfer responsibility geron during such time font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold janssen after delivery continuation notice font font size style font size event early termination janssen under section after delivery continuation notification then effective date such termination following provision shall apply addition those provision forth section font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license granted janssen under section shall terminate except that applicable license shall survive exclusive basis solely purpose duration transitional wind down activity conducted janssen accordance with this section font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size license granted geron under section shall terminate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size provision section shall apply font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size either janssen notice termination provided geron within month after date janssen continuation notification janssen notice termination provided after period following date janssen continuation notification geron exercised right then each case font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size with respect initial study additional study under clinical study under janssen each case only such study whether under janssen initiated with patient dosed provided that time termination there prohibition continuing such study applicable regulatory authority janssen shall continue fund share development cost under development budget janssen applicable such study incurred during period running month from date notice such termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size extent such other clinical study under clause ongoing date notice such termination being continued pursuant this clause unless geron request earlier wind down study transfer responsibility from janssen geron which event janssen shall reasonably cooperate with such request janssen shall continue execute operational activity such study under janssen applicable until date that twelve month from date notice such termination under oversight which shall connection therewith render decision within authority hereunder consensus vote party representative font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size during such time notwithstanding anything contrary herein oversee transfer responsibility geron during such time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size otherwise janssen notice termination provided after period from date janssen continuation notification geron exercised right then janssen shall have following obligation font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size with respect initial study additional study under clinical study under janssen each case only such study whether under janssen initiated with patient dosed provided that time termination there prohibition continuing such study applicable regulatory authority janssen shall continue fund share development cost under development budget janssen applicable such study incurred during period running month from date notice such termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size extent such other clinical study under clause ongoing date notice such termination being continued pursuant this clause unless geron request earlier wind down study transfer responsibility from janssen geron which event janssen shall reasonably cooperate with such request janssen shall continue execute operational activity such study under janssen applicable until date that twelve month from date notice such termination under oversight which shall connection therewith render decision within authority hereunder consensus vote party representative during such time notwithstanding anything contrary herein oversee transfer responsibility geron during such time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold other provision applicable early termination font font size style font size event early termination this agreement following provision shall also apply font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size other joint committee shall dissolve after completion activity event contemplated section above case font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size party which license granted been terminated accordance with this article shall other party request extent when permitted applicable destroy redact return cause affiliate third party subcontractor sublicensees destroy redact return record extent containing material constituting other party confidential information possession control upon request provide written certification such destruction redaction return provided that such party retain strict confidence copy other party confidential information legal archive font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold survival font font size style font size event expiration termination this agreement reason provision article with respect accrued payment obligation xiii section shall survive well other provision that apparent from their nature context intended continue remain such interpretation purpose shall survive further avoidance doubt upon font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size expiration termination this agreement reason neither party shall released from obligation that accrued prior term hereof accordingly termination expiration agreement whole part including relinquishment license right granted hereunder reason shall without prejudice obligation that accrued prior such termination expiration including payment hereunder regardless when payable damage arising from breach addition payment accrued prior such termination expiration shall become payable upon effective date such termination expiration such earlier time otherwise provided hereunder font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article font font size style font size font weight bold dispute resolution font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold referral executive officer font font size style font size event dispute either party refer matter party executive officer attempted resolution font font size style font size executive officer presence their legal advisor font font size style font size including patent counsel dispute involves patent controversy font font size style font size shall attempt good faith resolve dispute through negotiation executive officer unable resolve dispute referred them within business such other period agreed party writing after such referral dispute involve patent controversy subject other provision this agreement applicable ancillary agreement font font size style font size such dispute shall resolved provided below this article font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold arbitration font font size style font size executive unable resolve dispute referred them pursuant section within business after such referral then other than dispute subject expert proxy resolution under section either geron janssen after attempting resolve dispute through mediation provided section below shall refer dispute binding arbitration pursuant section only dispute involve patent controversy font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold mediation font font size style font size party shall first attempt good faith resolve dispute confidential mediation accordance with then current mediation procedure international institute conflict prevention resolution mediation procedure cpradr before initiating arbitration mediation procedure shall control except where conflict with these provision which case these provision control mediator shall chosen pursuant mediation procedure mediation shall held francisco california either party initiate mediation written notice other party existence dispute party agree select mediator within notice mediation will begin promptly after selection mediation will continue until mediator either party declares writing sooner than after conclusion full substantive mediation conference attended behalf each party senior business person with authority resolve dispute that dispute resolved mediation event however shall mediation continue more than from initial notice party initiate meditation unless party agree writing extend that period period limitation that would otherwise expire between initiation mediation conclusion shall extended until after conclusion mediation discussion between party attempting resolve dispute under section this section will admissible arbitration dispute font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold arbitration font font size style font size party fail reach resolution pursuant mediation party desire pursue resolution dispute other than patent controversy then dispute shall submitted either party resolution arbitration pursuant then current administered arbitration rule rule cpradr except where they conflict with these provision which case these provision control font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size arbitration will held chicago illinois aspect arbitration shall treated confidential font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size arbitrator will chosen from panel distinguished neutral unless candidate such panel approved both party each arbitrator shall lawyer with least year experience with firm corporate department over lawyer judge court general jurisdiction extent that dispute requires special expertise party will inform prior beginning selection process font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size arbitration tribunal shall consist three arbitrator whom each party shall designate accordance with screened appointment procedure provided rule chair will chosen accordance with rule font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size however aggregate award sought party than million equitable relief sought single arbitrator shall chosen accordance with rule font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size candidate arbitrator position interviewed representative party advance their selection provided that party represented font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size party agree select arbitrator within initiation arbitration hearing will concluded within month after selection arbitrator award will rendered within conclusion hearing post hearing briefing which briefing will completed both side within after conclusion hearing event party agree upon schedule then arbitrator shall schedule following time limit forth above closely practical font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size party shall have right conduct enforce hearing discovery accordance with then current federal rule civil procedure unless otherwise agreed party writing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size hearing will concluded hearing multiple hearing will scheduled consecutively greatest extent possible transcript testimony adduced hearing shall made shall made available each party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size discovery conducted pursuant arbitration proceeding will subject then current federal rule civil procedure unless otherwise agreed party writing font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size arbitrator shall decide merit dispute accordance with governing this agreement without application principle conflict that would result reference different arbitrator apply principle such amiable compositeur natural justice equity font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size arbitrator expressly empowered decide dispositive motion advance hearing shall endeavor decide such motion would united state district court judge sitting jurisdiction whose substantive governs font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size arbitrator shall render written opinion stating reason upon which award based party consent jurisdiction united state district court district which arbitration held enforcement these provision entry judgment award rendered hereunder should such court reason lack jurisdiction court with jurisdiction same fashion font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size each party right seek from appropriate court provisional remedy such attachment preliminary injunction replevin avoid irreparable harm maintain status preserve subject matter dispute rule rule apply this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size each party hereto waif right trial jury issue underlying dispute within scope this section with exception relief mandated statute claim punitive exemplary multiplied indirect consequential damage attorney font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold interim provisional relief font font size style font size nothing this agreement including section shall preclude either party from seeking interim provisional relief court competent jurisdiction including temporary restraining order preliminary injunction other interim equitable relief concerning dispute with other party either prior during dispute resolution procedure forth article protect interest such party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold consent jurisdiction font font size style font size each party purpose enforcing award under section seeking interim provisional relief contemplated section with respect disputed breach this agreement agrees raise objection time laying maintaining venue action suit proceeding such purpose such court irrevocably waif claim that such action suit other proceeding been brought inconvenient forum further irrevocably waif right object with respect such action suit other proceeding that such court have jurisdiction over such party each party further agrees that service process summons notice document registered mail such party notice address provided this agreement shall effective service process action suit proceeding court with respect matter which submitted jurisdiction this section font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold patent controversy font font size style font size notwithstanding anything this agreement contrary patent controversy shall subject adjudication accordance with applicable country jurisdiction which relevant patent right pending font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size been issued party agree that venue such adjudication involving patent right pending issued united state shall federal district court appellate body necessary sitting york patent right pending issued other country competent court having jurisdiction over subject patent controversy sitting capital such country there such competent court capital location reasonably proximate capital each party irrevocably submits jurisdiction such court each party agrees raise objection time laying maintaining venue action suit proceeding such purpose such court irrevocably waif claim that such action suit other proceeding been brought inconvenient forum including forum conveniens argument further irrevocably waif right object with respect such action suit other proceeding that such court have jurisdiction over such party font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold claim against employee font font size style font size each party undertakes make claim bring proceeding connection with this agreement subject matter against director officer employee agent other party apart from claim based fraud willful misconduct this undertaking intended give protection individual prejudice right which party might have claim against another party font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article font font size style font size font weight bold miscellaneous font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold assignment successor font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size term provision hereof shall inure benefit binding upon party their respective successor permitted assigns except expressly permitted this agreement neither party without prior written consent other party assign otherwise transfer this agreement notwithstanding foregoing either party without such consent assign this agreement entirety affiliate subject clarity section event assignment geron certain circumstance provided that except forth clause below such assignment affiliate shall terminate automatically such time such affiliate cease wholly owned directly indirectly geron janssen parent case unless such affiliate owns more than fifty percent voting equity geron janssen substantially asset geron affiliate janssen affiliate case relating licensed product each geron janssen without prior written consent other assign right under this agreement whether contract operation third party that acquires substantially business asset such party whether merger reorganization acquisition sale otherwise relating licensed product subject section assignment this agreement shall valid effective unless until assignee agrees writing bound term condition this agreement ancillary agreement surviving such assignment assignment this agreement accordance with this section shall null void font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size intellectual property third party successor interest assignee purchaser either party virtue transaction after effective date such third party applicable affiliate before such transaction acquiror owned controlled such acquiror immediately prior consummation such transaction other font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size than result license from acquired party provided that such acquiror intellectual property used applied development program after such consummation shall excluded from geron product patent right geron development program patent right janssen development program patent right geron product know geron development program know janssen development program know applicable font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold right diminished font font size style font size subject term condition hereof right party shall diminished obligation party increased during term result permitted assignment other party third party hereunder including result change control other party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold choice font font size style font size font font size style font size this agreement interpretation construction performance right granted obligation arising hereunder shall governed construed accordance with state york united state america exclusive conflict rule notwithstanding anything contrary herein interpretation construction patent right shall governed accordance with jurisdiction which such patent right were filed granted case font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold notice font font size style font size notice given under this agreement either party other party shall english language writing which shall exclude mail shall refer specifically this agreement shall delivered personally sent nationally recognized overnight courier sent facsimile sent registered certified mail postage prepaid return receipt requested following respective address such other address specified notice from time time relevant party font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign style padding width style margin text indent font size face time roman style font size geron font font size style font size font width valign style padding width style margin font size face time roman style font size geron corporation font style margin font size face time roman style font size commonwealth drive font style margin font size face time roman style font size menlo park california font style margin font size face time roman style font size attention president font style margin font size face time roman style font size facsimile font width valign style padding width style margin text indent font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size with copy font width valign style padding width style margin font size face time roman style font size cooley font style margin font size face time roman style font size hanover street font style margin font size face time roman style font size palo alto font style margin font size face time roman style font size attn font style margin font size face time roman style font size facsimile font width valign style padding width style margin text indent font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size janssen font font size style font size font width valign style padding width style margin font size face time roman style font size janssen biotech font style margin font size face time roman style font size ridgeview drive font style margin font size face time roman style font size horsham pennsylvania font style margin font size face time roman style font size attention nbsp president font style margin font size face time roman style font size facsimile font width valign style padding width style margin text indent font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size with copy font width valign style padding width style margin font size face time roman style font size office general counsel font style margin font size face time roman style font size johnson johnson font style margin font size face time roman style font size johnson johnson plaza font style margin font size face time roman style font size brunswick font style margin font size face time roman style font size attention nbsp general counsel pharmaceutical font style margin font size face time roman style font size facsimile font font size style font size font table style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size without prejudice earlier time which notice actually given received properly addressed notice shall event deemed have been received when delivered personally delivered during recipient normal business hour business after dispatch sent nationally recognized overnight courier proof delivery obtained business following electronic confirmation receipt sent facsimile third business following date mailing sent mail font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size where proceeding have been commenced arbitration hereunder court competent jurisdiction document issued course those proceeding will served accordance with procedural rule governing service document those proceeding font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size this section shall apply notice required given party other under this agreement other communication between party that routine nature such communication between alliance manager party member joint committee regarding their ongoing activity performed ordinary course their work under this agreement made mail notice communication between party hereunder shall english language font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold severability font font size style font size font font size style font size whole provision this agreement held invalid illegal unenforceable jurisdiction reason then fullest extent permitted applicable case illegality invalidity unenforceability whole this agreement shall terminate relation jurisdiction question case illegality invalidity unenforceability provision this agreement that part shall severed from this agreement jurisdiction question shall remain full force effect other jurisdiction other provision hereof shall remain full force effect relevant jurisdiction shall liberally construed order carry intent party nearly possible party agree reasonable effort negotiate provision replacement provision held invalid illegal unenforceable that consistent with applicable relevant jurisdiction accomplishes nearly possible original intention party with respect thereto font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold integration font font size style font size this agreement constitutes entire agreement between party hereto with respect subject matter this agreement supersedes previous agreement executed before execution date hereof whether written oral notwithstanding authority granted joint steering committee joint development committee joint marketing committee under this agreement this agreement amended only writing signed duly authorized representative each geron janssen event conflict between term exhibit other appendix this agreement body this agreement body this agreement shall control font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold independent contractor agency font font size style font size neither party shall have responsibility hiring firing compensating other party employee agent employee benefit employee representative party including affiliate joint committee member sale representative shall have authority bind obligate other party this agreement manner whatsoever font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size create impose contractual other liability other party purpose notwithstanding other provision this agreement contrary nothing font font size style font size this agreement shall construed establishing partnership joint venture relationship between party font font size style font size font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold performance affiliate font font size style font size except expressly prohibited hereunder either party more affiliate perform obligation duty hereunder provided that such party shall remain liable hereunder timely payment performance obligation duty hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold force majeure font font size style font size party shall deemed have defaulted under breached this agreement failure delay fulfilling performing term this agreement except payment amount under this agreement when such failure delay caused result from cause beyond reasonable control performing party including fire flood embargo shortage epidemic quarantine whether declared terrorism insurrection riot civil commotion omission delay acting governmental authority performing party shall notify other party such force majeure within five business after such occurrence giving written notice other party stating nature event anticipated duration action being taken avoid minimize effect suspension performance shall greater scope longer duration than necessary performing party shall throughout period suspension performance commercially reasonable effort remedy inability perform provided however that event suspension performance continues ninety after date such force majeure commences party shall meet discus good faith proceed order accomplish objective this agreement provided further however that suspension performance continues more than year after date such force majeure commences either janssen event that geron performing party geron event that janssen performing party shall have right terminate this agreement upon notice performing party purpose this agreement force majeure shall include failure commit sufficient resource financial otherwise activity conducted pursuant this agreement general market economic condition font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold construction font font size style font size heading used herein reference convenience only will enter into interpretation this agreement reference section include subsection which part related section except otherwise explicitly specified contrary reference section article exhibit mean section article exhibit this agreement subsection thereof unless another agreement specified reference particular statute regulation include rule regulation thereunder successor statute rule regulation then effect each case including then current amendment thereto word singular plural form include plural singular form respectively capitalized term expressly defined herein that corollary such pluralization change tense capitalized term defined herein shall have corresponding meaning unless context requires different interpretation word inclusive meaning that typically associated with phrase term including include such example used this agreement mean including generality description preceding such term will deemed followed without limitation whenever this agreement refers number such number will refer calendar unless business specified viii herein hereunder hereof like shall understood refer font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size this agreement entirety particular provision section which they appear reference particular party include such party successor assigns extent prohibited this agreement word used this agreement will construed such gender number circumstance require reference person includes individual body corporate wherever incorporated unincorporated association partnership word comprise comprising contain containing include including used their open limiting form shall understood include word without limitation even expressly stated xiii reference dollar shall mean united state dollar font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold clearance termination upon denial font font size style font size either each party reasonably determines that filing required applicable consummate transaction contemplated hereunder each party shall within business execution date such later time agreed writing party file with united state federal trade commission antitrust division united state department justice with equivalent governmental authority other country case filing under with respect transaction contemplated hereunder each party shall reasonable effort cause done thing necessary proper advisable promptly practicable take action necessary make filing required party their respective affiliate under party shall cooperate with another extent reasonably necessary preparation such filing each party shall responsible pocket cost expense including filing associated with filing provided however that janssen shall solely responsible other than penalty that incurred result action omission part geron required paid governmental authority connection with making such filing hereunder party make filing hereunder then this agreement shall terminate election either party immediately upon notice other party federal trade commission department justice equivalent authority european union seek preliminary injunction under antitrust against party enjoin transaction contemplated this agreement election either party immediately upon notice other party event that united state federal trade commission united state department justice equivalent governmental authority european union obtains preliminary injunction under antitrust against party enjoin transaction contemplated this agreement election either party immediately upon notice other party event that date clearance shall have occurred prior hundred eighty after effective date filing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold execution counterpart facsimile signature font font size style font size this agreement executed counterpart each which counterpart when executed delivered shall deemed original which counterpart taken together shall constitute same instrument even both party have executed same counterpart facsimile portable document format execution delivery this agreement party constitutes legal valid binding execution delivery this agreement such party font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font style italic remainder this page intentionally blank font align center style margin text align center font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size witness whereof each party caused this agreement duly executed authorized representative respective date written herein below font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold geron corporation font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width colspan valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size john scarlett font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style border none padding width style margin font size face time roman style font size name font width valign style border none border solid windowtext padding width style margin font size face time roman style font size john scarlett font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size title font width valign style padding width style margin font size face time roman style font size president font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size date font width valign style padding width style margin font size face time roman style font size november font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold janssen biotech font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width colspan valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size scott white font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style border none padding width style margin font size face time roman style font size name font width valign style border none border solid windowtext padding width style margin font size face time roman style font size scott white font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size title font width valign style padding width style margin font size face time roman style font size vice president oncology font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size date font width valign style padding width style margin font size face time roman style font size november font table style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold attachment font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold structure font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold structure font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold existing license third party font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold existing license from third party font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold additional existing third party agreement font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold initial global development plan including initial font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold solely owned geron product patent right font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold jointly owned geron product patent right font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold licensed geron product patent right font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold intentionally left blank font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold intentionally left blank font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold compliance with anti corruption font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold press release font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold johnson nbsp johnson universal calendar font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold form nbsp invoice font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold trap trapeze protocol within geron assay know font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold janssen policy employment young person font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold current manufacturing contract font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold promotion agreement font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold operational plan ongoing clinical trial regulatory transition font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold geron assay patent right font width valign style padding width style margin font size face time roman style font size font weight bold exhibit nbsp font font size style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold ongoing study font table style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size font weight bold nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold structure font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold structure font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold existing license third party font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font align center style margin text align center font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold existing license from third party font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size page nbsp omitted font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font align center style margin text align center font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold additional existing third party agreement font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold none font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold initial global development plan font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size page nbsp omitted font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold initial study work plan font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold proposed clinical trial timing font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold proposed budget value million rounded font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold solely owned geron product patent right font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size page nbsp omitted font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold jointly owned geron product patent right font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size page nbsp omitted font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold licensed geron product patent right font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size none font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold intentionally left blank font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold intentionally left blank font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold compliance with anti corruption font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size notwithstanding anything contrary this agreement each party hereby agrees that font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size shall perform action performing collaboration activity other activity under agreement that prohibited anti corruption applicable both party this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size shall directly indirectly make payment offer transfer anything value agree promise make payment offer transfer anything value government official regulatory authority employee political party candidate political office other third party related transaction with purpose influencing decision related janssen business geron business manner that would violate anti corruption font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size except provided nbsp below shall retain government official performance this agreement unless been approved other party necessary competent authority authority such government official employer font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size party acknowledge that there instance where government official knowledge expertise considered unique service required provided that government official reasonably provided other government official provider these case party retain government official connection with this agreement without prior consent other party extent that font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size service provided such government official permitted relevant regulation code practice applicable government official font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size prior written approval government official employer been obtained font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size prior approval from member senior management team party wishing make such engagement been obtained which confirms legitimate basis engagement government official which also establishes that engagement service legitimately required intended influence government official capacity government official font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size purpose this exhibit government official mean font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size officer employee government department agency instrumentality government font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size person acting official capacity behalf government department agency instrumentality government font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size officer employee state government owned company business font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size officer employee government international organization such world bank united nation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size officer employee political party person acting official capacity behalf political party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size candidate political office font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size healthcare professional when they official capacity behalf government including font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size hcps also hold official decision making role font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size hcps have responsibility performing regulatory inspection government authorization license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size hcps temporarily permanently assigned work local regional national government agency supranational body font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size shall style font weight bold include hcps considered government official only because they employed receive funding professional service other remuneration from government owned funded hospital clinic university other healthcare provider organization where they font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size solely their capacity healthcare professional prescribing administering supplying medicine influencing same conducting clinical trial scientific research font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size member advisory board with decision making capacity provide technical scientific medical advice government official relation healthcare font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size both section have official role government with capacity take decision that affect business relevant party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size shall disclose make available designated individual other party training practice material anti corruption rule nbsp interaction with healthcare professional requested each party will consider good faith comment made other party regard such training practice material font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size shall maintain interaction with government official shall provide such extract such relevant performance this agreement other party request font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size viii font font size style font size font font size style font size shall certify other party request more frequently than annually format agreed that font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size training training material anti corruption well applicable rule nbsp interaction with health care professional have been provided person employed perform work connection with this agreement interact with government official health care professional normal course their responsibility that provided necessary training training material subcontractor used performance this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size best knowledge there have been violation anti corruption person employed subcontractor used performance this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size personnel designated personnel mutual agreement janssen geron have changed except noted schedule attached certification provided font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size made change subcontractor perform service under this agreement except nbsp permitted under this agreement nbsp noted schedule attached certification provided font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size maintained true accurate record necessary demonstrate compliance with requirement this exhibit font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size each party shall maintain provide other auditor other representative with access record financial otherwise supporting documentation related subject matter this agreement requested other party order document verify compliance with provision this exhibit font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size party materially fails comply with provision this exhibit such failure shall deemed material breach this agreement upon such failure breaching party shall have right terminate this agreement with immediate effect upon written notice breaching party without breaching party having financial liability other liability nature whatsoever resulting from such termination font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold size width noshade color black align left font style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold press release font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold geron announces global strategic collaboration with janssen font align center style margin text align center font size face time roman style font size font weight bold develop commercialize imetelstat font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font style italic conference call scheduled friday morning november nbsp font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold menlo park calif november nbsp font font size style font size geron corporation nasdaq gern announced today that company entered into exclusive worldwide license collaboration agreement with janssen biotech nbsp janssen develop commercialize imetelstat geron telomerase inhibitor product candidate oncology including hematologic malignancy other human therapeutic imetelstat modified oligonucleotide that currently early phase clinical development myelofibrosis have activity other hematologic myeloid malignancy such myelodysplastic syndrome acute myelogenous leukemia under term agreement geron will receive initial payment million after applicable waiting period under hart scott rodino eligible receive additional payment potential total million achievement development regulatory commercial milestone well royalty worldwide sale certain regulatory development manufacturing promotional activity will managed through joint governance structure with janssen responsible operational implementation these activity sale will booked janssen font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size leveraging janssen ability fully integrate strategically align global oncology development commercialization expect this collaboration expand development imetelstat across range hematologic malignancy potentially increase speed with which imetelstat made available patient with these serious life threatening disease said nbsp john scarlett geron president chief executive officer font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size development imetelstat will proceed under mutually agreed clinical development plan which expected include phase study initial study additional registration study exploratory phase potential follow phase study geron expects initial phase study initiated followed later phase study development cost these study will shared between company basis font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size additional detail regarding collaboration found geron form nbsp filed today with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold conference call information font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size geron management will host conference call friday morning november nbsp nbsp discus global strategic collaboration with janssen participant access conference call live telephone dialing international passcode live audio only webcast also available http edge medium server dgquhmsw audio webcast conference call will available replay approximately hour following live broadcast through december nbsp font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold about imetelstat font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size imetelstat potent specific inhibitor telomerase that administered intravenous infusion this first class compound discovered geron specially designed modified short oligonucleotide which target bind directly with high affinity active site telomerase preliminary data suggest disease modifying activity imetelstat affecting malignant clone associated with hematologic malignancy imetelstat been approved marketing regulatory authority font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold size width noshade color black align left font style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin font size face time roman style font size font weight bold size width noshade color align left font geron corporation folio file disk _zdh user dnichol clear style page break before always style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold about geron font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size geron clinical stage biopharmaceutical company developing first class telomerase inhibitor imetelstat hematologic myeloid malignancy more information about geron visit geron font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold forward looking statement font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size except historical information contained herein this press release contains forward looking statement made pursuant safe harbor provision private security litigation reform investor cautioned that statement this press release regarding nbsp anticipated effectiveness collaboration agreement that geron will receive million payment potential receipt development regulatory sale milestone well royalty potential future sale imetelstat commercialized under collaboration with janssen nbsp timing conduct planned potential clinical trial imetelstat conducted under collaboration with janssen other potential activity nbsp other statement that historical fact constitute forward looking statement these statement involve risk uncertainty that cause actual result differ materially from those such forward looking statement these risk uncertainty include without limitation risk uncertainty related nbsp ability party satisfy condition effectiveness collaboration agreement including expiration termination waiting period under hart scott rodino nbsp uncertain time consuming product development regulatory process including whether party will succeed overcoming clinical safety efficacy technical scientific manufacturing regulatory challenge development commercialization imetelstat nbsp fact that geron receive milestone royalty other payment from janssen because janssen terminate collaboration agreement reason nbsp ability geron janssen protect maintain intellectual property right imetelstat nbsp geron dependence janssen including risk that janssen were breach terminate collaboration agreement otherwise fail successfully develop commercialize imetelstat timely manner geron would obtain anticipated financial other benefit collaboration agreement clinical development commercialization imetelstat could delayed terminated additional detailed information factor that could cause actual result differ materially from those forward looking statement contained geron periodic report filed with security exchange commission including exhibit nbsp current report form nbsp filed november nbsp undue reliance should placed forward looking statement which speak only date they made fact assumption underlying forward looking statement change except required geron disclaims obligation update these forward looking statement reflect future information event circumstance font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold contact font style margin font size face time roman style font size kevin font style margin font size face time roman style font size investor medium relation font style margin font size face time roman style font size font style margin font size face time roman style font size investor geron font style margin font size face time roman style font size medium geron font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin font size face time roman style font size font weight bold size width noshade color align left font geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold johnson nbsp johnson universal calendar font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size page nbsp omitted font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol style font family time roman align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold form nbsp invoice font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold from geron font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold invoice printed official geron letterhead with date payee janssen designated affiliate payor nbsp number inserted font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size date font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size invoice font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size geron font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size janssen nbsp number font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size term font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size amount payment font font size style font size font font size style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size payment according collaboration license agreement between geron corporation janssen biotech nbsp executed november nbsp font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold bill font style margin text indent font size face time roman style font size janssen biotech nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold wire instruction remittance font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold size width noshade color black align left font style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin font size face time roman style font size font weight bold size width noshade color align left font geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold trap trapeze protocol within geron assay know font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size page nbsp omitted font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold size width noshade color black align left font style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin font size face time roman style font size font weight bold size width noshade color align left font geron corporation folio file disk _zdh user dnichol clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold janssen policy employment young person font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold size width noshade color black align left font style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin font size face time roman style font size font weight bold size width noshade color align left font geron corporation folio file disk _zdh user dnichol clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold current manufacturing contract font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size page nbsp omitted font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold size width noshade color black align left font style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin font size face time roman style font size font weight bold size width noshade color align left font geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size font weight bold nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold promotion agreement font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size page nbsp omitted font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold size width noshade color black align left font style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin font size face time roman style font size font weight bold size width noshade color align left font geron corporation folio file disk _zdh user dnichol clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold operational plan ongoing clinical trial regulatory transition font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size page nbsp omitted font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold size width noshade color black align left font style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin font size face time roman style font size font weight bold size width noshade color align left font geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size font weight bold nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold geron assay patent right font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size page nbsp omitted font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold size width noshade color black align left font style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin font size face time roman style font size font weight bold size width noshade color align left font geron corporation folio file disk _zdh user dnichol clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold ongoing study font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold clinical study initiated assumed geron font align center style margin text align center font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold protocol font font size style font size font weight bold font font size style font size font weight bold number font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold protocol nbsp title font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold phase font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold patient nbsp population font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold study nbsp status font width bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size phase sequential cohort dose escalation trial determine safety tolerability maximum tolerated dose weekly administration patient with refractory relapsed chronic lymphoproliferative disease font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size refractory relapsed chronic lymphoproliferative disease font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width style padding width style margin font size face time roman style font size font width style padding width style margin font size face time roman style font size nbsp font width style padding width style margin font size face time roman style font size phase sequential cohort dose escalation trial determine safety tolerability maximum tolerated dose optimal infusion duration weekly administration patient with refractory relapsed solid tumor malignancy font width style padding width style margin font size face time roman style font size nbsp font width style padding width align center style margin text align center font size face time roman style font size font width style padding width style margin font size face time roman style font size nbsp font width style padding width style margin font size face time roman style font size refractory relapsed solid tumor malignancy font width style padding width style margin font size face time roman style font size nbsp font width style padding width align center style margin text align center font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size phase sequential cohort dose escalation trial determine safety tolerability maximum tolerated dose weekly administration patient with refractory relapsed multiple myeloma font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size refractory relapsed multiple myeloma font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width style padding width style margin font size face time roman style font size font width style padding width style margin font size face time roman style font size nbsp font width style padding width style margin font size face time roman style font size phase sequential cohort dose escalation trial determine safety tolerability maximum tolerated dose weekly administration combination with paclitaxel carboplatin patient with advanced metastatic small cell lung cancer font width style padding width style margin font size face time roman style font size nbsp font width style padding width align center style margin text align center font size face time roman style font size font width style padding width style margin font size face time roman style font size nbsp font width style padding width style margin font size face time roman style font size advanced metastatic small cell lung cancer font width style padding width style margin font size face time roman style font size nbsp font width style padding width align center style margin text align center font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size phase study combination with paclitaxel bevacizumab patient with locally recurrent metastatic breast cancer font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size locally recurrent metastatic breast cancer font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width style padding width style margin font size face time roman style font size font width style padding width style margin font size face time roman style font size nbsp font width style padding width style margin font size face time roman style font size phase study combination with bortezomib dexamethasone patient with relapsed refractory multiple myeloma font width style padding width style margin font size face time roman style font size nbsp font width style padding width align center style margin text align center font size face time roman style font size font width style padding width style margin font size face time roman style font size nbsp font width style padding width style margin font size face time roman style font size relapsed refractory multiple myeloma font width style padding width style margin font size face time roman style font size nbsp font width style padding width align center style margin text align center font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size randomized phase study imetelstat maintenance therapy after initial induction chemotherapy advanced small cell lung cancer nsclc font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size advanced nsclc font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font table align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin font size face time roman style font size font weight bold size width noshade color align left font geron corporation folio file disk _zdh user dnichol clear style page break before always align center style margin text align center font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size phase trial determine effect imetelstat patient with previously treated multiple myeloma font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size multiple myeloma font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width style padding width style margin font size face time roman style font size font width style padding width style margin font size face time roman style font size nbsp font width style padding width style margin font size face time roman style font size randomized phase study imetelstat combination with paclitaxel with without bevacizumab patient with locally advanced metastatic breast cancer font width style padding width style margin font size face time roman style font size nbsp font width style padding width align center style margin text align center font size face time roman style font size font width style padding width style margin font size face time roman style font size nbsp font width style padding width style margin font size face time roman style font size recurrent metastatic breast cancer font width style padding width style margin font size face time roman style font size nbsp font width style padding width align center style margin text align center font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size phase trial evaluate activity imetelstat patient with essential thrombocythemia require cytoreduction have failed intolerant previous therapy refuse standard therapy font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size essential thrombocythemia polycythemia font width bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width style padding width style margin font size face time roman style font size font width style padding width style margin font size face time roman style font size nbsp font width style padding width style margin font size face time roman style font size pilot open label study efficacy safety imetelstat myelofibrosis other myeloid malignancy font width style padding width style margin font size face time roman style font size nbsp font width style padding width align center style margin text align center font size face time roman style font size font width style padding width style margin font size face time roman style font size nbsp font width style padding width style margin font size face time roman style font size myelofibrosis other myeloid malignancy font width style padding width style margin font size face time roman style font size nbsp font width style padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size font weight bold certain confidential information contained this document marked bracket filed with security exchange commission pursuant rule nbsp security amended font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name _pb_ font style margin size width noshade color align left geron corporation folio file disk _zdh user dnichol tocexistflag body html text document